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Abstract 
This integrative review compared anesthetic usage and its impact on the cancer patient. 
Immunosuppression from anesthesia can have major impacts on the human body’s 
immune system and lead to a decrease in overall patient survival and an increase in 
cancer recurrence rates. A search was completed using electronic databases including 
CINAHL, PubMed Health, and Medline Plus. The studies were located with keyword 
searches and inclusion and exclusion criteria was used to locate a final 8 studies for the 
review. A critical appraisal was completed using Polit and Beck’s critical analysis tables, 
displaying key characteristics of the studies chosen. Outcomes reviewed included overall 
survival rates, cancer recurrence rates, time to recurrence and biomarker identification. 
The findings presented more beneficial outcomes with regional anesthesia, but larger 
prospective randomized studies are needed to validate these findings. Regional anesthesia 
has shown to increase time to recurrence, decrease recurrence rates, and limit the increase 
in immune biomarkers. However, regional anesthesia does not fully support an increase 
in overall survival rates. More research and randomized control trials are warranted on 
this topic. Overall, this integrative review has supported the use of regional anesthesia for 
more positive outcomes in the oncological surgical patient over general anesthesia. 
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Anesthetics and Cancer Recurrence in the Surgical Oncological Patient:  
An Integrative Review of the Literature 
Background/Statement of the Problem 
 An estimated 234 million surgeries are undertaken every year world-wide (Weiser 
et al., 2008) and of this 234 million, an estimated 20% are related to cancer (Hoekstra et 
al., 2015). Cancer is a global epidemic, being the leading and most common cause of 
death worldwide (Torre et al., 2015). This is amplified by the increasing age and growth 
of our population. The rise in cancer cases is strongly associated with an increase in 
sedentary lifestyles, poor diets and smoking (Torre et al., 2015).  
 The word ‘cancer’ constitutes immediate negative connotations for valid reasons. 
Each year in the United States over 1 million cases of individuals diagnosed with cancer 
are recorded (Le-Wendling, Nin, & Capdevila, 2015). In 2012, 14 million new cancer 
cases were documented, and 8.2 million cancer deaths occurred globally (Torre et al., 
2015). An additional 1.6 million cases were diagnosed in 2016 and of these cases an 
estimated 33% will die from the developed disease (Bharati, Chowdhury, Bergese, & 
Ghosh, 2016). These staggering figures provide us with a clear picture of why cancer 
remains one the leading causes of mortality in the world.  
Increased risk factors for cancer development  
 Threatened populations. Certain populations are at greater risk for cancer 
development, such as men and the elderly. The incidence in North America of cancer in 
men versus (vs.) women was 344:295 out of 100,000 (Torre et al., 2015). The cancer 
mortality rate per 100,000 of men vs. women was 123:91 (Torre et al., 2015). The 
underlying reasons for this disproportion relate closely to the differences in lifestyle of 
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men and women. Men show a higher tendency to participate in modifiable risk factors 
like alcohol consumption, cigarette smoking and physical inactivity (Torre et al., 2015).  
 Elderly. For the elderly population, the incidence is focused at the cellular level. 
The physiologic changes associated with aging promote cellular change from the buildup 
of oxidative free radicals and effects on the mitochondrial DNA. With time, the 
accumulations of mitochondrial DNA mutations lead to an increase in reactive oxidative 
species. Buildup of free radicals become harmful in large amounts to the body. In 
addition to the physiologic changes, our environment is also to blame for mutations 
(Tosato, Zamboni, Ferrini, & Cesari, 2007). Environmental toxins play a role in 
mitochondrial DNA damage, furthering mutations with time.  These non-modifiable 
factors contribute to homeostatic changes in the body and place our elderly population at 
greatest risk for cell mutation and cancer development. 
 Patients undergoing surgical interventions. In many cases, surgical 
interventions are considered the benchmark treatment for solid malignant tumors. The 
role of the stress response during and after surgery can have both positive and negative 
effects on the body. The primary function of the stress response is to promote healing. 
Occasionally, the stress response can also be the catalyst for micro-metastasis and 
promote cancer spread (Gottschalk, Sharma, Ford, Durieux, & Tiouririne, 2010). Stress 
can be perceived as a hazard to the body’s natural homeostasis with a known link existing 
between inflammation, immunity and neoplastic growth. The surgical stress response 
suppresses the immune system resulting in an acceleration of malignant growth and 
metastases (Kurosawa & Kato, 2008). Surgical interventions have shown to trigger 
immune suppressive responses and support new tumor growth or new locations for 
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metastases (Bharati et al., 2016).  
 Anesthesia impact. Immunomodulation from surgical stress represents one of the 
surgically related risks for cancer expansion. An integral piece of the surgical care plan 
involves the use of anesthesia. The body's response to anesthesia can hinder the immune 
system and promote metastatic spread (Exadaktylos, Buggy, Moriarty, Mascha, & 
Sessler, 2006). 
  Each case and each patient determine the type of anesthetic plan that will be 
delivered for the surgical procedure to ensure adequate patient safety. The choice of 
anesthetic provided will have varied effects on cell-mediated immunity. General 
anesthesia, involving the use of volatile anesthetic gases, has been documented to 
influence cancer recurrence. General anesthesia does this by inducing apoptosis of 
immune cells, causing stress to the body and tumor metastasis. General anesthesia has 
shown a direct suppression of cellular immunity, specifically to the body’s innate 
immune cells (neutrophils, macrophages, dendritic cells, T-lymphocytes, and natural 
killer cells). The innate immune system becomes activated when barriers are 
compromised due to injury. Initial responders, natural killer cells (NKC), magnify the 
immune response to provide protection against viral infections and oncologic disease 
(Stollings et al., 2016). Volatile gases directly suppress this mechanism, leaving the body 
exposed and unprotected, not only during surgery but several days following (Stollings et 
al., 2016). A combination of direct suppression from general anesthesia, 
immunosuppression, and neoangiogenesis from surgical stress, have been identified as 
predisposing the host to tumor metastasis. 
 The perioperative phase is a vulnerable period of immune compromise for 
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patients as a result of the surgical stress response (Bajwa, Jit, Anandl, & Kaur, 2015). The 
added anesthetic influence during this time, and postoperatively will be reviewed to 
support or reject its use with the cancer population.  
 The purpose of this project was to explore the literature from 2006 - present time 
to identify the best anesthetic practice for the oncological surgical patient. Current 
literature was compared to past studies to examine the evolution and advances in the 
knowledge of anesthesia techniques and their effect on immunomodulation and cancer 
recurrence. By reviewing both past and present literature, a better understanding of 
existing relationships between anesthetics and the effects on cancer recurrence and 
metastasis in the surgical patient was identified. An integrative review was conducted 
with an aim to identify the impact of anesthetics on cancer recurrence and metastasis in 
the surgical oncological patient. 
Next, a review of literature relevant to anesthetic use and cancer recurrence in the 
surgical oncological patient is presented. 
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Literature Review 
 The literature presented here will provide general background on cellular changes 
associated with cancer, effects on the immune system in relation to cancer, surgical stress 
response on immunomodulation and anesthetic impact on the compromised patients’ 
immune system. Immunomodulation from anesthesia and the impact on recurrence and 
metastasis of the cancer cells after anesthetic delivery will also be explored. Data were 
searched from 2006-present for this review. 
Searched databases include CINAHL, Medline Plus, and PubMed Health.  
 Keywords: anesthesia, cancer, recurrence, anesthesia, neuroendocrine stress, 
 surgery, immune system, immunosuppression, cancer cells, natural killer cells, 
 regional anesthetics, general anesthesia, volatile anesthetics, opioid impact 
 The primary aim of this project was to determine the effects of anesthetics on the 
immune system and their impact on cancer recurrence and metastasis in the oncological 
surgical patient. This project also intended to further identify the influences of anesthetics 
on the cellular immune system, and the stress impact on the human body leading to 
cancer recurrence. Topics for review included: the effects of stress on immune function, 
cancer and the surgical stress response, natural killer cell response to cancer invasion, and 
anesthesia’s impact on immunomodulation. These topics are relevant and valuable to the 
discussion of anesthetic impact on cancer recurrence. Immunomodulation begins with 
stress and unfolds as additional insults are made to the immune system by certain 
anesthetics used during the surgical phase of treatment. One must understand the initial 
physiologic effects of stress to understand why the addition of anesthesia places the 
vulnerable patient at an even greater risk.  
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Effects of stress on immune function 
Tosato et al. (2007) identified the leukocyte as the main modulator of innate 
immunity, inflammation and stress. As we age, chronic stress becomes more common on 
the body and an influx of leukocyte activity eventually leads to chronic inflammation. 
With constant activation, leukocytes enter a phase of exhaustion resulting in T-cell 
immunity shrinkage and progression to pathogen susceptibility (Tosato et al., 2007). Two 
of the regulatory proteins activated by the immune system are described as: 
proinflammatory cytokines and anti-inflammatory cytokines. Proinflammatory cytokines 
include tumor necrosis factor (TNF) and interleukin (IL) 1B, IL-6 and IL-8, while anti-
inflammatory cytokines include IL-10 IL-1RA, TNF binding factors 1 and 2. These 
cytokines will be referenced throughout this review.  
Stress and its effect on the immune system is dependent on the circumstance. The 
body’s natural response to a dangerous situation puts the body into survival mode, or 
‘fight-or-flight’. During this time the body delays immune suppression to optimize 
defense mechanisms when they are needed the most. This short-term, acute stress 
response may play a protective role in the body as stress hormones and neurotransmitters 
prepare the immune system for possible challenges experienced by the brain (Dhabhar, 
2009). By contrast, the body is known to suppress the immune system during prolonged 
bouts of chronic stress. Chronic stress has been shown to dysregulate immune function 
and is thought to play a role in the etiology of many diseases (Dhabhar, 2009). 
Chronic long-term stress can be immunopathological and immunosuppressive. 
Chronic stress can decrease baseline leukocyte numbers, suppress leukocyte function and 
mobilize immunosuppressive mechanisms, like regulatory T-cells (Dhabhar, 2009). This 
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results in a lower efficacy of vaccinations, prolonged wound healing and less resistance 
to infection and cancer. Chronic stress also appears to mobilize inhibitory mechanisms 
and is likely to exacerbate proinflammatory and cytokine responses increasing 
susceptibility to infections and cancer.  
A case-controlled study conducted by Saul, et al. (2012) evaluated the effects of 
chronic stress in SKH1 mice susceptible to ultra violet (UV) induced squamous cell 
carcinoma. Sixteen mice were exposed to UV radiation. Half of the mice exposed were 
left in non-stressed situations (remained in their cages), while the other half of the mice 
were exposed to chronically stressful situations (restrained and removed from normal 
habitat). The results showed that the stressed mice had a shorter median time to first 
tumor, 15 vs. 16.5 (15:16.5) weeks and reached tumor incidence earlier than the non-
stressed group. Further data indicated that the stressed mice had higher numbers of tumor 
infiltrating and suppressor cells (CD4+, CD25+) in circulation than the non-stressed 
mice, which lead to a suppression of antitumor activity. The non-stressed group showed 
30% regression at week 34 with no new tumors, while the stressed group did not 
demonstrate any tumor regression, but a 16% tumor number increase (Saul et al., 2012). 
Saul et al. (2012) concluded that chronic stress increased susceptibility to the UV-
induced carcinoma by suppressing skin immunity. 
Chronic stress also has the ability to alter gene expression. In a study conducted 
by Flores et al. (2017), adult male rat prostate tissue was studied after stress exposure. 
Rats exposed to repeated stress were compared to an unstressed group, and a group that 
was allowed to recover for 14 days following the stressful event. Prostate tissue was 
collected from the rats prior to exposure and then frozen for gene expression analyses by 
 
 
8 
 
PCR array. After exposure, rats were transcardially perfused and identification of 
neuronal activation was completed by brain tissue harvesting. Elevations in the Fos 
expression from the brain tissue staining were noted in the stressed mice. The data 
collected from the PCR arrays identified an increase in genes associated with cellular 
proliferation in the repeatedly stressed rats and the recovery rats (Flores et al., 2017).  
Data further identified both acute stressed and chronically stressed rats 
demonstrated significant metastatic changes in gene expression. The alteration in growth 
factor and apoptotic genes suggest stress is an inducer to pathway changes for prostate 
cancer. Flores et al. (2017) conclude that their findings support the idea that by 
interfering with neuroendocrine mechanisms, stress may have a large impact on cancer 
outcomes.  
Just as we have natural responses to stressful situations with immune activation, 
such as wounds and infection, many non-natural situations like surgery and vaccinations 
also induce a stress response. Stress is a major factor during the diagnosis, treatment, and 
follow-up for most diseases. Surgical interventions are particularly strong creators of 
stress and are known to be immunosuppressive and thus may result in an increased risk of 
neoplastic growth.  
Natural Killer Cells and Cancer. The immune system is the human body’s 
protection from harm, yielding physiologic changes to infections or injuries. Our immune 
system has numerous functions, including: elimination of invading pathogens, 
identification of harmful insults to the body, and fighting mutated cells secondary to 
illness. While there are a myriad of processes and activations that affect the immune 
system, the main fighter cell involved in cancer eradication is the natural killer cell.  
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Natural killer (NK) cells play an important role in cell-mediated immunity. Part of 
the innate immune system, NK cells can identify foreign invaders such as tumor cells or 
viruses through surface markers. Natural killer cells are a type of leukocyte cytotoxic 
tumor cell (Le-Wendling et al., 2016). These cells are unique because they are tumor 
preventers, aiding the body by directly killing tumor cells without initial priming, unlike 
other immune cells. A down regulation of the major histocompatibility complex (MHC), 
or the absence of MHC-I, signals NK cells to attack. The decrease or lack of MHC is 
associated with invasive tumor presence. NK cells are the primary metastatic eradicator 
for the human immune system (Welden, Gates, Mallari, & Garrett, 2009). Under surgical 
stress, the NK cell is suppressed and places the patient at risk for metastasis. 
Platelets and fibrinogen also appear to play a role in metastasis through 
impediment of NK cell potential. Platelets influence metastatic potential due to the 
cellular growth factors and inflammatory mediators contained in their granules. Platelets 
additionally support endothelial adhesion and aid in tumor formation. Their activation 
supports transmigration out of the vasculature and prevents innate immune cells from 
interacting with tumor cells, thereby inhibiting NK cell-to-cell contact for elimination 
(Palumbo et al., 2005).  
Palumbo et al. (2005) examined the role of platelets in tumor cell growth and 
dissemination. Palumbo et al. (2005) examined mice lacking Gαq (a protein needed for 
platelet activation) and Gαq positive (+) mice. Three time cohorts (20 minutes, 5 hours, 
and 24 hours) of 5 mice for Gαq negative (-) and Gαq positive (+) were used. All cohorts 
were intravenously injected with Lewin lung carcinoma (LLC) to examine circulating 
tumor cell fate. The cohorts were killed at 20 minutes, 5 hours and 24 hours after tumor 
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cell injection and distribution of LLC was measured. Twenty minutes post injection, 
tumor cells were noted 50% in the lungs of both groups. A wide distribution of cells 
showed <5% in blood, <10% in liver, and <1% in the spleen of the mice. Time dependent 
tumor elimination of Gαq (-) mice was shown with 10% remaining at 24 hours, and only 
1% of tumor cells after the 24 hours, compared to 15% in the Gαq + mice. Palumbo et al. 
(2005) concluded that their findings suggest a link between platelet activation and 
circulating tumor cell survival.  
Palumbo et al. (2005) also explored NK cell impact on tumor cell. The 
investigators formed a barrier to prevent the NK cells from interacting with malignant 
cells within the pulmonary vasculature. By depleting NK cells in Gαq – mice, using anti-
asialo GM1 polyclonal antibodies, a barrier was created. The process was verified by 
collecting splenic effector cells that demonstrated no NK function after administration. 
The Gαq – and Gαq + groups were once again used, with 5 mice from each group being 
injected with the LLC. Tumor cells, like the previous experiment, were significantly 
lower 24 hours post in the Gαq – mice (p <.03) (Palumbo et al., 2005). Mice pretreated 
with the polyclonal antibodies showed a decrease in tumor cell number in the Gαq – 
mice, and an increase in tumor cell numbers in the lungs of Gαq + mice (Palumbo et al., 
2005). This further supports NK cells’ importance in tumor cell eradication and platelet 
activation in tumor cell survival. Palumbo et al. (2005) demonstrated the platelets 
position in enhancing metastatic potential by impeding tumor cell clearance by the NK 
cells. By controlling platelet activation, NK cell activity could function properly and 
maintain tumor cell control.  
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 As disease progresses and more tissue injuries are sustained, platelet activity is 
increased, and NK function is suppressed. This allows metastatic cell spread due to lack 
of circulating NK cells within the body leading to advanced disease (Levy, Roverti, & 
Mordoh, 2011). Because NK cells have the ability to defend the body from metastatic 
spread, any inhibition of their function will consequently increase the probability of 
cancer recurrence, or metastasis. What is even more consequential is that the surgical 
stress response has been shown to directly suppress NK cells during the perioperative 
period (Bharati et al., 2016).  
Cancer and surgical stress response  
Surgery remains the primary intervention for solid tumor cancer treatment. Other 
treatments include radiation, chemotherapy, and endocrine therapy. However, surgical 
removal of the disease is assumed to provide the best prognosis for these patients 
(Exadaktylos et al., 2006). During surgical interventions, the body undergoes cellular 
changes in response to treatment. The metabolic, neuroendocrine and cytokine responses 
elicit a sequential stress response in the human body leading to a breakdown of the 
defense system (Exadaktylos et al., 2006). This is known as an inhibition, or suppression, 
of immunity within the body, which leaves the host unprotected and at risk for undesired 
invasion. Host defense remains important during surgical manipulation of tumors because 
possible dissemination of tumor cells into the systemic circulation becomes a potential 
risk. 
Gottschalk et al. (2010) identified cancer as one of the leading causes of death due 
to metastatic recurrence. This incidence is related to lingering disease, tumor dormancy 
or intraoperative tumor cell spread. During surgical stress, suppression of cell mediated 
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immunity mechanisms become vulnerable and depressed, allowing cancer cells to spread. 
Immunosuppression from surgical stress can last hours to days leaving large amounts of 
time for invasion and poor outcomes (Gottschalk et al., 2009).  
 The release of chemical mediators from surgical stimulation can influence cancer 
growth by disrupting the homeostatic nature of the tumor itself (Gottschalk et al., 2009). 
Chemical mediators promote the release of catecholamines causing a subsequent cascade 
release of adrenocorticotropic hormone and cortisol. This cascade causes inhibitory 
effects on the immune system and further supports immune suppression.  
Cancer metastasis is a very complex process within the cell. Other than NK 
suppression from chemical mediator release, inflammatory system cascades are 
established and potentiate problems further leading to cancer progression. The addition of 
cytokines (IL-10, IL-6), cyclooxygenase, prostaglandins and chemokines, products of the 
inflammatory system, are promoters for immunosuppression and cancer development and 
have been linked to increasing the duration of NK inhibition postoperatively (Gottschalk 
et al., 2009). 
Narita et al. (2013) evaluated perioperative serum inflammatory cytokines and 
three stress markers: body temperature (BT), white blood cell (WBC) count and C-
reactive protein (CRP) in patients with prostate cancer. A comparison of surgical stress in 
patients who underwent open radical prostatectomy (ORP) vs. laparoscopic radical 
prostatectomy (LRP) was completed by measurement of serum cytokine levels. One 
hundred and sixty-five patients were included in this quantitative study. Levels of serum 
cytokines were taken preoperatively (PO), immediately postoperatively (IPO) and one 
day postoperatively (POD1). Using the BD Cytometric Bead Array Human Inflammatory 
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Cytokine Kit, six inflammatory cytokines (Interleukin 10, 6, 1B, 8, 12 and tumor necrosis 
factor (TNF) were measured. All data were analyzed using the CBA software program. 
For all patients, the BTs, WBC counts, and IL-10, IL-6, IL-1B and IL-8 were each 
significantly elevated IPO vs. PO (p = .002, p < .001, p <.001, p =.009, p < .001, p < 001, 
respectively). On POD1, BT, WBC count, IL-10 and IL-6 continued to be considerably 
higher than PO (p < .001) (Narita et al., 2013). When evaluating between the ORP vs. 
LRP, there were no significant differences in stress markers or serum cytokines PO or 
IPO. The WBC was the only identifiable difference, shown to be lower IPO in the ORP 
(10,877 cells/uL) vs. LRP (11,993 cells/uL). At POD1, ORP showed higher BT, WBC, 
and CRP compared to LRP. After final evaluation, Narita et al. (2013) concluded that 
there was a relationship between stress response and tissue damage. These authors 
identified BT, WBC, IL-10 and IL-6 as surgical stress markers (Narita et al., 2013). 
Surgical stress markers may be a useful tool for future studies to help identify the 
presence of inflammation as well as to identify potential immune system suppression.   
 Natural Killer cells and the surgical response. Tai et al. (2012) evaluated the 
suppressive effects of surgical stress on NK cells. These researchers conducted an 
experimental study which examined 4 groups of mice all injected with 3e5B161acz cells 
(cancer cells). The groups included: mice with surgical intervention, mice with no 
surgical intervention, mice with surgical intervention and NK cell deficiency and mice 
with NK deficiency but no surgical intervention. The mice subjected to surgical 
intervention underwent abdominal laparotomy and left nephrectomy, 2 days after the 
intravenous infusion of 3e5B161acz cells to establish pulmonary metastasis. Three days 
post-surgery, a twofold increase in pulmonary metastasis was found in mice that 
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underwent surgical intervention (400%) vs. the mice that did not (200%). In the NK-cell 
depleted mice, surgical stressed and non-stressed mice both developed increased numbers 
in lung tumors (900% vs. 750%). Interestingly, the NK deficient mice were noted to have 
a faster pulmonary metastasis at 3 days vs. the mice with normal NK cell function (Tai et 
al., 2012). Tai et al., (2012) identified the importance of the NK cell presence and tumor 
metastasis. 
 Tai et al. (2012) observed changes in protein levels, consisting of increased 
cytokines and chemokines over time, as compared to the non-surgical intervention mice. 
These authors further observed an increase in IL- 5 and IL- 6 and tumor growth factor 
(TGF) in all the surgically stressed mice (Tai et al., 2012). All three of the above 
cytokines have immune-suppressive properties further identifying immune suppression 
factors released during the surgical stress response. Tai et al. (2012) concluded that the 
increase in serum cytokines, IL-5, IL-6, and TGF, may contribute to the dysfunction and 
suppression of NK cells late in the perioperative and postoperative phases.  
Anesthesia and immunomodulation  
 Anesthesia is a medical treatment that eradicates the feeling of pain during 
invasive surgery. The use of anesthetics has made numerous surgical procedures possible 
and has improved the quality of life for many. In addition to providing amnesia, 
analgesia, and immobility, anesthetics play a key role in inflammation and the immune 
system. Anesthetics contribute to immune alteration by temporarily activating the 
antinflammatory and proinflammatory responses. These responses are involved in the 
modulation of our innate immune system, leaving the human body vulnerable to invaders 
(Loop et al., 2005). Loop et al. (2005) studied the effects of Sevoflurane, Desflurane, and 
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Isoflurane, types of volatile anesthetics, on human T-lymphocytes in vitro. Using an 
airtight chamber, Loop et al. (2005) investigated which gases initiated apoptosis of T-
lymphocytes. This quantitative, experimental study used 95% air and 5% carbon dioxide 
mixture for the control. Sevoflurane was dosed at 2.5%, 5%, and 8%, Isoflurane at 1.5%, 
2.5% and 5% and Desflurane at 6%, 12%, and 18% volume (differences in percentages 
are based on MAC values). For each gas chamber, 10 human T-lymphocytes were used 
and exposed for 24 hours. After exposure, the cells were stained and frozen immediately 
until protein extraction took place. The results showed that the control cells did not have 
any increase in the number of GRP-annexin, V-positive apoptotic cells (Loop et al., 
2005). Sevoflurane showed an increase in apoptotic cells from 2.57% to 8.01% (16% vs. 
4% of control). Isoflurane showed an increase of apoptotic cells from 0.7% to 4.8%. 
Desflurane exposure did not show any increase in cellular apoptosis of T-lymphocytes 
(Loop et al., 2005). Loop et al. (2005) concluded that when human T-lymphocytes were 
exposed to Sevoflurane or Isoflurane, cell apoptosis occurred at an increased rate.   
Anesthetic agents, including inhaled and intravenous agents, depress immune cell 
function, not only by inducing cellular apoptosis, but also by suppression of NK cell 
activity. (Griffis, Page, Kremer, & Yermel, 2008). Opioids, a part of the anesthetic plan, 
have also demonstrated immune suppressive effects in animals (Griffis et al., 2008). They 
have been found to cause NK cell suppression, lymphocyte proliferation and 
inflammatory cytokine production (Griffis et al., 2008). The overall result of any 
anesthetic use on the human body is immunomodulation. Thorough understanding of this 
anesthetic impact on immune alteration is important for future guidance of anesthetic 
practice. The evidence has shown numerous ways to deliver anesthesia and techniques 
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that may be more effective in susceptible patients (Griffis et al., 2008). 
Opioids. Opioids are a common adjuvant to an anesthetic method and are 
therefore relevant to this review. They act at opioid receptors in the central nervous 
system (CNS) and in the peripheral system. Their binding facilitates a decrease in 
neurotransmission by increasing potassium conductance and calcium channel 
inactivation. This inactivation decreases neurotransmitter (NT) release by binding the 
opioid to its receptor. Once binding occurs, it results in a suppression of substance P 
release, inhibition of adenylate cyclase, and further leads to a reduction in cyclic 
adenosine monophosphate (cAMP) (Flood, Rathmell, & Shafer, 2015). Opioids are a 
large contributor to immunosuppression and are hypothesized to suppress the 
hypothalamic pituitary adrenal axis (HPA) (Smith & Vale, 2006). The HPA controls the 
body’s response to stress and regulates immune function. When the HPA is suppressed, 
the body is at greater risk for invasion. Identified effects of opioids on the immune 
system include cell suppression, lymphocyte proliferation and inflammatory cytokine 
production. 
Fentanyl, a common synthetic opioid used in the anesthetic medication plan, is 
another identified cause of immune suppression. Narahara, Kadoi, Hinohara, Kunimoto, 
and Saito (2013) examined the effects of Fentanyl and Flurbiprofen on NK cells, 
lymphocytes and cytokines in the post-surgical patient. In a prospective, randomized 
study that included 25 patients who underwent neck surgery, the same intraoperative 
anesthetic technique was used consisting of Propofol and Rocuronium. Patients’ 
anesthetic depth were then maintained with Sevoflurane, Remifentanil and intermittent 
Fentanyl boluses. Postoperatively, all patients were transferred to the ICU where random 
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sedation was maintained with both Propofol and Flurbiprofen (N) (n=12) or Propofol and 
Fentanyl (F) (n=13). Patients were followed for 48 hours while continuing to receive pain 
control and sedation with Propofol at 0.5mg/kg/hr, which was increased or decreased 
according to the Richmond Agitation Scoring System (RASS). The Flurbiprofen was 
dosed at a rate of 0.1mg/kg/hr and was increased by 0.02mg/kg/hr if the behavioral pain 
scale (BPS) score was greater than 5. Similarly, Fentanyl was dosed at 1ug/kg/hr and 
increased by 0.2ug/kg/hr for BPS score greater than 5 (Narahara et al., 2013). 
Arterial blood samples were obtained from all patients (15 ml) prior to surgery 
and at the completion of surgery. Blood was collected on postoperative (postop) day 
(POD) 1 and 2. From each sample, 5ml of blood was utilized for examination of 
lymphocytes, 5ml for NK cells exam and the remaining 5ml for plasma level evaluation 
of TNF and IL-6 (Narahara et al., 2013). In the preoperative (preop) evaluation, as well 
as in the immediate postoperative evaluation, both groups demonstrated similar NK cell 
levels N= 40% and F= 39% (preop) N=28% and F=22% (postop). This, however, 
changed on POD1 and POD2 N=15% and F=7% POD1; N=17% and F=10% (POD2). 
Lymphocyte changes (CD3+) of the N vs. F group averages were 63.4% vs. 67.3% 
(preop), 69.4% vs. 67.9% (postop), 61.7% vs. 56.5% (POD1), and 67.8% vs. 64.7 % 
(POD2). For TNF blood sample evaluation, N vs. F showed plasma concentrations of 
0.88 pg/ml vs. 0.96 pg/ml (preop), 1.74 pg/ml vs. 2.02 pg/ml (postop), 0.80 pg/ml vs. 
1.04 pg/ml (POD1), and 1.14 pg/ml vs. 1.06 pg/ml (POD2). For IL-6, 3.9 pg/ml vs. 3.1 
pg/ml (preop), 478.7 pg/ml vs. 506.9 pg/ml (postop), 44.3 pg/ml vs. 77.2 pg/ml (POD1), 
and 60.4 pg/ml vs. 60.3 pg/ml (POD2) (Narahara et al., 2013). Narahara et al. (2013) 
found a large decrease in NK cells on POD1 in the Fentanyl group, indicative of 
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immunosuppression. There were minimal differences between groups in relation to 
cytokine and lymphocyte levels.  
Large doses of opioids are used as adjuvants to both general anesthesia and 
regional anesthesia techniques. Both general anesthesia and regional anesthesia have 
demonstrated controversial effects on immunomodulation and potentially place 
susceptible patients at risk for tumor cell metastasis. Two types of anesthesia 
administration techniques will be further reviewed: general anesthesia (GA) and regional 
anesthesia (RA), and the different affects each play on the immune system.  
 General anesthesia. The goal of GA is to obtain and maintain unconsciousness, 
amnesia, analgesia, and loss of sensory processing and depression of reflexes. General 
anesthesia can involve the use of many different medications to produce 
unconsciousness. For example, the volatile anesthetic gases are utilized to maintain a 
constant state of anesthesia. Whereas, hypnotics, such as Propofol, work in the central 
nervous system (CNS) by selectively modulating gamma amino butyric acid (GABA) 
receptors (Flood et al., 2015). Opioids, addressed above, are an adjuvant to GA. Finally, 
benzodiazepines, another adjuvant to the anesthetic regimen, can be added to a general 
anesthetic for enhanced effects. Benzodiazepines act on GABA receptors by increasing 
the affinity of the receptors and causing chloride conductance and hyperpolarization 
(Flood et al., 2015).  
Scavonetto et al. (2014) investigated long-term outcomes for patients with 
adenocarcinoma of the prostate gland. This retrospective cohort study investigated 
surgical cases that utilized regional anesthesia with GA, vs. the use of GA only. 
Scavonetto et al. (2014) hypothesized that the use of neuraxial regional anesthesia in 
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patients with adenocarcinoma would have better outcomes with radical prostatectomy 
than with the use of GA alone, due to the decreased use of large dosed opioids and 
volatile anesthetics. The authors identified patients who had undergone a radical 
prostatectomy from January 1991- December 2005. The sample size included 3,284 
patients, and a 1:1 ratio was used for the study to evaluate combined regional anesthesia 
and GA effects vs. the solo general anesthetic. The GA anesthetic regimen included 
Propofol, Fentanyl, Midazolam and Succinylcholine and a maintenance volatile 
anesthetic. The neuraxial regional/GA-combined technique utilized a spinal anesthetic 
dose of 0.5% bupivacaine with intrathecal morphine, or an epidural with a continuous 
infusion of bupivacaine 0.125% and fentanyl 20mg. The patients who received neuraxial 
adjuvant therapy required less perioperative opioids, if any. The subjects participated in 
regularly scheduled follow-ups. The median follow-up time frame after the prostatectomy 
was 8.6 years in the neuraxial regional/GA group and 9.0 years for GA only group. The 
outcomes and deaths associated with each group were evaluated at 5, 10 and 15 years. 
For the GA vs. neuraxial regional/GA group, systemic progression of cancer was 1.2% 
vs. 0.8% (5 years), 3.2% vs. 1.3% (10 years), and 5.1% vs. 3.1% (15 years). The 
outcomes for cancer recurrence demonstrated return rates of (GA vs. neuraxial 
regional/GA): 14.7% vs. 12.8% (5 years), 22.8% vs. 20.8% (10 years), and 29.9% vs. 
25.2% (15 years). The prostate cancer death the rates of each group was (GA vs. 
neuraxial regional/GA): 0.6% vs. 0.3% (5 years), 1.4% vs. 0.4% (10 years), and 4.2% vs. 
2.2% (15 years) (Scavonetto et al., 2014). Scavonetto et al. (2014) noted that regional 
anesthesia combined with general anesthesia had less recurrence of prostate cancer 
compared to the sample that received general anesthesia alone. The supplementation of 
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neuraxial regional anesthesia showed a decrease in the use of opioids and volatile 
anesthetics. A conclusion was made that the decreased use of both volatile anesthetic and 
opioid use was associated with a decrease in systemic cancer progression and an overall 
reduced stress response (Scavonetto et al., 2014). Volatile anesthetics are a factor 
impairing host defenses against cancer through suppression of the NK cells and 
promotion of immunosuppression. 
Volatile anesthetics. Volatile anesthetics, used frequently in general anesthesia, 
are also demonstrating evidence that they factor into inflammation and survival. Fuentes 
et al. (2006) investigated the use of Isoflurane and its effect on the reduction of 
leukocytes in rats, and its ability to function as an anti-inflammatory agent. This 
experimental study included 10 eight-week-old mice in 2 separate cohorts. The first 
cohort was injected with a lethal dose of inflammatory lipopolysaccharide (LPS is a 
membrane component of gram negative bacteria) and then exposed to one hour of 2% 
Isoflurane. The second (control) cohort was only injected with LPS. Blood samples were 
then collected 1-hour after the interventions. Samples showed a reduction in serum TNF 
of 1,276 pg/ml (LPS/Isoflurane group) vs. 5,249 pg/ml (LPS control group), IL-6 (1,192 
pg/ml vs. 27,681pg/ml) and IL-10 (146 pg/ml vs. 1,166 pg/ml) between the 
LPS/Isoflurane and the LPS only control groups, respectively. After 48 hours, the 
Isoflurane/LPS mice survivors fully recovered, compared to 80 hours for full recovery in 
the LPS control mice survivors. After 72 hours, the mice exposed to both Isoflurane and 
LPS showed survival rates of 85% compared to the 23% survival rate of the mice only 
exposed to the LPS (Fuentes et al., 2006). Fuentes et al. (2006) concluded that 
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anesthetics, such as Isoflurane, demonstrate an ability to attenuate the systemic 
inflammatory response and increase survival times in LPS mice exposed to Isoflurane. 
Regional anesthesia. Regional Anesthesia is used to block the sensation of a 
specific part of the body for a specific procedure. Regional anesthesia includes nerve 
blockade by spinal, epidural, and peripheral blocks, to name a few. Spinal anesthesia 
utilizes local anesthetics administered intrathecally to block neuronal sensation. 
Occasionally, the uses of intrathecal opioids are used as an adjuvant to this technique. 
Decreases in cancer metastasis are possible with the use of regional anesthesia due to the 
decrease activation of the human stress response (Heinrich, Janitz, Merkel, Klein, & 
Schmidt, 2015). The benefits of regional anesthesia include decreases in the need for 
opioids perioperatively. The decrease in perceived pain subsequently leads to a decrease 
in requirements for opioids and therefore an overall reduction of altered immune 
responses (Heinrich et al., 2015).  
Local anesthetics delivered via epidural catheters have shown promise in 
suppression of tyrosine kinase receptor activity, a critical element for differentiation and 
proliferation of cancer cells. Tyrosine kinase receptors, in the compromised patient, play 
a crucial role in cancer development and progression. By suppressing this activity, cancer 
cell proliferation may also be suppressed.  Heinrich et al. (2015) evaluated the short and 
long-term outcomes of epidural analgesia use in patients with esophageal cancer after 
abdomino-right thoracic esophagectomy from 1995-2005. This retrospective study 
included 153 patients, of which 118 received an epidural and 35 did not. All patients 
received a balanced general anesthetic with 1.5-2% of Sevoflurane. Postoperative patients 
with epidural received injections of ropivacaine and patients without an epidural received 
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a continuous infusion of opioid analgesia (Heinrich et al., 2015). Heinrich et al. (2015) 
found that patients who did not receive the epidural had longer ICU stays and additional 
opioid requirements when compared to the epidural group. However, the investigators 
noted no significant differences in the recurrence of cancer between the two groups: 27% 
no epidural vs. 23% epidural group. There were no significant differences reported 
between 1-year or 5-year survival rates (Heinrich et al., 2015). Limitations to the study 
included epidural catheters were only used in the postoperative period. Intraoperative 
opioids were utilized and could have impacted the outcomes. Rationales for why epidural 
catheters were denied in some patients were not discussed and could have had further 
influence on the study results. The primary benefit of the study was the identification of 
decreased opioid requirements in the epidural anesthesia group compared to the non-
epidural group. This is noteworthy, because the literature (Narahara et al., 2013) has 
shown that a decreased use of opioids promotes better immune responses in surgical 
patients and decrease the possibility of immune suppression in susceptible patients. 
Local anesthetics are used to block pain sensations within an area of the body. 
Their mechanism of action involves binding to sites within the voltage-gated channels by 
blocking sodium and reducing the overall excitability in tissues within the CNS, cardiac 
or neuronal areas (Flood et al., 2015). Local anesthetics are used to reduce stress on the 
body during the perioperative phase and have been identified as improving overall patient 
outcomes and reducing the need for intraoperative medications. The use of regional 
anesthesia in surgical patients reduces the incidence of cancer recurrence. By weakening 
the sympathetic nervous system’s response during surgical interventions, less opioids are 
required, and the negative effects associated with opioid use are avoided (Le-Wendling et 
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al., 2016). Local anesthetics also have an antitumor and anti-inflammatory property, 
limiting cancer recurrence chances in high-risk patients (Le-Wendling et al., 2016), 
therefore possibly making regional anesthesia a preferred method for the oncological 
patient.  
General anesthesia vs. Regional anesthesia. The anesthetic used in all surgical 
procedures is chosen by the anesthesia provider to deliver the best outcome for the 
patient. Controversy exists, however, as to what the best anesthetic choice is in relation to 
type of surgery, and to possible cancer redevelopment. Thus, research has also focused on 
whether general anesthesia or regional anesthesia provides better long-term patient 
outcomes. For instance, Exadaktylos et al. (2006) performed a retrospective chart review 
to evaluate the effects of anesthetics and cancer recurrence in patients who had 
undergone primary breast cancer surgery. The use of paravertebral anesthesia, a type of 
regional anesthesia, was compared to general anesthesia and postoperative opioids to 
evaluate for an association with cancer recurrence. Recurrence was documented in 6% of 
the paravertebral group and 24% in the general anesthesia group. Exadaktylos et al. 
(2006) also found a slower time to recurrence for the paravertebral group.  
Similar research was conducted by Christopherson, James, Tableman, Marshall 
and Johnson (2008). These investigators designed a retrospective review of long-term 
survival after colon cancer surgery in relationship to anesthetic technique and the 
incidence of metastasis. A combination of epidural anesthesia given with general 
anesthesia vs. only general anesthesia was evaluated. The results demonstrated reduced 
incidences of death and major complications in patients who received combination 
epidural anesthesia and GA. Christopherson et al. (2008) reported a decreased incidence 
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of myocardial infarctions, respiratory failure, infections, and strokes in patients who 
received combination epidural anesthesia and GA. Patients without evidence of 
metastasis survived three times longer than the patients who developed cancer metastasis. 
Those patients who received GA only were more likely to develop metastasis (44.5%) 
than those who received combination epidural anesthesia and GA (28.2%) 
(Christopherson et al., 2008). 
General anesthesia encompasses many different methods for delivery of a proper 
anesthetic. Initial anesthetic choices may appear appropriate for individuals, but over 
time may have consequences. Lai et al. (2012) researched general vs. epidural anesthesia 
and cancer recurrence in patients with small hepatocellular carcinoma (HCC). This 
retrospective study evaluated 179 patients with small HCC from August 1999 to 
December 2008. Of the 179 patients, 108 patients underwent radiofrequency ablation 
(RFA) under GA and 57 patients underwent RFA with epidural anesthesia (EA) (the 
remaining were lost due to incomplete ablations or follow-up). The GA group was 
induced with 1-2 mcg fentanyl and 1mg/kg of Propofol and maintained with continuous 
IV infusion of Propofol at 5-8 mg/kg/hr. Type of volatile anesthetic used was not 
mentioned. Spontaneous ventilation was maintained throughout the RFA. The EA group 
received 1.5% Lidocaine at the thoracic level of T 8-10 twenty minutes prior to RFA. 
Postoperatively, both groups were given a transdermal opioid patch of either Fentanyl or 
Morphine for pain. In postoperative month one, imaging via CT scan or MRI was 
performed with liver function testing (LFT). Follow-up with imaging and LFTs were 
continued every two months for 24 months, and then every three months afterwards with 
chest x-rays performed every six months (Lai et al., 2012).  
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Results were classified by imaging results and LFTs. The absence of tissue 
growth at the tumor site was considered a complete ablation, and conversely the presence 
of tissue growth at the tumor site was considered an incomplete ablation. Tissue margins 
of the original tumor were used to identify local recurrence and a new separate lesion 
within the liver was considered intrahepatic recurrence (Lai et al., 2012). Metastatic 
lesions outside of the liver defined extrahepatic. Follow-up for patients ended in January 
2011. End points for the study included recurrence-free survival (between treatment and 
date of recurrence or death) and overall survival (between treatment and death or last 
follow-up). The results showed median follow-up to be 43 months (Lai et al., 2012). 
Cancer recurrence was detected in 40 patients in the GA group and 50 patients in the EA 
group. Survival rates for recurrence-free patients of GA vs. EA were 86% vs. 84% (1 
year), 60% vs. 40% (3 years) and 52% vs. 26% (5 years). Overall survival showed the EA 
group had 43 deaths in the follow-up time frame from HHC progression (38 patients), 
liver failure (4 patients) and other causes (1 patient) (Lai et al., 2012). In the GA group, 
41 deaths occurred in the same time frame from HCC progression (40 patients), liver 
failure (9 patients) and other causes not mentioned (2 patients). The results for estimated 
overall survival rates at one year were GA (95%) vs. EA (93%), at three years were GA 
(85%) vs. EA (79%) and at five years were GA (69%) vs. EA (53%) (Lai et al., 2012). 
These findings suggest that HCC patients who underwent RFA with GA had a decreased 
risk of cancer recurrence compared those who underwent the same procedure with EA. 
This study contradicts much of the current evidence available regarding general vs. 
regional anesthesia. Lai et al. (2012) point out that tumor type may have an impact on 
recurrence risk related to type of anesthesia.  
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As this study was retrospective, it also had limitations, including the need for the 
use of multivariate Cox regression model, with propensity score, and analysis adjusting 
for propensity score with inverse probability (Lai et al., 2012). This had to be repeated 
numerous times and resulted in 3 different HRs on recurrence free survival and 3 
different HRs on overall survival. Lai et al. (2012) discuss that anesthetic technique was 
not randomly assigned and therefore, they could not determine if the analgesia was 
sufficient. Researchers acknowledge RFA are associated with referred pain, and epidural 
anesthesia/analgesia may not have covered the referred pain areas, consequently 
additional opioid administration may have been warranted. Lai et al. (2012) also discuss 
the impact of GA on systolic blood flow reduction and a consequential decrease in 
hepatic blood flow that may increase coagulation diameter and impacting liver function 
markers and may account for the results of this study. Lai et al. (2012) recommended the 
need for a larger prospective study and that the results of this study should be interpreted 
cautiously because clear evidence in overall survival was not concluded. Further research 
is still required for this topic.  
 Brox, Chan, Cafri, and Inacio (2016), evaluated the use of neuraxial vs. general 
anesthesia on mortality rate in elderly patients requiring surgery for a hip fracture using a 
retrospective cohort study. These researchers used a hip fracture registry to identify 
patients with hip fractures who underwent surgery between January 2009 and December 
2012. The sample consisted of 7,585 patients who were between the ages 55-89 years. 
Anesthetic methods of GA only, neuraxial anesthesia only and GA with neuraxial 
anesthesia were evaluated for differences. The researchers evaluated post-surgical 
mortality at day 30, 90, and 365. Of the total, 4,257 patients underwent GA, 260 patients 
 
 
27 
 
underwent neuraxial, and 3,059 patients underwent combined method of GA and 
neuraxial (Brox et. al, 2016). Within 30 days of surgical intervention, there were 177 
(4%) reported deaths in GA group, 113 (4%) deaths in the neuraxial anesthesia group, 
and 17 (6%) deaths in the combination group. Within 90 days, there were 336 (8%) 
deaths from GA group, 224 (7%) deaths from the neuraxial anesthesia group, and 23 
(9%) deaths in the combined group. By day 365, GA deaths reached 661 (16%) deaths, 
neuraxial deaths reached 424 (14%) and mixed method reached 41 (15%) deaths (Brox et 
al., 2016). Brox et al. (2016) reported no significant differences between neuraxial 
anesthesia and general anesthesia on overall patient mortality. This study implied other 
variables, such as BMI, age, sex, race, and American Society of Anesthesiologists score 
(ASA) may have had a larger impact than what was explored. Although this study did not 
show any benefit of one technique over the other, it supports the need for further 
investigation into different anesthesia techniques for susceptible populations.  
Integrative review purpose 
 The purpose of this integrative review was to explore the literature from 2006 - 
present to identify the best anesthetic practice for the oncological surgical patient. All 
relevant literature was compared to examine the evolution and advances in knowledge of 
anesthesia's effect on immunomodulation, the alteration of the immune system, and 
cancer recurrence. By comprehensively reviewing the related literature, a better 
understanding of existing relationships between anesthetics and the effects on cancer 
recurrence in the surgical patient can be identified.  
Next the theoretical framework used to guide this study is presented. 
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Theoretical Framework 
 For this integrative review, Whittemore’s Stages of Review framework was used 
to overcome the challenges associated with locating adequate and reliable studies. This 
framework allows diverse data sources to be utilized to support the specific issues 
associated with the overall purpose of this review. Whittemore’s stages can be broken 
down into problem identification stage, literature search stage, data evaluation stage, data 
analysis stage and presentation stage (Whittemore & Knafl, 2005). The problem 
identification stage includes identification of the problem that the review addresses. The 
desired variables of interest and population should be determined in this stage. Having 
clear identification of the problem with the correct purpose will provide focus for the 
review. 
 The literature search stage starts with adequate search strategies in diverse 
databases. An adequate search will enhance the rigor and help to prevent bias. All 
relevant literature should be reviewed for the appropriate problem and topic of interest. 
All applicable research should be included for evaluation and assessment to further 
support the review (Whittemore & Knafl, 2005). 
 The data evaluation stage aims to assess primary sources located during the 
literature search. The data analysis will provide organization to the review and synthesis 
of the research will be included. Research questions will be answered, and an 
understanding of the problem should become evident. For this integrative review a 
constant comparison of similar designed studies/research will be used to locate patterns, 
themes, relationships and variations between sources. The analysis portion of the review 
will include additional steps including data reduction, display, comparisons and potential 
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conclusions (Whittemore & Knafl, 2005).  
 The final stage is presentation of the literature. This was done in a diagrammatic 
form. This stage will show results and evidence of the literature to support the overall 
purpose and understanding of the review. This stage helps to contribute to an enhanced 
understanding of the problem of interest (Whittemore & Knafl, 2005).  
Table 1 
Whittemore: Stages of Review 
Stage of Review  Decisions and Issues 
Problem 
Identification 
Initial stage to identify main purpose for review and variables of 
interest 
Literature Search To enhance rigor and to identify eligible primary sources 
Data Evaluation To evaluate and interpret similar quality research 
Data Analysis Use of constant comparison method to itemize studies and 
categorize data: includes data reduction, data display and data 
comparison 
Presentation Conclusions of review in diagrammatic form with logical 
evidence  
  
Next, the methods section is presented. 
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Methods 
Purpose 
The purpose of this integrative review was to explore the literature from 2006 - 
present to identify the best anesthetic practice for the oncological surgical patient. All 
relevant literature was compared in order to examine the evolution and advances in 
knowledge of anesthesia's effect on immunomodulation, the alteration of the immune 
system, and cancer recurrence. By comprehensively reviewing the related literature, a 
better understanding of existing relationships between anesthetics and the effects on 
cancer recurrence in the surgical patient can be identified.  
Search Strategy  
 A review of literature from 2006 to present was thoroughly investigated, using 
both quantitative and qualitative studies, as well as informative literature, to provide 
depth and evidence to this topic. The adult oncological patient, 18 years and older, was 
the population of interest for this review. The inclusion criteria used was: literature in the 
English language, human subjects, adults treated with surgical intervention for a primary 
cancer and the use of regional and general anesthetics. The search included all cancer 
types.  
Search Criteria 
 Exclusion criteria included current metastasis cancer studies prior to anesthetic 
use, studies examining children, and incomplete retrospective studies. Eight articles were 
used to provide satisfactory support for this review.  
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Data Collection 
 One reviewer collected data for this integrative review. Each article was reviewed 
to identify the inclusion and exclusion criteria for this integrative review. The literature 
search included the use of key words, and numerous databases. The use of The Integrative 
Review: Updated Methodology article by Whittemore and Knafl (2005) was used as a 
guide to help define methodology strategies for integrative reviews in stages. Stage one 
was to identify a problem within a target population. The second stage included a 
literature search using keywords, different search strategies and databases. The third 
stage included data analysis displaying and comparing the data with conclusions and 
creating generalized concepts. A presentation of findings to disseminate ideas of a given 
population for a given purpose concluded the final stage in Whittemore and Knafl’s 
guide. 
Critical Appraisal 
 To evaluate the strength and limits to each study chosen for this review, Polit and 
Beck’s Guide to a Focused Critique of Evidence Quality in a Qualitative /Quantitative 
Research Report (Polit & Beck, 2014) (Table 2) was used to identify whether the 
evidence in each study was accurate and clinically relevant. Using Polit and Beck’s 
method, an evaluation and appraisal of quantitative research, qualitative research, and 
literature reviews was completed.  
Next, the results section is presented.  
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Results 
 
 Articles chosen for this review were located through electronic searches in 
PubMed Health, CINAHL and Medline Plus. Key words used to search for the desired 
articles included; anesthesia and cancer, recurrence, time to recurrence, anesthesia 
technique, and regional vs. general anesthesia. Initial results from the search using 
keywords ‘anesthesia and cancer’ yielded 849 articles from CINAHL, 289 articles from 
PubMed and 511 articles from Medline Health. The search was narrowed by adding 
keyword ‘recurrence’ and yielded 120 articles from CINAHL, 131 articles from PubMed 
Health, and 30 articles from Medline Plus. Adding an additional keyword ‘anesthesia 
technique’ yielded 41 articles from CINAHL, 106 articles from PubMed Health, and 16 
articles from Medline Plus further narrowed the search. Duplicate studies found during 
the search in each database were discarded from the study selection. A final search 
included the above mentioned inclusion criteria search. Only full text articles were 
included. The result included a total of 8 articles for the integrative review.  
Results for this integrative review will be discussed by earliest date of research. A 
critique table for each study reviewed is contained in Appendix A. The findings for each 
reviewed article are provided in Appendix B. A critical analysis of the articles is located 
in Appendix C. 
Anesthetic Use in Oncologic Patients 
Exadaktylos et al. (2006) (Appendix A-1) conducted a retrospective study to 
investigate the association between anesthetic technique and the recurrence of, or 
metastasis of breast cancer after surgical intervention. The data was collected from the 
Mater Misericordiae University Hospital in Dublin, Ireland. The investigators of this 
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study examined a total of 129 medical records of breast cancer patients who underwent 
mastectomies with axillary clearance during September 2001 and December 2002. Two 
groups were formed; patients who received paravertebral anesthesia and analgesia (n=50) 
and patients who underwent general anesthesia and received postoperative morphine 
(n=79). Scheduled follow-up occurred at 32 months +/- 5 months. Exadaktylos et al. 
(2006) noted no significant differences between the patient’s tumor presentation, 
prognostic factors, or surgical details. All the patients studied were cared for by the same 
surgeon. The primary outcome measured was the incidence of cancer recurrence or 
metastatic spread through August 2005. The sample size was unequal, and small, which 
can be noted as a limitation to this study. Inclusion and exclusion criteria were clearly 
defined. The method of data analysis was addressed by the authors in both narrative and 
table format. 
The findings are presented in Appendix B-1. Exadaktylos et al. (2006) noted 
recurrence or metastasis documented in 3 out of 50 Paravertebral Block (PVB) patients 
(6%) and 19 out of 79 GA patients (24%). PVB showed slower times to recurrence (p = 
0.013). PVB risk of recurrence was significantly less (p = 0.012), HR 0.21 compared to 
the GA group. The authors concluded that using PVB for breast cancer surgical patients 
reduced the risk of recurrence or metastasis. Exadaktylos et al. (2006) reported that 
regional anesthesia may play an important role in preserving immune function during 
surgical intervention. This technique is thought to decrease the GA and opioid 
requirements known to suppress the immune system, and thus reduce the risk of tumor 
metastasis and/or recurrence.  
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Biki, et al. (2008) (Appendix A-2) conducted a retrospective analysis on 
anesthetic technique for radical prostatectomy surgery and its effects on cancer 
recurrence. Data was collected at the Mater Misericordiae University Hospital in Dublin, 
Ireland. Only records of patients with invasive prostatic carcinoma who underwent an 
open radical prostatectomy during January 1994 and December 2003 were included in the 
review. The patients were evaluated until October 2006. Biki, et al. (2008) provided a 
clear statement of the purpose with an informative literature review. The purpose of the 
study was to identify the risk of prostate cancer recurrence in patients who received either 
epidural anesthesia/analgesia with general anesthesia or general anesthesia with opioid 
analgesia. The hypothesis was clearly written, stating that the recurrence of prostate 
cancer is less common using a combined general anesthesia and epidural analgesia rather 
than with general anesthesia alone. The endpoint for data collection included evaluating 
biochemical recurrence in the postoperative phase. Biochemical recurrence, also referred 
to as an increase in prostate specific antigen (PSA), is indicative of cancer recurrence or 
metastatic spread (Biki, et al., 2008). Biki et al. (2008) also evaluated recurrence free 
time, which was defined as the time between surgery data and last PSA. The sample size 
included 103 patients in the group who received general anesthesia (GA) along with 
opioids, and 102 patients in the epidural-general anesthesia (EA) group. Limitations 
included failed epidurals and opioid administration to epidural recipients due to failed 
epidurals. The patients of the epidural group had higher ASA scores, more complications 
and shorter surgeries.  
Findings (Appendix B-2) demonstrated that the EA group had higher ASA scores 
(III) compared to the GA group at 8 patients to 3 patients (p = 0.11), and shorter 
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surgeries (1.8 +/- 0.4 hours vs. 2.0 +/- 0.5 hours) (p = 0.06) (Biki et al., 2008). The EA 
group was noted to have more postoperative complications, including pneumonia, 
postoperative bleeding and other respiratory issues (Biki et al., 2008). Patients who 
received EA had a decreased estimated risk of recurrence compared to that of the GA 
group, with a hazard ratio (HR) of: 0.34, 95% CI = [0.19-0.61]. A Gleason score, used to 
evaluate the prognosis of prostate cancer, showed 6.1% for general anesthesia vs. 5.9 % 
for epidural/general anesthesia (p = 0.42). The higher the Gleason score, the more likely 
for cancer spread. In the univariate analysis, the Cox Regression HR for the Gleason 
score was 1.53, 95% CI = [1.29-1.80], (p = 0.001), preoperative PSA HR 1.01, 95% CI = 
[1.00-1.03], the size of the tumor HR 1.25, 95% CI = [1.13-1.38], and length of surgery 
HR 1.79, 95% CI = [1.09-2.92] were noted to have relation with recurrence. After 
adjustments were made for the above variables, EA had a lower risk for recurrence 
compared to GA with a HR 57%, 95% CI = [17-78%]. The authors also used propensity 
matched analysis and found similar results, which indicated that patients who received 
EA were 52% less likely to have recurrence compared to that of the GA patients 
(univariable HR 0.48, 95% CI = [0.23-1.00], (p = 0.049)). Sensitivity analysis was also 
used to account for potential bias due to loss of follow-up after four years. Each 
anesthetic type reviewed against recurrence for the first 3 years showed univariable (p = 
0.012) and multivariable (p = 0.033) results. A limitation of this study was that it was a 
non-randomized, retrospective, observational design. This study was also limited because 
non-standardized clinical care was delivered, and there were imprecise data analyses due 
to wide CI’s. Biki, et al. (2008) also noted that possible selection bias, and unmeasured 
confounding variables, could not be dismissed as limitations. The authors acknowledged 
 
 
36 
 
similar results in a previous report in women who underwent breast cancer surgical 
intervention and discussed the need for an estimated effect size for larger randomized 
control trials. 
Lin et al. (2011) (Appendix A-3) conducted a retrospective review of medical 
records of women who underwent surgical interventions for ovarian serous 
adenocarcinomas. The records reviewed were from 1994 to 2006 for those who 
underwent the use of general anesthesia (GA) or epidural (regional) anesthesia (EA). 
Data was collected at the Sun Yat-sen University Cancer Center. One hundred and forty-
three medical records of patients who underwent surgical intervention for ovarian serous 
adenocarcinoma were reviewed. Survival rates in 106 patients who underwent EA with 
analgesia and 37 who underwent GA with opioid analgesia, were evaluated over 2-14 
years. The primary outcome measured in this study was death rate by survival analysis 
(Lin et. al, 2011) (Appendix B-3). The EA group was found to have shorter surgeries 3.3 
hours vs. 3.5 hours in the GA group (p = 0.06), and better International Federation of 
Gynecology and Obstetrics (FIGO) staging (2.3 vs. 2.9 respectively). The EA group, 
however, had more complications including: postoperative bleeding, pneumonia, 
respiratory tract infections and urinary tract infections (p = 0.07). The 3-yr. and 5-yr. 
overall survival rates for the EA group were 78% and 61%, and for the GA group, 58% 
and 49%, respectively. Both groups had attrition due to lack of follow up. Results suggest 
patients who underwent surgical intervention for ovarian serous adenocarcinoma with EA 
had better survival outcomes than GA patients.  
Lin et al. (2011) recognized two factors that may account for the results of the 
study. First, the immunosuppressive effects of general anesthesia were not present in the 
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epidural group. Secondly, the doses of opioids used in the epidural group were 10x lower 
than the general anesthesia group. Lin et al. (2011) stated that these two factors may have 
led to a reduced suppression of the NK cell activity, and thus prevented tumor spreading.  
Several limitations are identified in this study including; patient selection was not 
random, small, uneven sample size and the lack of standardized patient care. Due to these 
limits, effects of unmeasured confounding variables and selection bias cannot be 
excluded. The report did not address the issue of generalizability but did address the need 
for a large prospective randomized control trial to further support the impact of 
anesthesia technique on ovarian serous adenocarcinomas.  
 Cummings, Xu, Cummings, and Cooper (2012) (Appendix A-4) compared 
epidural/analgesia and traditional pain management on cancer recurrence and survival 
after colectomy for colon cancer. The data were collected from the Surveillance, 
Epidemiology, and End Results (SEER) Medicare data base, which was used to compare 
overall survival and cancer recurrence of patients who did/did not receive epidural 
anesthesia and/or analgesia for resection of non-metastatic colorectal cancer. Cummings 
et al. (2012) provided a clear statement of purpose and included a thorough and 
comprehensive literature review to build a strong basis of study. The purpose of the study 
was to compare cancer recurrence and survival in colorectal cancer patients who received 
epidurals and those who did not. The study included a clear hypothesis that epidural 
anesthesia and/or analgesia is associated with reduced cancer recurrence and improved 
mortality after colorectal cancer resection surgery. The methods included data collected 
from the Medicare-SEER database which is approved by the Case Comprehensive 
Cancer Center Institutional Review Board. The study included a cohort of patients aged 
 
 
38 
 
66 years or older who were diagnosed with incident nonmetastatic colorectal 
adenocarcinoma and underwent colectomy surgery between 1996 and 2006. The cohort 
population was chosen after several exclusions were made including; prior diagnosis of 
cancer and a history of inflammatory bowel disease. From this, two cohorts were defined 
that became the basis of the study. Criteria for inclusion in the primary cohort were: 
patients who were enrolled in Medicare within 1 year before cancer diagnosis, until 8 
months after diagnosis, or death. This primary cohort focused on overall survival after 
surgery. The second cohort, or recurrence cohort, focused on recurrence of cancer. The 
inclusion criteria for the recurrence cohort were: patients who were enrolled in Medicare 
within 1 year before cancer diagnosis until 4 years after diagnosis, or death who survived 
at least 12 months after surgery. Data for the primary cohort was ultimately collected 
from 42,151 patients, of whom 22.9% (9,670) had epidurals. Data for the recurrence 
cohort was collected from 40,377 patients, of whom 23.0% (9,278) had epidurals at the 
time of recurrence (Cummings et al., 2012). 
The findings (Appendix B-4) indicated that for the primary cohort, 5-yr overall 
survival was 61% (epidural group) and 56% (traditional pain management group). The 
median survival was 7.24 years (yrs.) (95% CI = [6.96, 7.51]) (Epidural group) and 6.09 
yrs. (95% CI = [5.97, 7.51] (non-epidural group). For the recurrence cohort, the overall 4-
yr cancer recurrence was 14.3% in the epidural group and 13.8% in the non-epidural 
group. In the unadjusted logistic regression, an association existed between epidural use 
and increased cancer recurrence with an (odds ratio = 1.14, 95% CI = [1.05,1.24], p = 
0.002). Adjusting for demographic and clinical covariates, no significant differences were 
noted in the odds of recurrence between the groups, (odds ratio= 1.05, 95% CI = [0.95, 
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1.15], p = 0.28). Cummings et al. (2012) found recipients of blood transfusions showed a 
significant relation to cancer recurrence in the adjusted model with an (odds ratio = 1.14, 
95% CI = [1.03, 1.25], p = 0.01). The difference in survival rates in the primary cohort 
that had epidurals, compared to those who did not, suggested that epidural use may be a 
preferable solution to pain management. Cummings et al. (2012) identified epidural use 
to be associated with improved survival rates in the colorectal cancer patient who 
underwent resection, but no significant relationship was made between epidural use and a 
reduction in cancer recurrence. 
 Chen and Miao (2013) (Appendix A-5) conducted a meta-analysis on the effects 
of anesthetic technique and survival in human cancers. Data were collected from the Web 
of Science database, PubMed, and Medline. The authors provided a clear statement of the 
purpose, and there was a brief literature review provided. The purpose of the analysis was 
to test the hypothesis that surgical cancer patients who underwent surgical intervention 
under EA would have better outcomes than those who underwent surgical intervention 
under general anesthesia. A hypothesis was included in the study which stated, epidural 
anesthesia/analgesia combined with or without general anesthesia may be associated with 
a decrease in cancer recurrence and improved survival after oncological surgery. The 
method included a meta-analysis of 14 articles. The analysis investigated recurrence free 
survival (RFS- from day of surgery to first disease relapse from primary cancer) and 
overall survival (OS- from day of surgery until death). The total numbers of epidural 
anesthesia cases were 12,000 and general anesthesia cases were 35,000. For OS, 7 studies 
were included, with 4 studies finding a positive relationship between EA and improved 
OS. The outcome measure of RFS included 11 studies with numerous cancer types (Chen 
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& Miao, 2013). Out of the 11 studies, 4 studies showed a positive relation between 
improved RFS and EA (Chen & Miao, 2013). 
The results of the study are summarized in Appendix B-5. Chen and Miao (2013) 
identified heterogeneity significance in the hazard ratio (HR) for OS: HR 0.84 95% CI = 
[0.74 to 0.96]. The random effects model was used to analyze data to identify if a 
favorable relationship exists between OS and EA vs. OS and GA (HR= 0.84, 95% CI = 
[0.74-0.96], p = 0.013). The authors identified a positive association between OS and EA 
in the five colorectal cancer studies (HR= 0.65, 95% CI = [0.43-0.99], p = 0.045) 
included in this review; however, there was no significant association noted between RFS 
and EA (HR=0.88, 95% CI = [0.64 -1.22], p = 0.457) in any of the studies reviewed. The 
use of regional anesthesia (RA) has been linked to a reduction of surgical stress response 
stimulation and decreased pain experience. With a decrease in pain, less opioids are 
required, and immune suppression effects are evaded. (Chen & Miao, 2013). This meta-
analysis suggested a positive relationship between the use of epidural 
anesthesia/analgesia and improved overall survival in patients undergoing colorectal 
cancer surgery. Chen and Miao (2013) stated that although this review was unable to 
support a relationship between epidural anesthesia and cancer control, it did offer some 
support of the use of RA techniques. The authors did acknowledge the need for further 
prospective studies to determine a causative association between survival and epidural 
use.  
Jang et al. (2016) (Appendix A-6) conducted a retrospective review of anesthetic 
technique effects on 5-year survival, and cancer recurrence rates, after transurethral 
resection for bladder tumors. The data was collected from the Chungnam National 
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University Hospital, Daejeon, Korea. The authors provided a clear statement of the 
purpose and included a brief review of the relevant literature. Jang et al. (2016) collected 
data to determine if mortality after bladder cancer differed between patients who 
underwent surgical intervention under GA vs. surgical intervention with RA. The 
methods utilized for this study made appropriate connections between anesthetics and 
patient outcomes. For the induction of general anesthesia, Propofol or Etomidate was 
used with Vecuronium or Rocuronium and Sevoflurane or Isoflurane to maintain the 
anesthetic depth. Ketorolac was given intravenously for postoperative pain control. For 
the RA, lidocaine and 0.75% bupivacaine were used. No analgesics were given to 
patients in the regional group for postoperative pain. The sample size was (n =137) 
patients who received RA and (n =24) who received GA. The authors examined the 5-
year recurrence rate, and recurrence free time, after surgical interventions.  
The results of the study are summarized in Appendix B-6. The length of 
anesthesia time was longer in the general group by 23 minutes. Patients who underwent 
surgical intervention with RA showed higher recurrence rate (0.9% +/1.4) compared to 
the GA group (0.5% +/- 0.8) during the 5-year follow-up period (Jang et al., 2016). The 
recurrence free time was noted to be 45 +/- 22 months for the GA group and 40 +/- 24 
months for the RA. A normal distribution was not shown; therefore, the Kruskal-Wallis 
test was used. For the GA group, 73 was the mean rank of recurrence and for RA group, 
mean rank of recurrence was 82 (p = 0.28), demonstrating no statistically significant 
differences between the two groups. The Chi-square test of five-year survival was also 
used. For the GA group, 5-year survival was 87.5% and for RA it was 96.3 %. Jang et al. 
(2016) further explored logistic regression analysis to examine survival rates. After 
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variable consideration, age was found to the primary contributor to a shorter 5-year 
survival after surgical intervention. To further evaluate age as a primary contributor to 
shorter 5-year survival, Spearman Rho correlation analysis was performed. A significant, 
positive correlation was made with age and recurrence (rs = 0.168, p = 0.033), in addition 
to a significant, negative correlation between age and survival (rs = -0.272, p = 0.000). 
This indicated that younger patients demonstrated longer recurrence free times and 
greater survival time (Jang et al., 2016). The length of anesthesia time displayed a 
positive relationship, through partial correlation analysis, with recurrence (coefficient = 
0.188, p = 0.017). This corresponded to the finding of a positive association between 
longer length of anesthesia time and shorter recurrence free time (coefficient = -0.169, p 
= 0.032). Partial correlation analysis was the only identifier of a true significant 
relationship between a better 5-year survival and use of RA (coefficient = -0.167, p = 
0.044) (Jang et al., 2016). Numerous limitations were identified in this study. These 
included: small, unequal sample sizes, a lack of randomization, a lack of uniform care, 
different anesthesia time lengths and age variations between groups. Jang et al., (2016) 
suggested a larger prospective study be performed with random allocation to support one 
technique over the other.  
Cho et al. (2017) (Appendix A-7) conducted a randomized prospective study to 
explore the effects of perioperative anesthesia and analgesia on the immune function of 
breast cancer patients undergoing resection. Data were collected at the Severance 
Hospital, Yonsei University Health System in Seoul, Korea. Cho et al. (2017) provided a 
clear purpose and literature review for the study. The purpose of the review was to 
compare the effects two different anesthetic techniques on Natural Killer cell counts in 
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patients with breast cancer undergoing surgical intervention. Researchers clearly 
hypothesized that avoiding volatile anesthetics and opioid analgesics might lessen 
immunosuppressive effects during perioperative periods. Fifty patients undergoing breast 
cancer resection were included in the study. Patients were randomly assigned into two 
groups; the first group of 25 patients received both Propofol and Remifentanil anesthesia 
with postoperative Ketorolac (P-R-K), and the second group of 25 patients received 
Sevoflurane and Remifentanil anesthesia with postop Fentanyl (S-R-F) analgesia. Cho et 
al. (2017) explored pain scores and inflammatory marker presence preoperatively and 
again, 24-hours postoperatively. The incidence of cancer recurrence/metastasis was then 
evaluated every 6 months for 2 years following surgical interventions. 
Cho et al. (2017) (Appendix B-7) found an increase in NK cell counts in the P-R-
K groups and a decrease in NKCC in the S-R-F group postoperatively. The findings 
suggest that S-R-F induced a more suppressive effect on lymphocytes compared to P-R-
K. Pain scores were comparable between the two groups 48 hours postop. One patient in 
S-R-F group showed recurrence in the contralateral breast and no recurrence or 
metastasis were found in the P-R-K group. The study concluded that there was a more 
favorable impact on immune function from the P-R-K group with the preservation of 
NKCC. Limits to the study included: non-blinded operating staff to the group allocation; 
however, follow-up staff were unaware of patient group involvement when assessing for 
pain. The use of Remifentanil and Tramadol for a control was used, and their impact on 
NKCC cannot be excluded. Cho et al. (2017) identified the use of combination drug 
groups and acknowledged the differences between the groups may be due to combination 
effects. Cho et al. (2017) pointed out that cancer metastasis within two years after surgery 
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did not occur in the study, and further evaluation of long-term outcomes are needed to 
make further conclusions about cancer recurrence or metastasis.  
Perez-Gonzalez, Cuellar-Guzman, Soliz and Cata (2017) (Appendix A-8) 
conducted a systematic review of literature regarding the impact of regional anesthesia on 
the recurrence/metastasis and the immune response in the breast cancer patient after 
surgical intervention. Perez-Gonzalez et al. (2017) used PubMed, EMBASE, MEDLINE, 
and Cochrane Trials Registers to perform the literature search of data from 2005-2017. 
Perez-Gonzales et al. (2017) hypothesized that the use of regional anesthesia was 
associated with better long-term outcomes after breast cancer surgical intervention. 
PRISMA was used for reporting, with a total of 467 pertinent studies initially located. 
Through screening and inclusion criteria methods, a final total of 15 studies were 
analyzed. To evaluate the methodological quality of the randomized control trials and 
observational retrospective studies, Perez-Gonzalez et al. (2017) used the Newcastle-
Ottawa scale and Jadad score. Outcome measures studied were broken into three 
categories to assess the impact of paravertebral blockade: (1) recurrence and survival, (2) 
humoral response and (3) cellular immune response. 
Perez-Gonzalez et al. (2017) identified 6 studies that explored the association of 
regional PVB/GA anesthesia and GA with volatile gases and opioid analgesia on overall 
survival and recurrence rates (Appendix B-8). All but 1 of the 6 studies were 
retrospective and included sample sizes ranging from 60 to 1107 patients. The only RCT 
included, by Finn et al. (2017), showed no difference in rate of recurrence between PVB 
vs. GA. A retrospective study by Exadaktylos et al. (2006), however, found a beneficial 
effect of PVB on lower rate of recurrence, with a recurrence rate of 24% for the GA 
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group vs. 6% for the PVB/propofol group HR 0.21 (p = 0.012). Yet another of the 5 
retrospective studies found a negative impact of PVB on cancer recurrence (Cata et al., 
2016). Median follow-up times were recorded at 5.8-6 yrs., and Cata et al. (2016) 
identified that the use of fentanyl was lower in the PVB group (122.8 +/- 77.8 ug) vs. the 
non PVB group, (402.23 +/- 343.8 ug). No association of changes in overall survival or 
recurrence free survival were identified (Perez-Gonzales et al., 2017). Perez-Gonzalez et 
al. (2017) identified that the remaining retrospective studies did not find any association 
between PVB and a reduction in rate of cancer recurrence or longer cancer- related 
survival time (Kairalumoma, Mattson, Heikkila, Pere, & Leidenius, 2016; Tsigonis et al., 
2016; Starnes-Ott, Goravanchi, & Meininger, 2015).  
Four RCTs (Deegan et al., 2010; Looney, Doran, & Buggy, 2010; O’Riain, 
Buggy, Kerin, Watson, & Moriarty, 2005; Sultan, 2013), evaluated in this systematic 
review explored the impact of PVB on inflammatory biomarkers (Perez-Gonzalez et al., 
2017). The effect of PVB/Propofol vs. GA showed minimal to no difference in 
inflammatory biomarkers and markers of stress response between regional and general 
anesthesia. Two studies (Looney et al., 2010; O’Riain et al., 2005) examined growth 
factor (GF) concentrations and effects of angiogenesis/proliferation in the PVB/propofol 
group and the GA group. Perez-Gonzalez et al. (2017) stated that neither of these studies 
(Looney et al., 2010; O’Riain et al., 2005) identified that the type of anesthesia given had 
any impact on concentrations of GF growth factor in the postoperative period. Two 
studies identified women who received GA showed significant decrease in NK cell 
function and count (Ramirez et al., 2015; Woo et al., 2015). Perez-Gonzalez et al. (2017) 
concluded that regional anesthesia could amend the suppressive effects of surgery on 
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human cells from avoiding harmful volatile anesthetics and opioids. Three studies 
(Deegan et al., 2010; O’Riain et al., 2005; Sultan, 2013), which focused on inflammatory 
mediators and surgical stress, demonstrated insignificant differences in markers of 
inflammation and stress response between regional and general anesthesia (Perez-
Gonzalez et al., 2017).   
Perez-Gonzalez et al. (2017) reviewed 4 RCTs (Buckley, McQuaid, Johnson, & 
Buggy, 2014; Deegan et al., 2009; Desmond, McCormack, Mulligan, Stokes, & Buggy, 
2015; Jaura, Flood, Gallagher, & Buggy, 2014) that investigated the impact of PVB on 
immune response and cancer cell function. A study by Deegan et al. (2009) showed 
reduction in breast cancer cells in the PVB/propofol group, while Desmond et al. (2015) 
showed an increase in NK cells and T-helper cells to breast cancer tissue in the 
PVB/propofol group. Buckley et al. (2014) showed the PVB/propofol group preserved 
NK activity, whereas Jaura et al. (2014) showed cancer cell apoptosis was reduced in the 
GA group, but that cancer cell viability was mutually the same in both groups. Women 
who received GA in these four studies (Buckley et al., 2014; Deegan et al., 2009; 
Desmond et al., 2015; Jaura et al., 2014) showed a significant decrease in NK cell 
function and count. A conclusion was made stating regional anesthesia could ameliorate 
the suppressive effects from surgical impacts, volatile anesthetic impact and opioid 
impact on these cells. Two studies involving anesthetic effect during breast cancer 
surgery on proliferation and apoptosis of cells showed antiapoptotic effects from women 
who received a GA and inhibition of cell proliferation after exposure to PVB (Deegan et 
al., 2010; Jaura et al., 2014). Buckley et al.  (2014) and Desmond et al. (2015) showed 
that after mastectomy surgery, women who received PVB anesthesia demonstrated NK 
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cell preservation vs. women in the GA group (Perez-Gonzalez et al., 2017). 
This review by Perez-Gonzalez et al. (2017) found a low level of supportive 
evidence of the impact of RA on survival outcomes after surgical intervention for breast 
cancer. Perez-Gonzalez et al. (2017) identified only one of the RCTs positively tested the 
hypothesis: PVB reduced the rate of recurrence after breast cancer surgery. This review 
further identified significant limits including: the retrospective designs, various statistical 
analysis, selection bias, heterogeneity in type of anesthesia technique used, and lack of 
detailed information on tumor description including size, stage, and adjuvant treatments 
(chemo/radiation). Perez-Gonzalez et al. (2017) concluded that there was a lack of 
persuasive data to support, or contest, a positive association between regional PVB and a 
reduction in cancer recurrence and improved overall survival rates. The data does, 
however, support PVB’s effect on decreasing the inflammatory response and it may 
prevent immune suppression during surgery. The authors identified the need for future 
large RCTs to further explore the anti-inflammatory effects of PVB and propofol as a 
combination to prevent immune suppression (Perez-Gonzalez et al., 2017).  
Cross Study Analysis 
 In this portion of the integrative review, a cross analysis of the included studies is 
presented. Appendix C illustrates findings and themes in each study. The risk of 
recurrence was a main outcome examined in this review. Biki et al. (2008), Chen and 
Miao, (2013), Cummings et al. (2012), Exadaktylos et al. (2006), Jang et al. (2016), and 
Perez-Gonzalez et al. (2017) all examined recurrence risk, and/or time to recurrence, in 
cancer patients after surgical intervention. The use of regional anesthesia as an adjuvant 
or a substitute for general anesthesia was found to decrease the risk of recurrence in 2 out 
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of the 6 studies (Biki et al., 2008; Exadaktylos et al., 2006). Jang et al. (2016) had found 
general anesthesia to have a longer recurrence free time compared to epidural anesthesia 
but did not show a normal distribution or statistical significance after the Kruskal-Wallis 
test was performed. The definition of recurrence free time was not uniform in any of the 
cancer recurrence studies (Biki et al., 2008; Chen & Miao, 2013; Cummings et al., 2012; 
Exadaktylos et al., 2006; Jang et al., 2016; Perez-Gonzalez et al., 2017).  
The next outcome investigated was the 3 or 5- yr. survival time for post-surgical 
patients. Five out of the 8 studies examined the survival times in the oncological surgical 
patient after either regional anesthesia or general anesthesia use (Chen & Miao, 2013; 
Cummings et al., 2012; Jang et al., 2016; Lin et al., 2011; Perez-Gonzalez et al., 2017). 
Significance was found between regional anesthesia use and increased survival in all 
studies (Chen & Miao, 2013; Cummings et al., 2012; Jang et al., 2016; Lin et al., 2011) 
except Perez-Gonzalez et al. (2017). Perez-Gonzalez et al. (2017) found no supportive 
data that the use of PVB showed any improvement in overall cancer-related survival. 
Perez-Gonzalez et al. (2017) did identify the use of PVB on improved immune responses 
in patients compared to those who underwent general anesthesia.  
 The effect of regional anesthesia vs. general anesthesia on the immune system of 
the oncological patient after surgical intervention was investigated in 8 of the studies. 
Cho et al., (2017) and Perez-Gonzalez et al. (2017) examined the impact of anesthesia 
technique on the immune system and both found the use of propofol to have beneficial 
effects on NK cell preservation. 
Age had a correlation with survival in several studies (Cummings et al., 2012; 
Jang et al., 2016). Cummings et al. (2012) noted after logistic regression analysis that 
 
 
49 
 
increasing age had an association with a lower risk of cancer recurrence. Jang et al. 
(2016) identified older age as an independent factor to a reduced 5-yr. survival. Smoking 
was identified as a contributor to bladder cancer but did not have significant impact on 5-
yr. survival or recurrence rates (Jang et al., 2016). Anesthesia time showed a positive 
correlation with recurrence and/or survival time (Biki et al., 2008; Jang et al., 2016; Lin 
2011).  
Many limits were noted in each study. Retrospective, non-randomized studies 
were a primary limit noted by authors (Biki et al., 2008; Exadaktylos et al., 2006; Lin et 
al., 2011) and non-standardized care was another common limit (Chen & Miao, 2013; 
Cummings et al., 2012; Exadaktylos et al., 2006; Jang et al., 2016; Lin et al., 2011; Perez-
Gonzalez et al., 2017). The inability to identify respective effects of independent drugs on 
survival time, recurrence and immune alteration is a limit across all studies. Final 
conclusions were made by numerous authors that the need for large, randomized, 
prospective studies is needed to identify association of regional anesthesia on recurrence 
(Biki et al., 2008; Chen & Miao, 2013; Cummings et al., 2012; Exadaktylos et al., 2006; 
Jang et al., 2016; Perez-Gonzalez et al., 2017), and overall survival (Chen & Miao, 2013; 
Cummings et al., 2012; Jang et al., 2016; Lin et al., 2011; Perez-Gonzalez et al., 2017). 
Future studies on methods to alleviate immunosuppression in surgery for cancer patients 
is warranted (Cho et al., 2017). 
Next, the summary and conclusions will be presented. 
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Summary and Conclusions 
Anesthesia is an essential piece of the surgical care plan. The wide variety of 
techniques used for surgery allows for individualized care plans to promote the best 
possible outcomes for susceptible cancer patients. Evidence regarding cell modulation 
and immune inhibition in humans after exposure to regional anesthesia and/or general 
anesthesia has been explored. With the substantial amount of research on the anesthetic 
techniques for oncological patients, evidence on best practice is not clearly defined or 
unanimous amongst all studies. All relevant literature was compared to examine the 
evolution and advances in research related to anesthesia's effect on immunomodulation 
and cancer recurrence. By comprehensively reviewing the related literature, a better 
understanding of existing relationships between anesthetics and the effects on cancer 
recurrence in the surgical patient was identified. 
Whittemore and Knafl’s, (2005) modified integrative review framework was used 
to guide this review. A literature review was carried out which explored the impact of 
anesthesia on the immune system and its effects on survival and recurrence in susceptible 
primary cancer patients. Following the literature review, a detailed search of relevant 
studies on anesthesia and its impact on cancer patients after surgical interventions were 
explored. Search strategies and key words are located in the methods section. All studies 
used for this project are reviewed in the results section.  
Exadaktylos et al. (2006) conducted a retrospective study to investigate the 
association between anesthetic technique and the recurrence or metastasis of breast 
cancer after surgical intervention. Two groups were formed: patients who received 
paravertebral anesthesia and analgesia (n=50) and patients who underwent general 
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anesthesia and received postoperative morphine (n=79). The authors noted no significant 
differences between the patients regarding tumor presentation, prognostic factors, or 
surgical details. Exadaktylos et al. (2006) identified that using PVB for breast cancer 
surgical patients reduced the risk of recurrence or metastasis. Exadaktylos et al. (2006) 
reported that regional anesthesia may play an important role in preserving immune 
function during surgical intervention. This technique is thought to decrease the GA and 
opioid requirements that are known to suppress the immune system, and thus reduce the 
risk of tumor metastasis and/or recurrence. 
Biki et al. (2008) conducted a retrospective study to investigate anesthetic 
technique for radical prostatectomy surgery. The endpoint for data collection included 
evaluating elevation in PSA in the postoperative phase and recurrence free time, after 
receiving either a combined general anesthesia and epidural analgesia or general 
anesthesia with traditional opioid analgesia. Biki et al. (2008) concluded that substituting 
epidural analgesia for postoperative opioids was associated with less risk of elevated PSA 
levels and cancer recurrence.  
Lin et al. (2011) conducted a retrospective review of women who underwent 
surgical interventions for ovarian serous adenocarcinomas from 1994 to 2006 under the 
use of general anesthesia (GA) versus epidural anesthesia (EA). The primary outcome 
measured in this study was death rate by survival analysis. Results suggested that patients 
who underwent surgical intervention for ovarian serous adenocarcinoma with EA had 
better survival outcomes than GA patients due to the lack of immunosuppression from 
preserved NK cell activity and the decreased use of opioids in the epidural group.  
Cummings et al. (2012) conducted a population-based study and compared 
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epidural/analgesia and traditional pain management on cancer recurrence and survival 
after colectomy for colon cancer. Cummings et al. (2012) found recipients of blood 
transfusions showed a significant relation to cancer recurrence. The difference in survival 
rates between cohorts suggests that epidural use may be a preferable solution to pain 
management. Cummings et al. (2012) identified epidural use to be associated with 
improved survival rates in the colorectal cancer patient who underwent resection, but no 
significant relationship was made between epidural use and a reduction in cancer 
recurrence. 
Chen and Miao (2013) conducted a meta-analysis on the effects of anesthetic 
technique and survival in human cancers. Patients with cancer who underwent surgical 
intervention under epidural anesthesia (EA) vs. general anesthesia were evaluated. The 
primary outcome measures included recurrence free survival (RFS- from day of surgery 
to first disease relapse from primary cancer) and overall survival (OS- from day of 
surgery until death). Chen and Miao (2013) identified a positive association between OS 
and EA in the colorectal cancer patient. The analysis proposed that epidural 
anesthesia/analgesia may be associated with improved overall survival but did not 
support an association between cancer control and epidural anesthesia. 
Jang et al. (2016) conducted a retrospective review of anesthetic technique effect 
on 5-year survival and cancer recurrence rates after transurethral resection for bladder 
tumors. The primary measure outcome was to identify which anesthetic approach had 
better overall cancer outcomes measuring 5-year recurrence and overall recurrence free 
time. Jang et al. (2016) found that 5-year survival was higher in patients whose surgery 
was completed with regional anesthesia compared to general anesthesia through partial 
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correlation. However, significance was not found using the chi-square test and logistic 
regression.  
Cho et al. (2017) conducted a randomized prospective study to explore the effects 
of perioperative anesthesia and analgesia on the immune function of breast cancer 
patients undergoing resection. Primary outcome measures included the effects of two 
different anesthesia and analgesia methods on NK cell cytotoxicity (NKCC) in patients 
undergoing breast cancer surgery. Cho et al. (2017) found an increase in NK cell counts 
in the P-R-K groups and a decrease in NKCC in the S-R-F group postoperatively. Cho et 
al. (2017) concluded that Propofol anesthesia with Ketorolac showed a positive impact on 
immune function by preservation of NK cell counts compared to Sevoflurane and 
Fentanyl.  
Perez-Gonzalez et al. (2017) conducted a systematic review of literature on the 
impact of regional anesthesia on the recurrence/metastasis and the immune response in 
the breast cancer patient after surgical intervention. Perez-Gonzalez et al. (2017) found 
insufficient data to support or contest the use of a PVB in decreasing cancer recurrence or 
increasing cancer survival rates. However, a reduction in inflammation and improved 
immune responses were noted in the PVB group compared to the general anesthesia 
group.  
This review has identified a positive relationship between the use of epidural 
anesthesia and decreased cancer recurrence in 2 out of the 8 studies (Biki et al., 2008; 
Exadaktylos et al., 2006). Three out of the 8 studies found increased overall survival rates 
with the use of regional anesthesia versus general anesthesia (Chen and Miao, 2013; 
Cummings et al., 2012; Lin et al., 2011). Two of the 8 studies found no associations 
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between decreased cancer recurrences or increased overall survival with regional 
anesthesia versus general anesthesia (Jang et al., 2016; Perez-Gonzalez et al., 2017). Two 
studies identified preservation of NK cells and decreased immunosuppression with 
epidural use (Cho et al., 2017; Lin et al., 2011). 
This review has identified marginal evidence that regional anesthesia, when 
compared to general anesthesia, promotes better long-term outcomes for the oncological 
surgical patient. This review has several limitations which must be acknowledged. The 
addition of opioid analgesia to numerous regional anesthesia regimens has a known effect 
on immune suppression and may have had a substantial impact on the outcomes of the 
studies. The studies included are mostly retrospective and the authors of all the above 
studies have identified the need for larger prospective randomized control studies to be 
performed to identify significant evidence of the proposed hypothesis that regional 
anesthesia is better suited for the vulnerable patient in preserving immune function and 
preventing cancer recurrence/metastasis.  
In conclusion, anesthetic agents and opioids can alter the systemic inflammatory 
response during surgical interventions. By modulating the immunologic mechanism 
within the body, direct effects on tumor growth rate and recurrence rate are possible. By 
impairing cellular immunity and blocking the body’s natural fighting mechanisms, 
accelerated cell growth and cancer recurrence becomes possible. The use of regional 
anesthesia during surgical interventions has shown the ability to minimize the stress 
response, preserve NK cell defenses, provide an anticancer immunity, decrease cancer 
recurrence rates and improve overall cancer survival. Extensive research is still required 
to show the positive relationship between regional techniques and cancer survival.  
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Next, the recommendations and implications for advanced nursing practice is 
presented.  
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Recommendations and Implications for Advanced Nursing Practice 
  Evidence-based research affords practitioners ways to deliver better patient care 
for improved patient outcomes. The objective of an integrative review is to deliver a 
current synthesis of knowledge regarding a clinical problem for a specific population, 
using evidence-based research to support practice. Advanced practice registered nurses 
(APRNs), such as the Certified Registered Nurse Anesthetist (CRNA) must strive to 
deliver safe care, using evidence-based practice, to improve the quality of life for the 
patient. Understanding the effects of anesthetics on the immune system and providing the 
safest delivery should be a standard of care, especially for susceptible cancer patients. 
Other than metastasis in the cancer patient, non-cancer patients are also at risk for life 
threatening infections from immune suppression. The importance of this review is for 
practitioners to understand what is being delivered to their patients, the harmful effects 
that could result from immune suppression and alternatives to bypass or minimize 
potential hazards. Identifying alternative ways to provide anesthesia/analgesia to facilitate 
surgical treatment to avoid, or minimize, immune suppression for cancer patients is 
imperative. A comprehensive synthesis of research which recommends RA use over GA 
use has been included.  
Collaboration in the medical field is necessary to ensure best practice and 
outcomes. This starts with the registered nurse in the preoperative period prior to entering 
the operative room. The administration of opioids begins the cascade of altering the 
immune system defenses. Entering the operating room and starting the induction of 
anesthesia with the CRNA and the anesthesiologist is the next insult to the defense 
system. Administration of volatile gases from the anesthesia team and the response to 
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surgical stress initiated by the surgeon, is the third insult. Postoperative care involving 
patient controlled opioid pumps ordered by APRNs and medical doctors, is a potential 
fourth insult to the immune system. There are many contributors impacting the overall 
outcome for the surgical patient.  
Although the CRNA does not always decide on the full plan of care for the 
patient, they can propose recommendations based on the best evidence. Staying up-to-
date with current research is a necessity to provide satisfactory care. Educating APRNs, 
registered nurses, surgeons, and anesthesiologists via research dissemination, as well as 
best practice alert emails, would be a way to integrate significant empirical evidence with 
current practices. Educating surgeons on the benefits of epidural anesthesia and the 
ability to perform certain surgeries and provide postoperative pain control via this method 
could ameliorate immune defense dysfunction. Educating registered nurses on 
alternatives to opioid analgesia could prompt them to suggest future alternatives for their 
patients. Advocating for regional anesthesia workshops for both CRNAs and 
anesthesiologists to enhance skills would be a great way to promote an increase in 
frequency of regional anesthesia use.  
Based on this review, the CRNA can make evidence based clinical decisions to 
improve outcomes and avoid future risks for susceptible patients. Assisting as a 
researcher, educator, advocate and mentor are responsibilities of the CRNA, and will be 
needed to foster clinical practice change. Understanding immune effects from everyday 
used medications may help educate and change future practice. As the CRNAs scope of 
practice evolves to meet the needs of individual patients, an understanding of this 
important topic is necessary and will be a common topic for discussion in the near future. 
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This review will be helpful in providing supporting evidence for future research. The 
information provided is relevant and consistent, however, the need for large prospective 
trials are still warranted. 
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Appendix A-1 
Exadaktylos, Buggy, Moriarty, Mascha, and Sessler. (2006). Can anesthetic technique for 
primary breast cancer surgery affect recurrence or metastasis?  
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title is 12 words in length and 
clearly identifies for the reader the 
purpose of the study. It identifies 
what is to be studied and the 
population being assesses 
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• Authors provide the reader with a 
succinct overview of the study and 
include information regarding the 
purpose, the methods and sample 
size, findings and conclusions.   
  
Introduction 
Statement of the 
problem 
Was the problem stated 
unambiguously, and 
was it easy to identify? 
 
Does the problem 
statement build a 
persuasive argument for 
the new study? 
 
Was there a good match 
between the research 
problem and the 
methods used –that is, 
was a quantitative 
approach appropriate? 
• The problem statement was concise 
and easy to understand and locate by 
the reader.   
• The authors identify the effect of 
anesthetic technique on breast 
cancer outcome had not been 
conducted in the clinical setting.  
• The problem statement built a good 
argument for this study. Authors 
acknowledged previous studies have 
shown perioperative factors, 
including regional anesthesia and 
postoperative analgesia have shown 
reductions in the metastatic problem 
in animals with breast 
adenocarcinomas.   
• Authors recognize that inhibition of 
the surgical stress response by 
paravertebral anesthesia could 
attenuate perioperative factors that 
enhance tumor growth and spread. 
Authors build their argument for the 
study by identifying limited research 
on the effect of anesthetic technique 
on breast cancer outcomes in the 
clinical setting. 
Hypotheses or 
research 
questions 
Were research questions 
and/or hypotheses 
explicitly stated?  If not, 
• The authors hypothesized that breast 
cancer patients undergoing surgery 
with PVB combined with general 
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was their absence 
justified? 
 
Were questions and 
hypotheses 
appropriately worded, 
with clear specification 
of key variables and the 
study population? 
 
Were the 
questions/hypotheses 
consistent with existing 
knowledge? 
anesthesia have a lower incidence of 
cancer recurrence/metastases than 
patients undergoing surgery with 
general anesthesia and patient-
controlled morphine analgesia. 
• The hypothesis was consistent with 
existing knowledge supported by 
background information as well as 
the literature review. 
Literature 
review 
Was the literature 
review up-to-date and 
based mainly on 
primary sources? 
 
Did the review provide 
a state-of-the-art 
synthesis of evidence on 
the problem? 
 
Did the literature review 
provide a strong basis 
for the new study? 
• The literature review is based 
mainly on primary sources from 
1998-2005. 
• The authors discuss the 
understanding that regional 
anesthesia attenuates the surgical 
stress response by the blocking of 
afferent neural transmission. Further 
the authors explain the PVB 
anesthesia and its use in suppression 
of surgical stress response in breast 
cancer surgery, without a reduction 
in associated tumor cell 
angiogenesis.  This has been 
explored in animals but not in 
human clinical settings.  
• The introduction sets the stage for 
the new study by describing the gap 
of breast cancer outcomes not being 
evaluated in the clinical setting. 
Conceptual/ 
theoretical 
framework 
Were key concepts 
adequately defined 
conceptually? 
Was a 
conceptual/theoretical 
framework 
articulated—and, if so, 
was it appropriate?  If 
not, is the absence of a 
framework justified? 
Were the 
questions/hypotheses 
• Key concepts were addressed and 
with brief conceptual definitions.  
• Concepts were defined to a specific 
population. Authors did not further 
explore/explain regional anesthesia 
for the general population.  
• No framework was articulated in 
this study.  
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consistent with the 
framework? 
Method 
Protection of 
human rights 
Were appropriate 
procedures used to safe-
guard the rights of study 
participants? 
 
Was the study 
externally reviewed by 
an IRB/ethics review 
board? 
Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
• Approval was obtained by the ethics 
committee of the Mater 
Misericordiae University Hospital, 
Dublin, Ireland. 
• This type of study was designed to 
minimize risks and maximize 
benefits to future breast cancer 
patients. 
Research design Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of data 
collection points 
appropriate? 
 
Did the design 
minimize biases and 
threats to the internal, 
construct, and external 
validity of the study 
(e.g., was blinding used, 
was attrition 
minimized)? 
• A Retrospective design is not the 
most rigorous design that could be 
used for this study purpose. 
Randomized control trials would be 
the most rigorous design. This 
retrospective study was used to 
review past cases to evaluate the 
effects of PVB vs. GA and the 
effects on cancer recurrence and 
metastasis.  
• Appropriate comparisons were made 
to enhance the findings including 
anesthetic technique, age, time from 
surgery to recurrence, duration of 
surgery, blood loss during surgery, 
pain score, tumor grades, lymph 
node involvement.  
• Numbers of PVB/GA vs. 
GA/morphine were not even and 
could have included a larger sample 
size.  
• The same anesthetist placed all PVB 
catheters, and the same surgeon 
performed all of the operations, and 
the oncologist for all the patients 
was the same as well.  
• With operations, data entry and 
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collection already completed, this 
compromises the study and is 
considered selection bias as well. 
Other biases include lack of follow-
up and unknown deaths.  
Population and 
sample 
Was the population 
identified?  Was the 
sample described in 
sufficient detail? 
 
Was the best possible 
sampling design used to 
enhance the sample?  
Were sampling biases 
minimized? 
 
Was the sample size 
based on a power 
analysis? 
• The population was clearly 
identified as breast cancer patients 
who underwent mastectomy with 
axillary clearance or simple 
mastectomy from Sept. 2001-Dec. 
2002.  
• Retrospective studies have selection 
bias because the population was 
based on treatment and outcomes 
and is predetermined without 
randomization.  
• Sample size was not based on a 
power analysis.  
Data collection 
and 
measurement 
 
 
 
Were the operational 
and conceptual 
definitions congruent? 
 
Were key variables 
measured using an 
appropriate method? 
 
Were specific 
instruments described 
and were they good 
choices, given the study 
population and the 
variables being studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Operational and conceptual 
definitions are congruent and well 
defined. The authors explored 
regional and general anesthesia 
impact on cancer 
recurrence/metastasis.  
• The main outcome measure was the 
incidence of metastatic spread or 
cancer recurrence.  
• Specific instruments used were 
described and were good choices for 
the type of study.  
Procedures If there was an 
intervention, was it 
adequately described, 
and was it rigorously 
developed and 
implemented?  
• Retrospective, observational designs 
are not randomized so selection bias 
and effects of unmeasured 
confounding variable cannot be 
excluded.  
• Data collected is prone to selection 
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 Did most participants 
allocated to the 
intervention group 
actually receive it?  
Was there evidence of 
intervention fidelity? 
 
Were data collected in a 
manner that minimized 
bias?  Were the staff 
who collected data 
appropriately trained? 
bias, as mentioned above. Staff 
collecting data however are 
appropriately trained: staff includes 
a researcher anesthesia, senior 
lecturer in anesthesia, professors in 
anesthesia, a statistician of 
quantitative health science, and a 
director of outcomes research.  
Data Analysis Were analyses 
undertaken to address 
each research question 
or test each hypothesis? 
 
Were appropriate 
statistical methods used, 
given the level of 
measurement of the 
variables, number of 
groups being compared, 
and assumptions of the 
texts? 
 
Was a powerful analytic 
method used?  (e.g., did 
the analysis help to 
control for confounding 
variables)? 
 
In intervention studies, 
was an intention-to-treat 
analysis performed? 
• The main outcome measure was the 
incidence of metastatic spread or 
cancer recurrence after use of 
regional or general anesthesia. 
• All of the data was recorded in 
coded Excel form and imported into 
SAS statistical software for analysis.  
• Appropriate statistical methods were 
used. 
• t- tests were used to compared 
normally distributed continuous 
variables, and non-normal variables 
were compared with Mann–Whitney 
U tests.  
• Categorical variables were 
compared with chi-square tests or 
Fisher exact tests. 
• A Kaplan-Meier log-rank test was 
used for univariable analysis. 
• Cox proportional hazards regression 
was used for multivariable analysis 
of the time to recurrence of cancer 
between groups. Factors for the 
multivariable model; age, family 
history of cancer, tumor size, 
histologic grade, duration of 
surgery, and blood loss. 
• All factors significant at p < 0.25 
were retained in the model. 
Associations with p <0.05 were 
deemed statistically significant. 
 
  
 
 
 
73 
 
Data Analysis 
(continued) 
Were problems of 
missing values 
evaluated and 
adequately addressed? 
 
• One patient died in GA group and no 
further values were used for this 
patient.  
• Unmeasured confounding variables 
cannot be excluded given the 
retrospective design.  
• The amounts of opioids given, and 
the type of chemotherapy were not 
available in the patient records.  
Findings Was information about 
statistical significance 
presented?  Was 
information about 
effect size and 
precision of estimates 
(confidence intervals) 
presented? 
 
Were the findings 
adequately 
summarized, with good 
use of tables and 
figures? 
 
Were findings reported 
in a manner that 
facilitates a meta-
analysis, and with 
sufficient information 
needed for EBP? 
• Statistical significance was presented. 
Information about effect size and 
precision estimates were presented.  
• The findings were adequately 
summarized and both tables and 
narrative forms were used to do so.   
• Confidence intervals were provided. 
Discussion 
Interpretation 
of the findings 
Were all major 
findings interpreted 
and discussed within 
the context of prior 
research and/or the 
study’s conceptual 
framework? 
 
Were casual 
inferences, if any, 
justified? 
 
Was the issue of 
clinical significance 
discussed? 
 
• Major findings were discussed within 
the context of prior research and the 
study’s research findings. 
• Exadaktylos et al. (2006) conclude 
that regional anesthesia may play an 
important role in maintaining immune 
function during surgical intervention.  
• Authors found significance in their 
hypothesis: PVB for breast cancer 
surgery reduces the risk of 
recurrence/metastasis fourfold during 
a 2.5 to 4 yr. follow up. 
• Limitations were addressed; lack of 
randomization of patients, non-
standardized clinical care, selection 
bias and effect of unmeasured 
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Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
Did the report address 
the issue of the 
generalizability of the 
findings? 
confounding variables.    
Implications/ 
recommendati- 
ons 
Did the researchers 
discuss the 
implications of the 
study for clinical 
practice or further 
research—and were 
those implications 
reasonable and 
complete? 
• Exadaktylos et al. (2006) believe they 
generated a hypothesis and that an 
estimated effect size for future large 
randomized controlled trails is 
warranted.  
General Issues 
Presentation 
Was the report well-
written, organized, and 
sufficiently detailed for 
critical analysis? 
 
In intervention studies, 
was a CONSORT 
flowchart provided to 
show the flow of 
participants in the 
study? 
• The report was well-written and 
organized with good flow and clear 
statistical information.  
• A consort flowchart was not provided 
in the study. 
General Issues 
Presentation 
(continued) 
Was the report written 
in a manner that makes 
the findings accessible 
to practicing nurses? 
• The report was written for the general 
anesthesia population. Numerous 
definitions are needed for this article 
to be made accessible to all practicing 
nurses.  
• No implication for nursing practice 
was included in the written report. 
Researcher 
credibility 
Do the researchers’ 
clinical, substantive, or 
methodologic 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
• Researchers experience does enhance 
the confidence in the findings and 
interpretations; with backgrounds in 
anesthesia, research and statistics.  
Summary 
assessment 
Despite any 
limitations, do the 
study findings appear 
• Given the limitations, the significance 
values observed can provide strength 
to the research. A larger study would 
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to be valid—do you 
have confidence in the 
truth value of the 
results? 
 
Does the study 
contribute any 
meaningful evidence 
that can be used in 
nursing practice or that 
is useful to the nursing 
discipline? 
be needed to deem truth in the value 
of the results.  
• The study identified a benefit of 
regional anesthesia vs. GA and 
opioids in preserving immune 
function. With this knowledge, the 
study has some external validity. This 
knowledge will help guide practice 
and be useful to anesthesia nursing 
disciplines 
Note. PVB= paravertebral block, GA=general anesthesia 
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Appendix A-2 
 
Biki, Mascha., Moriarty., Fitzpatrick, Sessler, and Buggy. (2008). Anesthetic technique 
for radical prostatectomy surgery affects cancer recurrence: Retrospective analysis  
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title identifies the 
population of interest; 
however, it does not indicate 
which anesthetic techniques 
are being studied.  
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract is organized with 
headings allowing for easy 
reading and identification of 
specific interest.  
Introduction 
Statement of the 
problem 
Was the problem stated 
unambiguously, and 
was it easy to identify? 
 
Is the problem 
statement build a 
persuasive argument 
for the new study? 
 
Was there a good 
match between the 
research problem and 
the methods used –that 
is, was a quantitative 
approach appropriate? 
• The abstract and the 
introduction of this review 
provide the reader with the 
initial concise identification of 
the problem upfront.  
• The problem statement sets the 
stage for an argument for new 
evidence to support the 
hypothesis.  
Hypotheses or 
research questions 
Were research 
questions and/or 
hypotheses explicitly 
stated?  If not, was 
their absence justified? 
 
Were questions and 
hypotheses 
appropriately worded, 
with clear specification 
of key variables and 
the study population? 
 
Were the 
questions/hypotheses 
• The hypothesis was explicitly 
stated: “Recurrence of prostate 
cancer is less common with 
combined general anesthesia 
and epidural analgesia than 
with general anesthesia alone” 
(Biki et al., 2008). 
• The hypothesis was 
appropriately worded including 
the key variables: general 
anesthesia (GA) and epidural 
anesthesia (EA), as was the 
study population, prostate 
cancer patients. However, the 
population studied included 
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consistent with existing 
knowledge? 
only patients who underwent 
an open radical prostatectomy. 
• Hypothesis was consistent with 
existing knowledge and 
supported with previous 
studies. 
Literature review Was the literature 
review up-to-date and 
based mainly on 
primary sources? 
 
Did the review provide 
a state-of-the-art 
synthesis of evidence 
on the problem? 
 
Did the literature 
review provide a strong 
basis for the new 
study? 
• The literature review was 
thoroughly written and easy to 
read.  
• The primary objective was 
identified: Post prostatectomy 
increase in PSA is indicative of 
metastatic spread or local 
cancer recurrence.  
• The literature review provided 
a strong background of 
knowledge to facilitate the 
need for a new study.  
Conceptual/theoretical 
framework 
Were key concepts 
adequately defined 
conceptually? 
 
Was a 
conceptual/theoretical 
framework 
articulated—and, if so, 
was it appropriate?  If 
not, is the absence of a 
framework justified? 
 
Were the 
questions/hypotheses 
consistent with the 
framework? 
• Conceptual definitions are 
clearly defined, with a clear 
understanding for the 
investigation.  
• No framework was utilized. 
•  
Method 
Protection of human 
rights 
Were appropriate 
procedures used to 
safe-guard the rights of 
study participants? 
 
Was the study 
externally reviewed by 
an IRB/ethics review 
board? 
 
• Approval from the ethics 
committee of the Mater 
Misericordiae University 
Hospital was obtained prior to 
medical record review.  
• Only records of patients with 
invasive prostatic carcinoma 
who underwent an open radical 
prostatectomy were included. 
• Clear identification of what 
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Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
was reviewed in each chart was 
documented.  
Research design Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of 
data collection points 
appropriate? 
 
Did the design 
minimize biases and 
threats to the internal, 
construct, and external 
validity of the study 
(e.g., was blinding 
used, was attrition 
minimized)? 
• The retrospective study was 
appropriate for the goals of the 
study.  
• The primary outcome measure 
was identified and presented to 
the readers: the incidence of 
biochemical recurrence of 
prostate specific antigen.  
• Appropriate comparisons were 
made to enhance the findings.  
• The interval validity of the 
study was compromised using 
opioids in both the general vs. 
the general and epidural 
groups. The knowledge that 
opioids independently impact 
immunosuppression may have 
impacted the outcome of the 
study results.  
Population and 
sample 
Was the population 
identified?  Was the 
sample described in 
sufficient detail? 
 
Was the best possible 
sampling design used 
to enhance the 
sample’s 
representativeness?  
Were sampling biases 
minimized? 
 
Was the sample size 
based on a power 
analysis? 
• The population was clearly 
identified- prostate cancer 
patients who underwent an 
open radical prostatectomy. 
Clear inclusion and exclusion 
criteria were provided.  
• The design chosen was 
appropriate for the study.  
• Sampling was not random, the 
retrospective designed 
reviewed patients who 
underwent open radical 
prostatectomy. 
• The sample was not based on a 
power analysis. 
Data collection and 
measurement 
 
 
 
Were the operational 
and conceptual 
definitions congruent? 
 
Were key variables 
• Operational and conceptual 
definitions for the study were 
congruent.  
• Key variables were measured 
appropriately. 
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measured using an 
appropriate method 
(e.g., interviews, 
observations, and so 
on)? 
 
Were specific 
instruments adequately 
described and were 
they good choices, 
given the study 
population and the 
variables being 
studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Adequate descriptions of 
anesthetic techniques used for 
each group was described in 
detail with each variable 
reviewed. 
• The report provided evidence 
that the data collected was 
reliable and valid. 
• Specific instruments were used 
to describe the variables 
studied.  
Procedures If there was an 
intervention, was it 
adequately described, 
and was it rigorously 
developed and 
implemented?  Did 
most participants 
allocated to the 
intervention group 
actually receive it?  
Was there evidence of 
intervention fidelity? 
 
Were data collected in 
a manner that 
minimized bias?  Were 
the staff who collected 
data appropriately 
trained? 
• No interventions were 
developed in the retrospective 
study. 
• A sensitivity analysis was 
utilized in this study to explore 
the potential for bias. 
• Selection bias and unmeasured 
confounding variables could be 
factors for limitation. 
• Data collection staff was not 
described in the study.  
Data Analysis Were analyses 
undertaken to address 
each research question 
or test each 
hypothesis? 
 
• Comparison of anesthetic 
technique groups on 
recurrence-free survival was 
completed. The multivariable 
cox proportional hazards 
regression was used.  
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Were appropriate 
statistical methods 
used, given the level of 
measurement of the 
variables, number of 
groups being 
compared, and 
assumptions of the 
texts? 
 
Was a powerful 
analytic method used?  
(e.g., did the analysis 
help to control for 
confounding 
variables)? 
 
Were type I and Type 
II errors avoided or 
minimized? 
 
In intervention studies, 
was an intention-to-
treat analysis 
performed? 
• t-tests and Wilcoxon rank sum 
test were used for continuous 
variables. 
• Stepwise regression was used 
with a significance value of p 
<0.30. 
• Comparisons were made with 
the log rank test 
• All potential confounding 
variables were tested using the 
Cox proportional hazards 
regression. 
• Authors of the study identified 
a decreased risk of cancer 
recurrence when substituting 
epidural analgesia for post-
operative opioids. 
Data Analysis 
(continued) 
Were problems of 
missing values 
evaluated and 
adequately addressed? 
 
• N/A 
Findings Was information about 
statistical significance 
presented?  Was 
information about 
effect size and 
precision of estimates 
(confidence intervals) 
presented? 
 
Were the findings 
adequately 
summarized, with good 
use of tables and 
figures? 
Were findings reported 
in a manner that 
• Statistical significance was 
adequate presented by the 
authors as was effect size and 
confidence intervals.  
• Use of tables were utilized to 
provide a clear understanding 
of the findings and to facilitate 
a future analysis. 
• EA group was noted with more 
postoperative complications 
including pneumonia, 
postoperative bleeding and 
other respiratory 
complications. These variables 
were included in the 
multivariate model. 
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facilitates a meta-
analysis, and with 
sufficient information 
needed for EBP? 
• Patients who received EA had 
a lowed estimated risk of 
recurrence to that of GA group. 
• Research data is for a 
retrospective review and could 
be used for meta-analysis. 
Discussion 
Interpretation  
of the findings 
Were all major 
findings 
interpreted/discussed 
within the context of 
prior research and/or 
the study’s conceptual 
framework? 
 
Were casual 
inferences, if any, 
justified? 
 
Was the issue of 
clinical significance 
discussed? 
 
Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
 
Did the report address 
the issue of the 
generalizability of the 
findings? 
• Major findings were 
interpreted and discussed. 
• Biki et al. (2008) identified a 
57% lower risk in the EA 
group for cancer recurrence 
compared to GA group.  
• Propensity matching showed 
similar results of 52% lower 
risk in the EA group for cancer 
recurrence compared to the GA 
group.  
• Limitations included: non-
randomized, non-standardized 
clinical care, imprecise data 
due to wide CI, retrospective, 
observational design. Selection 
bias and unmeasured 
confounding variables cannot 
be dismissed.  
• Biki et al. (2008) acknowledge 
similar results in a previous 
report in women who 
underwent breast cancer 
surgical intervention.  
• The need for a larger 
randomized control trial is 
warranted.  
•  
Implications/ 
recommendati- 
ons 
Did the researchers 
discuss the 
implications of the 
study for clinical 
practice or further 
research—and were 
those implications 
reasonable and 
complete? 
• Biki et al. (2008) discussed the 
implications of the study and 
the need for a larger 
randomized control trial. 
General Issues 
Presentation 
Was the report well-
written, organized, and 
• The retrospective analysis was 
well written and organized. 
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sufficiently detailed for 
critical analysis? 
 
In intervention studies, 
was a CONSORT 
flowchart provided to 
show the flow of 
participants in the 
study? 
Easy to read for any medical 
professional. Consort flow 
charts were not included. 
General Issues 
Presentation 
(continued) 
Was the report written 
in a manner that makes 
the findings accessible 
to practicing nurses? 
• The report was written to be 
understood by medical 
professional but finding 
accessible to anesthesia 
providers and surgeons.  
Researcher credibility Do the researchers’ 
clinical, substantive, or 
methodologic 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
• This article came from the 
Anesthesiology Journal, and 
the qualifications enhance 
confidence in the findings and 
interpretations.  
Summary assessment Despite any 
limitations, do the 
study findings appear 
to be valid—do you 
have confidence in the 
truth value of the 
results? 
 
Does the study 
contribute any 
meaningful evidence 
that can be used in 
nursing practice or that 
is useful to the nursing 
discipline? 
• The study does contribute 
meaningful evidence, however, 
the need for a larger sample 
size with similar ages and 
randomization are still 
recommended. 
•  
Note. RA= regional anesthesia, EA= epidural anesthesia, GA= general anesthesia  
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Appendix A-3 
 
Lin, Liu, Tan, Ouyang, Zhang, and Zeng. (2011).  Anesthetic technique may affect 
prognosis for ovarian serous adenocarcinoma: a retrospective analysis.  
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title for this article describes the 
key points for this retrospective 
analysis. Central topics include 
anesthesia technique and ovarian 
serous adenocarcinoma. The study 
population was identified. The title 
however did not communicate the 
nature of the analysis of what 
specific technique was being 
compared.  
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract was written as a 
traditional abstract with 
subheadings. The abstract was 
detailed with major aspects of the 
study described. 
Introduction 
Statement of 
the problem 
Was the problem stated 
unambiguously, and was 
it easy to identify? 
 
Does the problem 
statement build a 
persuasive argument for 
the new study? 
 
Was there a good match 
between the research 
problem and the 
methods used –that is, 
was a quantitative 
approach appropriate? 
• The problem was stated and easily 
identifiable. Ovarian serous tumors 
were described as the most common 
ovarian epithelial tumor, with 1/3 
being malignant adenocarcinomas.  
• An introduction to regional 
anesthesia and its impact on the 
surgical stress response in 
preserving immune function and 
better long-term outcomes was 
presented. 
Hypotheses or 
research 
questions 
Were research questions 
and/or hypotheses 
explicitly stated?  If not, 
was their absence 
justified? 
 
Were questions and 
hypotheses 
appropriately worded, 
• A research hypothesis was stated 
patients with ovarian serous 
adenocarcinoma who had surgery 
with epidural anesthesia (EA) and 
analgesia would have better long-
term outcome than those who were 
given general anesthesia (GA) and 
IV opioid analgesia. 
• Hypothesis was worded correctly 
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with clear specification 
of key variables and the 
study population? 
 
Were the 
questions/hypotheses 
consistent with existing 
knowledge? 
including the study population. 
• The hypothesis was consistent with 
existing knowledge of other cancer 
types; however, the study was 
performed to prove consistency with 
ovarian adenocarcinoma.  
Literature 
review 
Was the literature 
review up-to-date and 
based mainly on 
primary sources? 
 
Did the review provide 
a state-of-the-art 
synthesis of evidence on 
the problem? 
 
Did the literature review 
provide a strong basis 
for the new study? 
• The literature review ranged from 
1997-2010 from primary sources.  
• The review provided a synthesis of 
the problem, identifying general 
anesthetic effect on immune 
responses by depression of bone 
marrow activity, altering 
phagocytosis by macrophages and 
inducing immunosuppression. 
• A strong basis for a new study was 
provided including evidence that 
several clinical studies have 
observed that different anesthetic 
techniques have effects on tumor 
recurrence, not including ovarian 
serous adenocarcinoma. The 
outcome had not been evaluated in a 
clinical setting for the ovarian serous 
adenocarcinoma.  
Conceptual/ 
theoretical 
framework 
Were key concepts 
adequately defined 
conceptually? 
 
Was a 
conceptual/theoretical 
framework articulated—
and, if so, was it 
appropriate?  If not, is 
the absence of a 
framework justified? 
 
Were the 
questions/hypotheses 
consistent with the 
framework? 
• Key concepts were adequately 
addressed. Authors clearly described 
the actions for the analysis: A 
retrospective analysis of medical 
records was reviewed to compare 
survival time in patients who had 
ovarian serous adenocarcinoma 
surgery with either EA and analgesia 
or GA combined with postoperative 
intravenous analgesia. 
• No framework was articulated.  
Method 
Protection of 
human rights 
Were appropriate 
procedures used to safe-
guard the rights of study 
• The ethics committee of the Sun 
Yat-sen University Cancer Center 
approved the research study. The 
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participants? 
 
Was the study externally 
reviewed by an 
IRB/ethics review 
board? 
 
Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
medical records of all patients who 
underwent ovarian serous 
adenocarcinoma surgery at the 
center between January 1994 and 
October 2006 were reviewed.  
• The retrospective design minimizes 
physical risk to patients and 
maximizes benefits for future cases 
and research. 
Research 
design 
Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of data 
collection points 
appropriate? 
 
Did the design minimize 
biases and threats to the 
internal, construct, and 
external validity of the 
study (e.g., was blinding 
used, was attrition 
minimized)? 
• This retrospective analysis was not 
the most rigorous but was the most 
appropriate design given the study 
purpose.  
• The comparison of EA and GA with 
analgesia was reviewed. 
• The number of data collection points 
was appropriate for the analysis.  
• Survival analysis was made with the 
main outcome measure of death. 
Population and 
sample 
Was the population 
identified?  Was the 
sample described in 
sufficient detail? 
 
Was the best possible 
sampling design used to 
enhance the sample’s 
representativeness?  
Were sampling biases 
minimized? 
Was the sample size 
based on a power 
analysis? 
• A retrospective review of medical 
records identified 143 patients with 
ovarian serous adenocarcinoma who 
underwent surgery; n =106 patients 
and the GA group consisted of n=37 
patients. 
• The sample was described in limited 
detail. 
• No information was provided about 
patients regarding comorbidities or 
social environments.   
• Sample size was not based on a 
power analysis.  
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Data collection 
and 
measurement 
 
 
 
Were the operational 
and conceptual 
definitions congruent? 
Were key variables 
measured using an 
appropriate method 
(e.g., interviews, 
observations, and so 
on)? 
 
Were specific 
instruments adequately 
described and were they 
good choices, given the 
study population and 
the variables being 
studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Operational and conceptual 
definitions were congruent. Use of 
EA vs. GA and its impacts on patient 
outcomes including death rate.  
• Key variables were measured using 
chart reviews for patients from 1994-
2006. 
• Specific instruments were used to 
describe variables for the study. Cox 
regression and Kaplan Meier tests 
were used to identify survival 
significance.  
• Report provided evidence data that 
was reliable and valid.  
Procedures If there was an 
intervention, was it 
adequately described, 
and was it rigorously 
developed and 
implemented?  Did 
most participants 
allocated to the 
intervention group 
actually receive it?  
Was there evidence of 
intervention fidelity? 
 
Were data collected in a 
manner that minimized 
bias?  Were the staff 
who collected data 
appropriately trained? 
• Interventions were not developed for 
this study.  
• Participants were not random, 
allowing for selection bias. 
Data Analysis Were analyses 
undertaken to address 
each research question 
• SPSS software was used for all 
analyses for the hypothesis. 
• A stepwise regression with 
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or test each hypothesis? 
 
Were appropriate 
statistical methods 
used, given the level of 
measurement of the 
variables, number of 
groups being compared, 
and assumptions of the 
texts? 
 
Was a powerful 
analytic method used?  
(e.g., did the analysis 
help to control for 
confounding variables)? 
significance of (p < 0.30)  
• Appropriate statistical methods were 
utilized including; t-test or 
Wilcoxon’s rank-sum test for 
continuous variables to compare base 
confounding variables.  
• Kaplan-Meier survival estimates 
were used for univariate association 
between overall survival and 
anesthetic technique.  
• Groups were compared using the 
log-rank test.  
• Cox proportional hazards regression 
was used for univariate association 
between overall survival and all 
potential baseline confounders.  
• Primary analysis compared survival 
rate by multivariable Cox’s 
proportional hazards regression. 
• Propensity score matching was used 
to assess the strength of the primary 
analysis results between the type of 
anesthesia–analgesia and survival 
rate. 
Data Analysis 
(continued) 
Were problems of 
missing values 
evaluated and 
adequately addressed? 
 
• Missing values were not addressed in 
detail in this study.  
Findings Was information about 
statistical significance 
presented?  Was 
information about effect 
size and precision of 
estimates (confidence 
intervals) presented? 
 
Were the findings 
adequately summarized, 
with good use of tables 
and figures? 
 
Were findings reported 
in a manner that 
facilitates a meta-
analysis, and with 
• Statistical significance was presented 
with information on effect size and 
confidence intervals. 
• Findings were summarized in both 
table and narrative format. 
• Results suggest patients who 
underwent surgical intervention for 
ovarian serous adenocarcinoma 
intervention with EA had better 
survival outcomes than GA patients.  
• Findings were reported in a manner 
that could facilitate a meta-analysis, 
• This research identifies testable 
possibilities.  
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sufficient information 
needed for EBP? 
Discussion 
Interpretation 
of the findings 
Were all major findings 
interpreted and 
discussed within the 
context of prior 
research and/or the 
study’s conceptual 
framework? 
 
Were casual inferences, 
if any, justified? 
 
Was the issue of 
clinical significance 
discussed? 
 
Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
 
Did the report address 
the issue of the 
generalizability of the 
findings? 
• Authors interpreted and discussed 
results in the context of prior 
research for support.  
• Results suggest potential suppression 
of immune defense mechanisms 
during surgery and in the 
postoperative period. Immune 
compromise could affect the 
postoperative infection rate, healing, 
and rate and extent of tumor 
dissemination. 
• Authors recognize at least two 
factors may account for the results of 
the study.  
1. The immunosuppressive effects of 
GA were not present in the EA 
group.  
2. The dose of opioids used in the 
EA was 10x lower than the GA 
group.  
• Authors speculate that these two 
factors could lead to a reduced 
suppression of the NK cell activity, 
and thus prevent tumor spreading. 
• Authors identify several limitations 
in this retrospective study.  
1. Patients were not random, clinical 
care was not standardized, and 
effects of unmeasured confounding 
variables cannot be excluded.  
2. A large difference between sample 
sizes existed between the two 
groups- EA consisted of 106 patients 
and GA consisted of 37 patients.  
This study, like most retrospective 
analyses, identifies testable 
possibility. 
• The report did not address the issue 
of generalizability but does address 
the need for a large prospective 
randomized control trial.  
Implications/ 
recommendati- 
Did the researchers 
discuss the implications 
• Researchers discussed their findings 
suggesting for additional questions 
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ons of the study for clinical 
practice or further 
research—and were 
those implications 
reasonable and 
complete? 
and evidence best addressed by a 
prospective randomized-controlled 
trial comparing the effect of epidural 
anesthesia on ovarian cancer 
outcome.  
• The study also suggests future 
studies to evaluate the effect of 
different anesthetic techniques on the 
immune function after ovarian serous 
adenocarcinoma surgery.  
General Issues 
Presentation 
Was the report well-
written, organized, and 
sufficiently detailed for 
critical analysis? 
 
In intervention studies, 
was a CONSORT 
flowchart provided to 
show the flow of 
participants in the 
study? 
• The report was well written and 
organizes with an easy flow and a 
detailed critical analysis. 
• A consort flowchart was provided to 
show the flow of participants in the 
study. Two hundred and thirty-four 
patients had initially undergone 
ovarian serous adenocarcinoma 
surgery, 30 were lost to follow up, 56 
had inadequate documentation of 
medical records, 5 died from other 
causes unrelated to the study. 
General Issues 
Presentation 
(continued) 
Was the report written 
in a manner that makes 
the findings accessible 
to practicing nurses? 
• The report was written to provide 
current evidence and background 
literature for support. Findings are 
accessible to practicing nurses as a 
reference but not as a definitive 
guide.  
Researcher 
credibility 
Do the researchers’ 
clinical, substantive, or 
methodological 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
• The qualifications of the researchers 
do add confidence in the findings and 
provide strength to the rational of 
their interpretations. Researchers are 
associated with the Department of 
Anesthesia Cancer Center and 
Department of Gynecology.  
Summary 
assessment 
Despite any limitations, 
do the study findings 
appear to be valid—do 
you have confidence in 
the truth value of the 
results? 
 
Does the study 
contribute any 
meaningful evidence 
• The study contributes meaningful 
evidence; however, the authors 
identify the need for a randomized 
study with equal sample sizes to 
provide a clear, distinct relationship 
of anesthesia technique. 
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that can be used in 
nursing practice or that 
is useful to the nursing 
discipline? 
Note. EA= epidural anesthesia (EA); GA= general anesthesia; PCA= patient-controlled 
analgesia, HR= hazard ratio; NK= natural killer 
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Appendix A-4 
 
Cummings, Xu, Cummings, and Copper. (2012). A Comparison of Epidural Analgesia 
and Traditional Pain Management Effects on Survival and Cancer Recurrence after 
Colectomy: A Population-based Study  
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title of this study was concise 
and clearly stated what the authors 
were studying. Key aspects of the 
study were included. Central topics 
were clearly identifiable. The study 
population was included. 
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract was written with 
subheadings- background, methods, 
results and conclusion. The abstract 
was brief but clearly described the 
reason for the study and the major 
aspects of the study for readers to 
browse and understand clearly what 
the study was about.  
Introduction 
Statement of 
the problem 
Was the problem stated 
unambiguously, and was 
it easy to identify? 
 
Is the problem statement 
build a persuasive 
argument for the new 
study? 
 
Was there a good match 
between the research 
problem and the 
methods used –that is, 
was a quantitative 
approach appropriate? 
• The problem of cancer recurrence 
after surgery is stated 
unambiguously. Colorectal cancer 
was identified as the third most 
common cancer diagnosed in the US 
and accounted for 9% of all U.S 
cancer deaths (Cummings et al., 
2012). The factors including surgical 
stress, anesthetic drugs, and opioids 
were identified as a major cause of 
immunosuppression.  
• This study compared survival and 
cancer recurrence rates for resection 
of colorectal cancer between patients 
who received epidurals and those 
who did not. 
• The problem statement built a 
convincing argument for a new 
study; identifying the valuable use of 
regional anesthesia and its 
association with lower recurrence 
rates of breast and prostate cancer. 
The results for colon cancer are 
mixed encouraging the need for 
additional research.   
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Hypotheses or 
research 
questions 
Were research questions 
and/or hypotheses 
explicitly stated?  If not, 
was their absence 
justified? 
 
Were questions and 
hypotheses appropriately 
worded, with clear 
specification of key 
variables and the study 
population? 
 
Were the 
questions/hypotheses 
consistent with existing 
knowledge? 
• The study included a clear 
hypothesis; epidural anesthesia 
and/or analgesia are associated with 
reduced cancer recurrence after 
colorectal cancer resection and 
improved all-cause mortality after 
surgery. 
• The hypothesis is consistent with 
previous knowledge; however, some 
existing knowledge has found no 
evidence of this and others oppose it. 
Justification for this study included 
the need for a larger sample for 
adequate results. 
Literature 
review 
Was the literature review 
up-to-date and based 
mainly on primary 
sources? 
 
Did the review provide a 
state-of-the-art synthesis 
of evidence on the 
problem? 
 
Did the literature review 
provide a strong basis 
for the new study? 
• The literature review was up-to-date 
including primary sources from 
1997-2010. 
• The review provided the reader with 
an understanding of colorectal cancer 
and the impacts of certain factors on 
immunosuppression including, 
surgical factors, allogeneic blood 
transfusions, and general anesthesia. 
Cummings et al. (2012) identify with 
previous studies, regional anesthetic 
techniques and their association with 
lower recurrence rates of breast and 
prostate cancers. The results for 
colon cancer are mixed, encouraging 
the need for a larger database 
analyses as prospective trials are 
conducted.  
Conceptual/ 
theoretical 
framework 
Were key concepts 
adequately defined 
conceptually? 
 
Was a 
conceptual/theoretical 
framework articulated—
and, if so, was it 
appropriate?  If not, is 
the absence of a 
framework justified? 
• Key concepts of epidural anesthesia 
use and non-use for colorectal 
patients receiving a colectomy were 
defined.  
• A population-based study using the 
Medicare database was used.   
• No framework was articulated for 
this study.  
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Method 
Protection of 
human rights 
Were appropriate 
procedures used to safe-
guard the rights of study 
participants? 
 
Was the study externally 
reviewed by an 
IRB/ethics review 
board? 
 
Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
• The Medicare-SEER database search 
for colorectal cancer patients was 
used and approved by Case 
Comprehensive Cancer Center 
Institutional Review Board 
(Cleveland, Ohio) and the National 
Cancer Institute (Bethesda, 
Maryland). 
• SEER Medicare database was used 
to compare overall survival and 
cancer recurrence of patients who 
did/did not receive epidural 
anesthesia and/or analgesia for 
resection of non-metastatic colorectal 
cancer.  
• The population cohort study was 
designed to reduce risks to patients, 
and to improve the future use of 
anesthesia use for the colorectal 
patient.  
Research 
design 
Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of data 
collection points 
appropriate? 
 
Did the design minimize 
biases and threats to the 
internal, construct, and 
external validity of the 
study (e.g., was blinding 
used, was attrition 
minimized)? 
• A population cohort study was a 
good choice for this study. The 
population-based study is selected 
for a longitudinal assessment to 
expose outcomes. The justification 
for this study is its external validity 
(the applicability to colorectal cancer 
patients). The cohort study is 
adequate for the large sample size.  
• The SEER tumor registry provides a 
population-based source of 
information about patients with 
colorectal cancer. The SEER data 
includes; primary site of the cancer, 
previous cancer diagnoses, histology, 
tumor stage, site specific surgery, 
reasons patients did not undergo 
surgery, surgery of distant sites, and 
initial course of therapy. 
Population and 
sample 
Was the population 
identified?  Was the 
sample described in 
sufficient detail? 
 
Was the best possible 
• The population of interest included 
patients aged 66 years or older 
diagnosed with non-metastatic 
colorectal adenocarcinoma who 
underwent surgical intervention 
between the dates 1996 and 2005. 
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sampling design used to 
enhance the sample’s 
representativeness?  
Were sampling biases 
minimized? 
 
Was the sample size 
based on a power 
analysis? 
This time frame allowed for 4 years 
of follow-up for cancer recurrence.  
• Patients aged 66 years or older were 
included who presented with local or 
regional stage disease (Stages I, II, 
and III) according to SEER and those 
who underwent a colectomy within 6 
months of diagnosis. 
• Inclusion and exclusion criteria was 
provided. Sample size was based on 
a power analysis, original cohort 
included 357,137 patients. After 
exclusions, study included a primary 
sample of 42,151 patients, and 
analysis sample of 40,377. 
Data 
collection and 
measurement 
 
 
 
Were the operational and 
conceptual definitions 
congruent? 
 
Were key variables 
measured using an 
appropriate method (e.g., 
interviews, observations, 
and so on)? 
 
Were specific 
instruments adequately 
described and were they 
good choices, given the 
study population and the 
variables being studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Conceptual definitions were defined 
and congruent.  
• Variables measured included-  
Exposure. Type of anesthetic- 
epidural analgesia/analgesia use or 
none.  
Outcome. All-cause mortality after 
cancer resection determined by the 
date of death, secondary outcome 
was colorectal cancer recurrence, 
recurrence within a 4-yr window 
after surgery, receipt of 
chemotherapy 16 months or more 
after the date of surgery and/or 
radiation therapy 12 months or more 
after the date of surgery were also 
measured, radiation therapy was also 
included.  
Covariates. Included patient 
demographic and clinical variables 
including age, gender, race, marital 
status, SEER site, year of diagnosis, 
anatomical site, stage of disease at 
diagnosis, and date of death. 
Socioeconomic factors anatomical 
tumor site was included, and blood 
transfusions. 
Colectomy. They examined 
MedPAR for surgical procedure 
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codes. 
Complications. To account for 
differences in perioperative 
complications, Medicare claims data 
was searched from surgery date until 
30 days after surgery. Complications 
included retrieval of retained foreign 
body, management of postoperative 
shock/hemorrhage, management of 
abdominal infection, repair of an 
organ injury/laceration, reoperative 
laparotomy, management of wound 
complication, management of fistula. 
• Evidence provided was reliable 
responsive data.   
Procedures If there was an 
intervention, was it 
adequately described, 
and was it rigorously 
developed and 
implemented?  Did most 
participants allocated to 
the intervention group 
actually receive it?  Was 
there evidence of 
intervention fidelity? 
 
Were data collected in a 
manner that minimized 
bias?  Were the staff 
who collected data 
appropriately trained? 
• No interventions were included given 
this was a population based 
longitudinal study.  
• The data was collected from a 
primary cohort that focused on 
overall survival and its criteria 
included patients who were enrolled 
in Medicare within 1 year before 
cancer diagnosis until death or 8 
months after diagnosis. Of 42,151 in 
the primary cohort patients, 22.9% 
had epidurals (n =9,670).  
The second cohort (recurrence 
cohort) focused on recurrence. Of 
40,377 patients of whom 23% (n 
=9,278) patients had epidurals. Staff 
was not mentioned in the study.  
•  
Data Analysis Were analyses 
undertaken to address 
each research question 
or test each hypothesis? 
 
Were appropriate 
statistical methods used, 
given the level of 
measurement of the 
variables, number of 
groups being compared, 
and assumptions of the 
• Statistical Analysis of patient 
characteristics were compared 
according to the presence or absence 
of epidural anesthesia/analgesia.  
• Pearson’s chi-square test was used to 
compare groups.  
• Wilcoxon rank sum test were used to 
compare the groups.  
• Survival time was defined from the 
date of surgery to all-cause mortality 
or last follow-up through December 
31, 2009. Kaplan–Meier survival 
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texts? 
 
Was a powerful analytic 
method used?  (e.g., did 
the analysis help to 
control for confounding 
variables)? 
 
Were type I and Type II 
errors avoided or 
minimized? 
 
In intervention studies, 
was an intention-to-treat 
analysis performed? 
curves were generated, and group 
comparison was based on the log-
rank test.  
• A marginal Cox model was 
constructed. Propensity score was 
used as a continuous covariate to be 
included in the survival models.  
•  A conditional logistic regression 
was used to predict the likelihood of 
cancer recurrence, controlling for 
hospital effect.  
• All data were analyzed using SAS 
software version 9.2 (SAS Institute, 
Cary, NC) and R 2.9.2.  
• All comparisons used two-sided tests 
at a significance level of 0.05. 
Data Analysis 
(continued) 
Were problems of 
missing values evaluated 
and adequately 
addressed? 
 
• Problems of missing information was 
addressed in the limitations section 
of the study, see below.  
Findings Was information about 
statistical significance 
presented?  Was 
information about effect 
size and precision of 
estimates (confidence 
intervals) presented? 
 
Were the findings 
adequately summarized, 
with good use of tables 
and figures? 
 
Were findings reported 
in a manner that 
facilitates a meta-
analysis, and with 
sufficient information 
needed for EBP? 
• Information about statistical 
significance was presented. Effect 
size and confidence intervals were 
presented.  
• The findings were adequately 
summarized with good figures.  
• Association between epidural and 
overall survival was evaluated.  
• Kaplan–Meier survival curves for the 
two groups; the curves were 
significantly different (log-rank test p 
< 0.001).  
• The association between epidural use 
and colorectal cancer recurrence was 
also evaluated.  
 
• .  
Discussion 
Interpretation 
of the findings 
Were all major findings 
interpreted and 
discussed within the 
context of prior research 
and/or the study’s 
conceptual framework? 
• All major findings were interpreted 
and discussed.  
• Results suggest early beneficial 
effects of epidural use on all 
mortality after colorectal resection 
for cancer.  
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Were casual inferences, 
if any, justified? 
 
Was the issue of clinical 
significance discussed? 
 
Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
 
Did the report address 
the issue of the 
generalizability of the 
findings? 
• This study did contrast other studies 
that did not show any beneficial 
effects on mortality.  
• Some included literature is consistent 
with the findings provided here.  
• Distal cancers were associated with 
higher risk of mortality and 
recurrence than proximal in the 
analysis, a potential difference 
between rectal and more proximal 
cancers were noted.  
• The survival rates for this study were 
slightly lower than other reports.  
• Differences in surgical technique, 
patient populations and/or length of 
follow-up were identified.  
• The analysis found no association 
between epidural use and colorectal 
cancer recurrence; these results are 
similar with the current literature.  
• Logistic regression analysis showed 
increasing age is independently 
associated with lower risk of cancer 
recurrence. Authors identify an 
interest for further explanation and 
research into this result.  
• Strengths of this study included the 
SEER-Medicare database usage. This 
data base is very large and provided 
the study with detailed tumor 
information for each patient. Data 
quality is good and provided the 
study with information across the US 
not just in a single facility. This is 
the first study in anesthesia literature 
to utilize this data base.  
• Limits to this study included, 
weakness due to the observational 
study including susceptibility to bias, 
confounding and effect cause 
associations.  
• Propensity scores were used to adjust 
for potential selection bias in 
treatment assignment but were 
limited to the covariates available in 
the database. Further, the database 
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limited clinical data such as other 
surgical and anesthesia techniques, 
and other drugs administered. 
Timing of epidural placement was 
not clear and placement time is 
skewed for this report.   
• Generalizability was not discussed. 
Implications/ 
recommendati- 
ons 
Did the researchers 
discuss the implications 
of the study for clinical 
practice or further 
research—and were 
those implications 
reasonable and 
complete? 
• Cummings et al. (2012) concluded 
the large population-based cohort 
study suggested that epidural 
anesthesia/analgesia was associated 
with improved survival in patients 
with non-metastatic colorectal cancer 
undergoing resection. The results did 
not support an association between 
epidural anesthesia/analgesia and 
recurrent disease.  
• Prospective studies are needed to 
determine whether the association 
between epidural use and survival is 
causative. 
General 
Issues 
Presentation 
Was the report well-
written, organized, and 
sufficiently detailed for 
critical analysis? 
 
In intervention studies, 
was a CONSORT 
flowchart provided to 
show the flow of 
participants in the study? 
• This analysis was organized, very 
detail oriented and well written for a 
critical analysis 
General 
Issues 
Presentation 
(continued) 
Was the report written in 
a manner that makes the 
findings accessible to 
practicing nurses? 
• This report was written in an 
organized, and easily understandable 
manner allowing for easy access to 
findings and results for practicing 
nurses.  
Researcher 
credibility 
Do the researchers’ 
clinical, substantive, or 
methodologic 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
• Researchers include an Assistant 
Professor of Anesthesiology and 
Outcomes Research, from the 
Anesthesiology Institute, Cleveland 
Clinic, a Statistical Analyst, 
Digestive Health Research Center, 
Case Western Reserve University, an 
Assistant Professor of Medicine, and 
a Professor of Medicine, Division of 
Gastroenterology and Liver Disease, 
 
 
99 
 
Department of Medicine, University 
Hospitals Case Medical Center, (all 
Cleveland, Ohio) 
• The qualification and experience do 
enhance confidence in the finding 
and interpretations of this article.  
Summary 
assessment 
Despite any limitations, 
do the study findings 
appear to be valid—do 
you have confidence in 
the truth value of the 
results? 
 
Does the study 
contribute any 
meaningful evidence 
that can be used in 
nursing practice or that 
is useful to the nursing 
discipline? 
• The study identified the benefits of 
epidural anesthesia regardless of 
placement time for colorectal patient 
undergoing resection.  
• The research appears to be valid with 
appropriate utilization of 
measurements including statistical 
analysis and logistic regression to 
name a few.  
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Appendix A-5 
 
Chen, and Miao. (2013). The effect of anesthetic technique on survival in human cancers: 
A Meta-analysis of Retrospective and Prospective Studies 
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title  Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title is brief without a specific 
identification of the type of 
anesthetics that are under review. A 
brief anesthetic technique phase is 
utilized in the title, rather than 
identifying the individual types being 
examined. 
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract is clearly written with a 
concise summary of the problem, 
methods for the analysis, results, and 
conclusions.  
Introduction 
Statement of 
the problem  
 
Were authors’ 
affiliations provided? 
Did the review have 
support of at least 2 
authors? 
 
Was the study objective 
& rationale given? 
Terms defined?  
 
Was there enough 
information on the 
population studied, the 
intervention given and 
the outcomes considered 
• Two Authors completed this meta-
analysis. Chen and Miao are affiliated 
with the department of 
Anesthesiology at the Shanghai 
Cancer Center and Cancer institute at 
the Shanghai Medical College at 
Fudan University.  
• The meta-analysis was performed to 
test the hypothesis that patients with 
cancer who underwent surgical 
intervention under epidural anesthesia 
(EA) vs. those who underwent 
general anesthesia (GA) would have 
better outcomes.  
• The study objective and rationale for 
analysis are clearly stated and terms 
are defined.  
Hypotheses 
or research 
questions 
Is the main question or 
problem clear and 
focused? PICO format 
used? 
 
 
• The main questions are used in a 
PICO format and is clear with a 
specific focus.  
Literature 
Review  
Was the literature review 
up-to-date and based 
mainly on primary 
• The literature of 14 primary studies 
were reviewed. The review was 
published February 20,2013 and the 
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sources? 
 
Did the review provide a 
state-of-the-art synthesis 
of evidence on the 
problem? 
 
Did the literature review 
provide a strong basis 
for the new study? 
knowledge was up-to-date.  
• Authors provide the audience with a 
brief understanding of EA benefits 
including pain relief, decrease 
incidence of side effects, and the 
proposed benefit of decrease of 
attenuation of the immune response.  
• Identification of the impact of the 
surgical stress response on the 
immune system and the impact of 
opioid induced immune suppression 
were investigated. The authors 
believe regional anesthetic techniques 
could cause less immune suppression 
compared to GA and opioid 
analgesia.  
• Studies have identified relationships 
between improved outcomes after 
surgical intervention for cancer and 
regional anesthesia use, and some 
have not.  
• The literature review provides a 
mediocre basis for a new study.  
• To improve the authors hypothesis of 
an association with decreased cancer 
recurrence after surgical intervention 
with the use of EA, this meta-analysis 
was performed.  
Search 
Criteria 
Methods 
Please describe the 
search criteria the 
authors used.  
Inclusion / exclusion 
criteria listed. Was there 
enough information on 
the population studied, 
the intervention given, 
and the outcomes 
considered? 
 
Comprehensive, 
systematic search used? 
Explicit criteria listed? 
Search terms and 
databases used? grey 
literature discussion?  
 
• The search criteria from included 
Web of Science database, PubMed, 
and Medline. 
• Search terms included; 
regional/epidural anesthesia, general 
anesthesia, anesthetic technique, 
metastasis, recurrence, survival and 
cancer/carcinoma.  
• Inclusion criteria included; published 
in English, with abstract or full text 
paper, comparison of EA vs. GA on 
survival or recurrence in cancer 
surgery, prospective or retrospective 
studies, data with hazard ratio (HR) 
and 95% confidence intervals (CI). 
• Exclusion criteria included; 
experimental studies, not comparing 
EA and GA, not for survival or 
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Is it likely that all 
relevant studies 
(published and 
unpublished) were 
identified? 
recurrence, unavailable HR and 95% 
CI.  
• 731 articles were located for research. 
135 articles with abstracts were 
identified as potentially eligible.  
• After all full text reviews were 
completed, (n =14) studies were 
considered eligible for the meta-
analysis.  
Framework Did authors use a model 
or guideline for SRs and 
inclusive of the model 
they used? 
• The PRIMSA flowchart was utilized 
by the authors. 
• The meta-analysis and the systematic 
review adhered to all standards for 
quality reporting.  
Included 
studies  
 
Was sufficient 
information given on 
chosen studies to 
determine validity of the 
research? 
 
Were PICO and 
methodological quality 
of each study addressed 
in table format? Did the 
authors critically 
appraise each study? 
 
Were the criteria used to 
select articles for 
inclusion predetermined, 
clearly stated, and 
appropriate? 
• All studies were reviewed by two 
authors independently. Variables 
taken from each study included; 
authors, year of publication, type of 
cancer, design, EA group total, HR, 
95% CI for outcomes of treatment. 
• HR, 95% CI was taken from each to 
identify an association between the 
outcomes of survival and EA use.  
• To assess the quality of the study, the 
9-star Newcastle-Ottawa Scale was 
used. 
• To assess heterogeneity the use of 
Cochran chi-squared Q squared, and 
I-squared statistics were used.  
• To assess publication bias, authors 
used a funnel plot of ln vs. standard 
error. 
• The use of Egger’s test was used to 
test degree of symmetry of study.  
• A sensitivity analysis to find potential 
outliers and thus were omitted if 
found.  
• Stata/SE version 10.0 was used for all 
statistical analyses.  
• Criteria used was predetermined, 
clear and appropriate.  
Results: 
 
Were results of review 
clearly described in a 
critical fashion? In table 
and narrative?  
• Results were provided in a critical 
fashion including tables and narrative 
form.  
• Search flowchart identified the 14 
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Were results similar 
across studies? Was a 
cross-analysis 
performed?  
 
Are the results of all 
included studies clearly 
displayed? If the study 
results were combined, 
was it appropriate to do 
so?  
 
How precise are the 
results? Do the results of 
the studies have 
significant findings, and 
do the researchers 
provide evidence of 
such? Did the 
interpretation of the 
review’s results 
accurately reflect the 
actual results? Are 
results generalizable? 
eligible studies included in this 
analysis.  
• For the EA group, 12,000 cases were 
included. For the GA group, 35,000 
cases were included.  
• End points that were reviewed 
included, recurrence free survival 
(RFS- from day of surgery to first 
disease relapse from primary cancer) 
and overall survival (OS- from day of 
surgery until death). 
• For the OS- 4 studies showing a 
significant relationship between that 
of EA and improved OS. 
• For the RFS- 11 studies with 
numerous cancer types were included 
in the meta-analysis. Out of the 11 
studies, 4 showed positive relation 
between improved RFS and EA.  
•  Significant findings were provided, 
and authors provide an interpretation 
of the result. 
 
Meta-
analysis 
 
Was a meta-analysis 
performed? Please 
describe.  
 
How are meta-analysis 
results displayed?  
 
Was a rationale for the 
statistics used provided? 
Was this cohesive with 
what you have learned? 
 
Was statistical 
significance tested? 
• A meta-analysis was performed, see 
above.  
• Results were displayed in graphs and 
narrative form.  
• Statistics rationales were performed, 
suggesting a positive effect of EA use 
on overall survival after surgical 
intervention for cancer. 
• The meta-analysis’ findings were 
consistent with many other results 
from current literature, but there are 
still some with that are not. Chen and 
Miao, (2013) also identified that the 
RFS and EA do not show a beneficial 
effect.  
• Given there were 5 out of 7 studies 
that were colorectal cancer specific, 
another meta-analysis was performed 
to identify a correlation between EA 
and improved OS. Chen and Miao 
(2013) found a positive correlation 
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for EA and OS with a HR = 0.65, 
95% CI = [0.43 to 0.99], (p =0.045). 
• The meta-analysis showed beneficial 
evidence on colorectal cancer 
surgical patients and the use of EA. 
The SEER- surveillance, 
epidemiology and result study with 
the largest sample size, showed 
significant results associated with 
colorectal surgical intervention and 
EA use on all-cause mortality. The 
MASTER trial- prospective study, 
did not show significance for surgical 
patients of abdominal cancers.  
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Was the discussion 
section clear and 
comprehensive? 
 
What do the main 
findings mean  
 
Are the conclusions 
justified  
 
How do the findings 
compare with what 
others have found?  
Application of findings  
 
Were limitations 
discussed? Implications? 
• The discussion was clear and 
comprehensive. Authors identify 
probable cause for results. 
• Authors acknowledge their analysis 
was not able to demonstrate immune 
surveillance interventions that 
focused on immunosuppression 
reduction. 
• Authors identify their analysis did not 
support a relation between EA and 
decreased cancer recurrence.  
• Authors identify their analysis did 
support a relation between EA and 
overall survival. 
• Study limited by non-randomization, 
primarily retrospective studies used, 
surgical technique differences, 
problems with long term follow up, 
different patient populations, and 
differences among studies of how 
recurrence is defined. Other 
limitations include; types of cancer 
and tumor biology, and English 
studies only.  
• Authors state prospective studies are 
needed to find an association between 
survival and epidural anesthesia use.  
 
Note. RA= regional anesthesia; EA= epidural anesthesia; GA= general anesthesia; CI= 
confidence interval; OS= Overall survival; HR= hazard ratio; RFS= recurrence free 
survival  
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Appendix A-6 
 
Jang, Lim, Shin, Kwon Ko, Park, Hyun Song, and June Kim. (2016). A comparison of 
regional and general anesthesia effects on 5 years survival and cancer recurrence after 
transurethral resection of the bladder tumor: a retrospective analysis 
Aspect of the Report Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title for this article 
described the key points for 
this retrospective analysis. 
Central topics, including 
regional and general 
anesthesia effect on cancer 
recurrence, were included. 
The title communicated the 
intended comparison for the 
analysis between regional 
anesthesia (RA) and general 
anesthesia (GA). The title 
identified the population of 
concern, cancer patients with 
bladder tumors. 
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract for this research 
was written clear and concise 
with subheadings. The 
abstract was clearly labeled 
with each important section of 
the study, allowing for quick 
review of the topic. The 
background of the topic was 
clear and concise, identifying 
the purpose of the study. 
Introduction 
Statement of the 
problem 
Was the problem stated 
unambiguously, and 
was it easy to identify? 
 
Is the problem statement 
build a persuasive 
argument for the new 
study? 
 
Was there a good match 
between the research 
problem and the 
methods used –that is, 
was a quantitative 
approach appropriate? 
• The introduction to this study 
was clear and concise to the 
trained professional in 
anesthesia. RA was not 
defined for the non-medical 
professional. The introduction 
begins with cancer and 
treatments currently in 
practice, identifying surgical 
intervention as the main 
treatment of choice.  
• The importance of the topic 
was not identified, nor was 
bladder cancer prevalence. 
RA was briefly discussed, 
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with reference to a single 
research study. 
Hypotheses or 
research questions 
Were research questions 
and/or hypotheses 
explicitly stated?  If not, 
was their absence 
justified? 
 
Were questions and 
hypotheses 
appropriately worded, 
with clear specification 
of key variables and the 
study population? 
 
Were the 
questions/hypotheses 
consistent with existing 
knowledge? 
• The introduction describes 
RA as decreasing surgery 
induced stress and opioid 
requirements, and the belief of 
its role in reduction of cancer 
recurrence. GA is briefly 
discussed and its general role 
in the research. 
• Jang et al. (2016) collected 
data to determine if mortality 
after bladder cancer differed 
between patients who 
underwent surgical 
intervention under general 
anesthesia (GA) vs. surgical 
intervention with regional 
anesthesia (RA). 
Literature review Was the literature 
review up-to-date and 
based mainly on 
primary sources? 
 
Did the review provide 
a state-of-the-art 
synthesis of evidence on 
the problem? 
 
Did the literature review 
provide a strong basis 
for the new study? 
• This study lacked an adequate 
literature review, however, the 
literature used were mainly 
primary sources. The 
literature review did not 
provide a strong basis for the 
new study, especially due to 
the lack of statistical support 
of bladder cancer prevalence. 
The introduction does set up 
the study identifying no 
current retrospective studies 
available on bladder cancer in 
early stages (stages I-II). 
Further stating the purpose of 
the retrospective study, to 
investigate which anesthetic 
approach results in a better 
bladder cancer prognosis. 
Conceptual/theoretical 
framework 
Were key concepts 
adequately defined 
conceptually? 
 
Was a 
conceptual/theoretical 
framework articulated—
and, if so, was it 
• Adequate identification of 
comparison was made for the 
research question. Key 
concepts were identified, GA 
vs. RA in bladder surgery and 
cancer recurrence.  
• No theoretical/conceptual 
framework was identified. 
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appropriate?  If not, is 
the absence of a 
framework justified? 
 
Were the questions/ 
hypotheses consistent 
with the framework? 
Method 
Protection of human 
rights 
Were appropriate 
procedures used to safe-
guard the rights of study 
participants? 
 
Was the study 
externally reviewed by 
an IRB/ethics review 
board? 
 
Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
• Jang et al. (2016) received 
approval from the Chungnam 
National University Hospital 
Institutional Review Board, 
and waiver consents were 
distributed to patients prior to 
study. How the waivers were 
delivered and how many were 
received were not included in 
the study. The retrospective 
research is a safe way to 
identify outcomes and make 
appropriate connections 
between anesthetics delivered 
and patient outcomes 
Research design Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of data 
collection points 
appropriate? 
 
Did the design minimize 
biases and threats to the 
internal, construct, and 
external validity of the 
study (e.g., was blinding 
used, was attrition 
minimized)? 
• A retrospective study was 
appropriate for the study 
purpose.  
• Appropriate comparisons 
were made between GA and 
RA use. A consort flow chart 
was used to clearly sort 
patient selection.  
Population and 
sample 
Was the population 
identified? Was the 
sample described in 
sufficient detail? 
• Five hundred and thirty-one 
total patients were reviewed, 
final included in study (n= 
137) patients for RA and (n 
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Was the best sampling 
design used? 
representativeness?  
Were biases minimized? 
 
Was the sample size 
based on a power 
analysis? 
=24) for GA after exclusion 
criteria was evaluated.  
• Inclusion criteria and 
exclusion criteria were 
included. 
Data collection and 
measurement 
 
 
 
Were the operational 
and conceptual 
definitions congruent? 
 
Were key variables 
measured using an 
appropriate method 
(e.g., interviews, 
observations, and so 
on)? 
 
Were specific 
instruments adequately 
described and were they 
good choices, given the 
study population and the 
variables being studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Data was collected and 
reviewed by three residents 
and the statistics were 
conducted by specialists.  
• Data was collected to 
determine if mortality due to 
bladder cancer differed 
between the patients who 
underwent surgical 
intervention and received 
general anesthesia vs. regional 
anesthesia. This study was 
done to identify which 
approach had better cancer 
outcomes.  
• Conceptual and operational 
definitions were clearly 
defined and are congruent.  
• Demographic data was 
collected and present in chart 
formation.  
• Logistic regression analysis 
for 5-year survival assessed 
independent demographics to 
find association.  
• Logistic regression was used 
to identify any relation 
between; BCG Treatments, 
sex, smokers, hypertension, 
diabetes, age, anesthesia type, 
anesthesia time or length of 
stay, and survival rates. 
• 5-year recurrence rate and 
recurrence free time were 
studied after the surgery using 
Chi Squared test. 
• To evaluate age, Spearman 
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Rho correlation analysis was 
used. 
Procedures If there was an 
intervention, was it 
adequately described, 
and was it rigorously 
developed and 
implemented?  Did most 
participants allocated to 
the intervention group 
actually receive it?  Was 
there evidence of 
intervention fidelity? 
 
Were data collected in a 
manner that minimized 
bias?  Were the staff 
who collected data 
appropriately trained? 
• Chart reviews were performed 
at the Chungnam National 
University Hospital. Data was 
collected by three residents 
and all statistical data was 
processed by two independent 
specialists. Numerous 
analyses were undertaken to 
evaluate the impact of 
variables on the 5-year 
survival rate and recurrence 
free time. 
• All TURB surgeries were 
performed by the same 
surgical team and the same 
anesthesia team.  
• Data was collected by three 
different residents. 
• The statistics were reviewed 
and processed independently 
by two different specialists.  
•  
Data Analysis Were analyses 
undertaken to address 
each research question 
or test each hypothesis? 
 
Were appropriate 
statistical methods used, 
given the level of 
measurement of the 
variables, number of 
groups being compared, 
and assumptions of the 
texts? 
 
Was a powerful analytic 
method used?  (e.g., did 
the analysis help to 
control for confounding 
variables)? 
 
Were type I and Type II 
errors avoided or 
• Analyses were undertaken to 
address the research question 
and to test the hypothesis.  
• Statistical methods were used 
for the study. 
• The study included:  
Kruskal-Wallis test was used 
to help show normal 
distribution between variables 
(regional vs. general 
anesthesia). 
Chi-square test was also 
incorporated to test observed 
distribution of 5-year survival 
between regional vs. general 
technique.  
Logistic regression analysis 
was used to help identify 
relationships among all the 
variables (age, sex weight, 
height, anesthesia time, 
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minimized? 
 
In intervention studies, 
was an intention-to-treat 
analysis performed? 
hospital stay, pathology stage, 
BCG treatment, and medical 
history including; diabetes, 
hypertension, and smoking).  
To evaluate age, Spearman 
Rho correlation analysis was 
used. 
Multivariate correlation 
analysis was used in the study 
to analyze numerous variables 
impacting recurrence free 
time and 5-year survival rate.  
Partial correlation analysis 
was used to eliminate other 
variables influence to identify 
a relationship between only 2 
variables (regional vs. general 
anesthesia) to find the true 
factor influencing recurrence 
free time and 5-year survival. 
The data analysis section 
lacked a thorough explanation 
of the statistical analyses. 
Evidence was shown, but not 
explained very well for the 
untrained audience.   
• Minimal explanation was used 
by the researchers to describe 
each data analysis method. 
The data analysis section 
lacked a thorough explanation 
of the statistical analyses. 
Data Analysis 
(continued) 
Were problems of 
missing values 
evaluated and 
adequately addressed? 
• Missing values were not 
evaluated or addressed in the 
study.  
•  
Findings Was information about 
statistical significance 
presented?  Was 
information about effect 
size and precision of 
estimates (confidence 
intervals) presented? 
 
• Demographic data was 
collected and present in chart 
formation. Logistic regression 
analysis for 5-year survival 
assessed independent 
demographics to find 
association.  
• Findings were adequately 
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Were the findings 
adequately summarized, 
with good use of tables 
and figures? 
 
Were findings reported 
in a manner that 
facilitates a meta-
analysis, and with 
sufficient information 
needed for EBP? 
summarized (Appendix B-6)  
Evidence was provided, but 
difficult for a reader not in the 
field of anesthesia.   
• Findings are not sufficient to 
facilitate a metanalysis.  
Discussion 
Interpretation of the 
findings 
Were all major findings 
interpreted and 
discussed within the 
context of prior research 
and/or the study’s 
conceptual framework? 
 
Were casual inferences, 
if any, justified? 
 
Was the issue of clinical 
significance discussed? 
 
Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
 
Did the report address 
the issue of the 
generalizability of the 
findings? 
• A vague discussion of the 
findings was included. The 
discussion included 
information that would have 
been better suited for the 
introduction section of this 
research to grab a larger 
audience’s attention and to 
provide a better understanding 
of anesthetic impact on 
cellular immunity and its 
importance in surgical 
interventions. As the 
discussion continues, a 
comparison of previous 
studies results of regional 
anesthesia and the effect on 5-
year survival and recurrence 
free time in other types of 
cancers is included.  
• Limitations were discussed, 
and the authors stated they 
could not easily conclude the 
effects of anesthesia technique 
on prognosis on bladder 
cancer. The use of three 
different analyses were 
needed. Jang et al. (2013) 
acknowledged the need for a 
large sample size with random 
experiments.  
• The report did not address 
issue of generalizability. 
Implications/ 
recommendati- 
Did the researchers 
discuss the implications 
• The need for further research 
was discussed. 
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ons of the study for clinical 
practice or further 
research—and were 
those implications 
reasonable and 
complete? 
General Issues 
Presentation 
Was the report well-
written, organized, and 
sufficiently detailed for 
critical analysis? 
 
In intervention studies, 
was a CONSORT 
flowchart provided to 
show the flow of 
participants in the 
study? 
• Overall, the report was not as 
organized as it could have 
been. The use of numerous 
analyses was needed to prove 
a piece of the study. The use 
of the consort flowchart 
helped in the organization for 
this study.  
General Issues 
Presentation 
(continued) 
Was the report written 
in a manner that makes 
the findings accessible 
to practicing nurses? 
• This study needs to be 
reorganized to be understood 
by all professionals and not 
just specific specialties. 
Currently the study is written 
only for the trained anesthesia 
provider. 
Researcher credibility Do the researchers’ 
clinical, substantive, or 
methodologic 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
• The study was published in 
the BMC Anesthesiology 
Journal; however, 
qualifications and experience 
of authors were not included. 
Summary assessment Despite any limitations, 
do the study findings 
appear to be valid—do 
you have confidence in 
the truth value of the 
results? 
Does the study 
contribute meaningful 
evidence that can be 
used in nursing 
practice? 
• The study does contribute 
meaningful evidence, 
however, the need for a larger 
sample size with similar ages 
and randomization are 
recommended. This study 
could be used as a guide for  
future studies.  
•  
Note. RA= regional anesthesia; GA= general anesthesia 
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Appendix A-7 
 
Cho, Lee, Kim, Park, Park, Oh, Ho Lee, and Koo. (2017). The effects of perioperative 
anesthesia and analgesia on immune function in patients undergoing breast cancer 
resection: a prospective randomized study 
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title Is the title a good one, 
succinctly suggesting key 
variables and the study 
population? 
• The title is 16 words in length and 
clearly identifies the purpose of the 
study. The title does not specify 
what is being compared.   
Abstract Did the abstract clearly 
and concisely summarize 
the main features of the 
report (problem, 
methods, results, 
conclusions)? 
• The abstract is clearly written with a 
concise summary of the report. 
Subheadings are included; 
Introduction, methods, results, and 
conclusion. 
• The introduction provides the reader 
with an explanation of the impact of 
anesthesia on the immune system. It 
identifies the important role the 
Natural Killer (NK) cells play in 
anti-tumor immunity. The intro 
further identifies what is being 
compared in the study; effects of 
two different anesthesia and 
analgesia methods on NK cell 
cytotoxicity (NKCC) in patient 
undergoing breast cancer surgery.   
Introduction 
Statement of 
the problem 
Was the problem stated 
unambiguously, and was 
it easy to identify? 
 
Is the problem statement 
build a persuasive 
argument for the new 
study? 
 
Was there a good match 
between the research 
problem and the methods 
used –that is, was a 
quantitative approach 
appropriate? 
• Cho et al. (2017) identify the impact 
of anesthesia and surgical stress on 
anti-tumor defenses within the body. 
Authors clearly identify the problem 
of anesthesia on NKC function.  
• Prior prospective studies comparing 
the effects of anesthetics 
perioperative use on NKCC in 
cancer patients undergoing surgical 
intervention have been 
acknowledged. 
• Previous studies have identified the 
use of volatile anesthetics as 
decreasing NKCC. Opioids have 
shown suppression of NKC 
function. The use of Propofol did 
not suppress NKCC and non-
steroidal anti-inflammatory drugs 
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have not shown evidence of NKC 
suppression (Cho et al., 2017). 
• A quantitative approach was used 
for this study. 
Hypotheses or 
research 
questions 
Were research questions 
and/or hypotheses 
explicitly stated?  If not, 
was their absence 
justified? 
 
Were questions and 
hypotheses appropriately 
worded, with clear 
specification of key 
variables and the study 
population? 
 
Were the 
questions/hypotheses 
consistent with existing 
knowledge? 
• Researchers hypothesized that 
avoiding volatile anesthetics and 
opioid analgesics might attenuate 
immunosuppressive effects during 
perioperative periods. 
• The hypothesis was consistent with 
prior knowledge, included in study 
by researchers. 
Literature 
review 
Was the literature review 
up-to-date and based 
mainly on primary 
sources? 
Did the review provide a 
state-of-the-art synthesis 
of evidence on the 
problem? 
 
Did the literature review 
provide a strong basis for 
the new study? 
• A literature review was based on 
primary sources from 2003-2015. 
• The literature included a review on 
the evidence of the problem, which 
could have been more in-depth with 
a deeper impact of the importance of 
the problem. 
• The literature did not provide a 
strong basis for the new study. A 
more detailed literature review is 
recommended.  
Conceptual/ 
theoretical  
framework 
Were key concepts 
adequately defined 
conceptually? 
 
Was a conceptual 
theoretical framework 
articulated—and, if so, 
was it appropriate?   Is 
the absence of a 
framework justified? 
 
Were the 
questions/hypotheses 
• Key concepts were addressed, and 
brief conceptual definitions were not 
included for all concepts.  
• No framework was articulated in 
this study.  
 
 
115 
 
consistent with the 
framework? 
Method 
Protection of 
human rights 
Were appropriate 
procedures used to safe-
guard the rights of study 
participants? 
 
Was the study externally 
reviewed by an 
IRB/ethics review board? 
 
Was the study designed 
to minimize risks and 
maximize benefits to 
participants? 
• Approval was obtained by the 
Institutional Review Board and 
Hospital Research Ethics Committee 
of Severance Hospital, Yonsei 
University Health System, Seoul, 
Korea, on February 2014. It was 
registered at clinicaltrial.gov on 
March 2014.  
• Written informed consent was 
obtained from all patients 
• Fifty patients were randomly 
assigned into one of the study 
groups (25 patients each) using a 
computer-generated random number 
table.  
Research 
design 
Was the most rigorous 
design used, given the 
study purpose? 
 
Were appropriate 
comparisons made to 
enhance interpretability 
of the findings? 
 
Was the number of data 
collection points 
appropriate? 
 
Did the design minimize 
biases and threats to the 
internal, construct, and 
external validity of the 
study (e.g., was blinding 
used, was attrition 
minimized)? 
• An experimental randomized control 
study was utilized for this study.  
• Appropriate comparisons were 
made, using other research for 
support and credibility. The number 
of data points were appropriate, 
including natural killer cell 
cytotoxicity, serum concentration 
levels of IL-2, inflammatory 
response, pain score, and 
postoperative outcomes.  
• The design did minimize biases and 
threats to internal and external 
validity. Blinding was used 
however, staff in operating room 
were aware of which technique was 
utilized for each patient. Attrition 
was factored in as a 10% dropout 
rate. Attrition was not an issue.  
Population and 
sample 
Was the population 
identified?  Was the 
sample described in 
sufficient detail? 
 
Was the best possible 
sampling design used to 
enhance the sample’s 
representativeness?  
• The population was identified as 
breast cancer patients, 20-65 years 
old who underwent elective surgery 
for breast cancer and had an 
American Society of 
Anesthesiologists (ASA) physical 
status classification of I to III.  
• The exclusion criteria were patients 
with renal or hepatic impairment, a 
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Were sampling biases 
minimized? 
 
Was the sample size 
based on a power 
analysis? 
body mass index > 35 kg/m2, 
immunosuppressive therapy, 
immune disorders, steroid 
administration within the last six 
months, metastasis, or radiotherapy 
or chemotherapy before surgery. 
Written formed consent was 
obtained from all of patients.  
• The sample was small  
The same was based on a power 
analysis. The sample size was 
calculated based on preliminary 
results for the first five patients of 
each group and estimated that 22 
patients in each group would be 
required to detect a mean difference 
of 10% and standard deviation of 
10% in the NKCC after surgery with 
90% power at a significance of (p < 
0.05). 
• Twenty-Five patients were enrolled 
to factor in for a 10% dropout rate. 
Data collection 
and 
measurement 
 
 
 
Were the operational and 
conceptual definitions 
congruent? 
 
Were key variables 
measured using an 
appropriate method (e.g., 
interviews, observations, 
and so on)? 
 
Were specific 
instruments adequately 
described and were they 
good choices, given the 
study population and the 
variables being studied? 
 
Did the report provide 
evidence that the data 
collection methods 
yielded data that were 
reliable, valid and 
responsive? 
• Operation and conceptual 
definitions for the study appear 
congruent.  
• Key variable measures were 
completed by observations and 
interviews. 
• The primary aim was to compare the 
effects of two anesthetic and 
analgesic methods on the immune 
function assessed by NKCC, 
measured preoperatively and at 24 
hours postoperatively. Other 
outcome measures included 
postoperative pain scores, IL-2 
levels, and inflammatory responses 
assessed by white blood cell, 
neutrophil, and lymphocyte counts. 
The incidence of cancer recurrence 
or metastasis was evaluated with a 
breast ultrasound, abdomen 
ultrasound, and whole-body bone 
scan every 6 months after surgery. 
•  
Procedures If there was an • Interventions were adequately 
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intervention, was it 
adequately described, and 
was it rigorously 
developed and 
implemented?  Did most 
participants allocated to 
the intervention group 
actually receive it?  Was 
there evidence of 
intervention fidelity? 
 
Were data collected in a 
manner that minimized 
bias?  Were the staff who 
collected data 
appropriately trained? 
described. 
• Data was collected in a manner that 
minimized bias.  
Data collected included: 
• Assay for natural killer cell 
cytotoxicity:   Blood samples were 
obtained before and at 24 hours after 
surgery. A colorimetric assay was 
used and measured lactate 
dehydrogenase (LDH), a stable 
cytosolic enzyme that is released 
upon cell lysis.  
• Assay for IL-2: IL-2 was measured 
in serum using an ELISA kit 
preoperatively and at 24 hours after 
surgery. 
• Pain scores were assessed using an 
11-point numerical scale at 
postoperative intervals: 30 minutes, 
6 hours, 24 hours, and 48 hours.  
For immediate postoperative 
analgesia, the P-R-K group received 
ketorolac 60 mg and the S-R-F 
group received fentanyl 50 μg at the 
end of surgery.  
In the post-anesthesia care unit, 
propacetamol 2 g in the P-R-K 
group or fentanyl 50 μg in the S-R-F 
group was available as an additional 
analgesic for patients with an NRS ≥ 
4. In the ward, both groups received 
tramadol 50 mg as a rescue 
analgesic, which does not suppress 
NKCC.  
• Staff who collected the data were 
appropriately trained in research.  
Data Analysis Were analyses 
undertaken to address 
each research question or 
test each hypothesis? 
 
Were appropriate 
statistical methods used, 
given the level of 
measurement of the 
variables, number of 
• Statistical analyses were performed 
with IBM SPSS 20.0 and SAS 9.2  
• Continuous variables were analyzed 
with the independent t-test or Mann-
Whitney U test, after testing for 
normality of distribution using 
Kolmogorov-Smirnov test. 
• Categorical variables were analyzed 
with χ2 test or Fisher exact test.   
• Variables measured were analyzed 
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groups being compared, 
and assumptions of the 
texts? 
 
Was a powerful analytic 
method used?   
 
Were type I and Type II 
errors avoided or 
minimized? 
 
In intervention studies, 
was an intention-to-treat 
analysis performed? 
with a linear mixed model, with 
patient indicator as a random effect 
and with group, time, and group-by-
time as fixed effects. The group-by-
time interaction assesses whether 
the change over time differs 
between groups. Post-hoc analyses 
with the Bonferroni correction were 
performed for comparisons when 
variables with repeated measures 
showed significant differences 
between groups. Statistically 
significance was (p <0.05).  
• Type I errors were minimized by 
having significance of (p < 0.05), 
reducing the probability of a type I 
error. 
• A larger sample size should be used 
to avoid or minimize type II errors. 
Data Analysis 
(continued) 
Were problems of 
missing values evaluated 
and adequately 
addressed? 
 
• Of 50 patients enrolled, one patient 
in each group was eliminated due to 
concurrent breast reconstruction 
surgery. The remaining 48 patients 
completed the study without any 
complications. 
Findings Was information about 
statistical significance 
presented?  Was 
information about effect 
size and precision of 
estimates (confidence 
intervals) presented? 
 
Were the findings 
adequately summarized, 
with good use of tables 
and figures? 
 
Were findings reported in 
a manner that facilitates a 
meta-analysis, and with 
sufficient information 
needed for EBP? 
• Information about statistical 
significance was presented including 
confidence intervals.  
• Findings were summarized in both 
tables and figures. 
• Findings were reported in a manner 
to facilitate a meta-analysis. 
Discussion 
Interpretation 
of the findings 
Were all major findings 
interpreted and discussed 
within the context of 
• Major findings were included and 
discussed within the context of prior 
research.  
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prior research and/or the 
study’s conceptual 
framework? 
 
Were casual inferences, 
if any, justified? 
 
Was the issue of clinical 
significance discussed? 
 
Were interpretations 
well-founded and 
consistent with the 
study’s limitations? 
 
Did the report address the 
issue of the 
generalizability of the 
findings? 
• Clinical significance was discussed. 
• Patients who received P-K 
anesthesia exhibited preserved 
NKCC compared to pts who 
received S-F anesthesia.  
• Postoperative inflammatory 
responses and the incidences of 
short-term cancer recurrence and 
metastasis were not different 
between the two anesthetic and 
analgesic methods. 
• Evidence suggests that surgery and 
anesthesia cause a brief period of 
immunosuppression, which may 
encourage both the implantation of 
surgically disseminated neoplastic 
cells and the growth of existing 
micro-metastases. 
• Limits included non-blinded 
operating staff to the group 
allocation, however follow-up staff 
was unaware of patient group 
involvement when assessing for 
pain. 
-The use of Remifentanil and 
tramadol for a control was used, and 
their impact on NKCC cannot be 
excluded.  
• Generalizability of findings was 
discussed. 
Implications/ 
recommendati- 
ons 
Did the researchers 
discuss the implications 
of the study for clinical 
practice or further 
research—and were those 
implications reasonable 
and complete? 
• Researchers discuss the implications 
of the study for future research. 
Researchers acknowledged that 
cancer metastasis within two years 
after surgery did not occur in the 
study, further evaluation of long-
term outcomes are needed to make 
further conclusions about cancer 
recurrence or metastasis.  
General 
Issues 
Presentation 
Was the report well-
written, organized, and 
sufficiently detailed for 
critical analysis? 
Was a CONSORT 
flowchart provided? 
• The report was well written and 
organized. The literature review 
could have used more information to 
educate the reader on the importance 
and impact of the immune system. A 
longer, more detailed study is 
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recommended.  
• A consort flowchart was not 
provided.  
General 
Issues 
Presentation 
(continued) 
Was the report written in 
a manner that makes the 
findings accessible to 
practicing nurses? 
• The report was written in a manner 
that makes the findings accessible to 
practicing nurses. The journal is a 
part of the international journal of 
medical sciences and is an open 
article available to all. Good 
background support provides a 
strong confidence in the benefit of 
Propofol and Ketorolac’s use in the 
cancer patient to decrease immune 
suppression.  
Researcher 
credibility 
Do the researchers’ 
clinical, substantive, or 
methodologic 
qualifications and 
experience enhance 
confidence in the 
findings and their 
interpretation? 
Researchers qualifications/experience are as 
follows:  
• Department of Anesthesiology and 
Pain Medicine, Anesthesia and Pain 
Research Institute, Yonsei 
University College of Medicine, 
Seoul, Republic of Korea  
• National Leading Research 
Laboratory of Clinical 
Nutrigenetics/Nutrigenomics, 
Department of Food and Nutrition, 
College of Human Ecology, Yonsei 
University, Seoul, Republic of 
Korea 
• Korea Ginseng Corporation 
Research Institute, Korea Ginseng 
Corporation, Daejeon, Republic of 
Korea 
• Department of Surgery, Yonsei 
University College of Medicine, 
Seoul, Republic of Korea. 
• Department of Food and Nutrition, 
Brain Korea 21 PLUS Project, 
College of Human Ecology, Yonsei 
University, Seoul, Republic of 
Korea 
• Research Center for Silver Science, 
Institute of Symbiotic Life-TECH, 
Yonsei University, Seoul, Republic 
of Korea. 
• These experiences enhance the 
confidence in the finds and 
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interpretations of this study. 
Summary 
assessment 
Do the study findings 
appear to be valid: do 
you have confidence in 
the truth value of the 
results? 
 
Does the study contribute 
meaningful evidence that 
can be used in nursing 
practice. 
• The findings of the present study are 
consistent with the hypothesis that 
avoiding volatile anesthetics and 
opioids could reduce the 
immunosuppression during surgery. 
All supportive literature was 
appropriately cited and congruent 
with this study’s findings. 
Further studies to find anesthetic and 
analgesic methods which mitigate 
immunosuppression in cancer surgery are 
warranted. 
Note: NK= natural killer cell; NKCC= natural killer cell cytotoxicity; P-R-K= propofol, 
remifentanil, ketorolac; S-R-F= sevoflurane, remifentanil, fentanyl; IL= interleukin 
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Appendix A-8 
 
Perez-Gonzalez, Cuellar-Guzman, Soliz, and Cata. (2017). Impact of reginal anesthesia 
on recurrence, metastasis, and immune response in breast cancer surgery: a systematic 
review of the literature. 
Aspect of the 
Report 
Critiquing Questions Detailed Critiquing Guidelines 
Title  Is the title a good one, 
succinctly suggesting 
key variables and the 
study population? 
• The title identified breast cancer 
patients as the population of interest 
and the key variables; regional 
anesthesia use, and the effects of 
cancer recurrence, 
immunomodulation and survival rate.  
Abstract Did the abstract clearly 
and concisely 
summarize the main 
features of the report 
(problem, methods, 
results, conclusions)? 
• The abstract identified the 
perioperative period as an important 
time for long-term outcomes for 
breast cancer. Methods include a 
systematic literature search for breast 
cancer surgeries conducted with the 
use of a paravertebral regional block 
(PVB) anesthetic. The use of both 
retrospective studies and randomized 
control trials were included. 
• The results identified 467 studies, 15 
studies were included and underwent 
full review. The conclusions included 
a lack of substantial data regarding 
the use of PVB in cancer recurrence 
reduction rates.  
• The review did identify a relation 
between PVB and decreased levels of 
inflammation and improved immune 
response compared to general 
anesthesia and opioid-based 
analgesia. 
Introduction 
Statement of 
the problem  
 
Were authors’ 
affiliations provided? 
Did the review have 
support of at least 2 
authors? 
 
Was the study objective 
& rationale given? 
Terms defined?  
 
Was there enough 
• The author’s affiliations were not 
provided. 
• The study was objective and provided 
adequate rationale for the review. The 
authors use statistics to support the 
purpose. Peres-Gonzales et al. (2017) 
identify breast cancer as the second 
most common cancer and the 5th 
cause of death related to cancer with 
30%-40% of these patients dying due 
to metastatic spread of the disease. 
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information on the 
population studied, the 
intervention given, and 
the outcomes considered 
The authors identify surgical 
intervention as the primary treatment. 
• The authors identified the aim to 
assess the impact that regional 
anesthesia, on metastasis, 
inflammation, immunosuppression 
during breast cancer surgery, and 
recurrence of cancer after surgical 
intervention. 
Hypotheses 
or research 
questions 
Is the main question or 
problem clear and 
focused? PICO format 
used? 
 
 
• The hypothesis was clear and focused 
with the use of PICO: the use of a 
regional anesthesia technique could 
be associated with better long-term 
outcomes after breast cancer surgical 
intervention.  The audience was able 
to clearly identify the population, 
intervention and outcome. The 
comparison was not identified but 
discussed in different parts of the 
review. 
Literature 
Review  
Was the literature review 
up-to-date and based 
mainly on primary 
sources? 
 
Did the review provide a 
state-of-the-art synthesis 
of evidence on the 
problem? 
 
Did the literature review 
provide a strong basis 
for the review? 
• The literature review was up-to-date 
including primary sources from 2005-
2017. The review provided a clear 
understanding of the problem. Breast 
cancer was identified as the second 
most common cancers and identify 
metastatic recurrence as the primary 
cause of breast cancer related deaths. 
The literature provided the reader 
with an understanding of the primary 
therapy being surgical intervention 
for this population. Evidence was 
provided from primary sources of the 
association with surgical trauma and 
cell proliferation. Anesthetic drugs, 
anesthesia technique and opioid use 
were also included as having 
involvement in the metastatic 
process.  
Search 
Criteria 
Methods 
Please describe the 
search criteria the 
authors used.  
 
Inclusion / exclusion 
criteria listed. Was there 
enough information on 
• The systematic literature included 
search portals: PubMed, 
EMBASE,MEDLINE, the Cochrane 
Trials Register, and Web of Science 
databases. The search was conducted 
by all authors from inception through 
December 2017. Methods of the 
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the population studied, 
the intervention given 
and the outcomes 
considered? 
 
Comprehensive, 
systematic search used? 
Explicit criteria listed? 
Search terms and 
databases used? grey 
literature discussion?  
 
Is it likely that all 
relevant studies 
(published and 
unpublished) were 
identified? 
Cochrane Collaboration and the 
Preferred Reporting Items for 
Systematic Reviews and Meta-
analyses statement were used for 
strategy. Searched terms included 
Breast Cancer, Anesthetic Technique, 
Anesthesia, Epidural Anesthesia, 
Regional Anesthesia, Disease Free 
Survival, Progression Free Survival, 
Recurrence and Metastasis. Filters 
were added, including Randomized 
Controlled Trials (RCT), Controlled 
Trials, and Human. Bibliographies of 
retrieved studies were also examined. 
Added to the search were survival 
and metastasis-related, to avoid 
missed studies.  
• Inclusion criteria included; RCT, 
observational cohort studies 
published in English, adult patients, 
patients undergoing breast cancer 
surgery, regional anesthesia 
technique for BC surgery, effects of 
regional anesthesia or analgesia on 
post op outcomes, inflammatory 
process and immune function, cancer 
recurrence rates, disease free 
survival. Exclusion criteria included; 
in vitro and animal studies, case 
reports.  
• Four hundred and sixty-seven 
relevant studies were located, 121 
underwent abstract review, 107 
excluded for not meeting inclusion 
criteria, 15 studies were included.  
• Only published studies included in 
the review. 
Framework Did authors use a model 
or guideline for SRs and 
inclusive of the model 
they used? 
• The Preferred Reporting Items for 
Systematic Reviews and Meta-
analyses (PRISMA) was used to 
complete this review.  
Included 
studies of the 
Systematic 
Review 
 
Was sufficient 
information given on 
chosen studies to 
determine validity of the 
research? 
• Two authors independently reviewed 
titles and abstracts for inclusion to 
this review. Any disagreements were 
settled by a third author. 
• The Newcastle-Ottawa scale was 
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Were PICO and 
methodological quality 
of each study addressed 
in table format? Did the 
authors critically 
appraise each study? 
 
Were the criteria used to 
select articles for 
inclusion predetermined, 
clearly stated, and 
appropriate? 
utilized to grade the quality of the 
retrospective studies. Scores >8 were 
considered high quality and included 
in the review.  
• The Jadad score was utilized to assess 
the methodological quality of the 
RCTs. Scores of >3 were indicative 
of a high-quality study and were 
included in the review.  
• PICO and methodological quality of 
study were organized in table format 
for review. 
Results: 
 
Were results of review 
clearly described in a 
critical fashion? In table 
and narrative?  
 
Were results similar 
across studies? Was a 
cross-analysis 
performed?  
 
Are the results of all 
included studies clearly 
displayed? If the study 
results were combined, 
was it appropriate to do 
so?  
How precise are the 
results? Do the results of 
the studies have 
significant findings, and 
do the researchers 
provide evidence of 
such? Did the 
interpretation of the 
review’s results 
accurately reflect the 
actual results? Are 
results generalizable? 
• Results were clearly defined in each 
category, in both table and narrative 
format. 
• Results varied across studies. A cross 
analysis was not performed.  
• Results were briefly included for all 
studies involved, with clear 
explanations.  
• Results are defined and briefly 
explained as to what type of 
correlation, positive or negative, were 
found between PVB analgesia and 
overall survival. 
• The review found a low level of 
supportive evidence of the impact of 
regional anesthesia’s impact on 
survival outcomes after surgical 
intervention for breast cancer.   
 
Meta-
analysis 
 
Was a meta-analysis 
performed? Please 
describe.  
 
How are meta-analysis 
• A Meta-analysis was not conducted 
because of lack of uniform definitions 
among primary outcomes. 
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results displayed?  
 
Was a rationale for the 
statistics used provided?  
 
Was statistical 
significance tested? 
Discussion Was the discussion 
section clear and 
comprehensive? 
 
What do the main 
findings mean  
 
Are the conclusions 
justified  
 
How do the findings 
compare with what 
others have found?  
 
Application of findings  
 
Were limitations 
discussed? Implications? 
• The discussion section was clear and 
easy to understand.  
• Perez-Gonzales et al. (2017) 
identified only one of the RCTs 
positively tested the hypothesis: PVB 
reduced the rate of recurrence after 
breast cancer surgery. The study was 
inadequately powered and noted 
results should be taken with caution.  
• No association was made between 
anesthesia technique and 
improvement in survival in 3 of the 
studies. 
• The review identified significant 
limits including: the retrospective 
designs, various statistical analysis, 
selection bias, heterogeneity in type 
of anesthesia technique used, and 
lack of detailed information on tumor 
description including size, stage, and 
adjuvant treatments 
(chemo/radiation). 
• The review concluded a lack of 
convincing data to support or contest 
regional PVB as a cancer recurrence 
reducer or improver in survival rates. 
The data supported PVB’s effect on 
decreasing the inflammatory response 
and noted its possible prevention on 
immune suppression during surgery. 
A cross analysis was not performed 
and could impact validity of the 
study. 
• The need for future large RCT to 
further explore the anti-inflammatory 
effects of PVB and propofol as a 
combination to prevent immune 
suppression is recommended. 
Propofols anti-inflammatory 
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properties will also be explored 
further. 
Note. PVB= paravertebral regional block; GA= general anesthesia; RCT= randomized 
control trial; NK= natural killer; GF= growth factor. 
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Appendix B-1 
Exadaktylos, Buggy, Moriarty, Mascha, and Sessler. (2006). Can anesthetic technique for 
primary breast cancer surgery affect recurrence or metastasis?  
Purpose Design Findings 
To compare 
local cancer 
recurrence and 
metastases in 
patients who 
underwent 
breast cancer 
surgery with 
and without 
paravertebral 
regional 
analgesia. 
Retrospective Study • One hundred and twenty-nine 
patients who underwent surgical 
mastectomy and axillary clearance 
were reviewed. Sixty-five patients 
were excluded for not meeting 
inclusion criteria. A total of 50 
patients for PVB and 79 patients for 
GA were included.  
• The median pain score was noted 
less in PVB than GA with morphine 
analgesia. At 4 hours PVB vs. GA 
1:3 (p = 0.02), at 24 hours 1:2 (p = 
0.04). 
• Incidence of therapies after surgical 
treatment did not differ between 
groups significantly (p > 0.05) 
• Recurrence or metastasis 
documented in 3:50 PVB patients 
(6%) and 19:79 GA patients (24%) 
• Adjusted follow up done with the 
Kaplan-Meier analysis; PVB showed 
slower times to recurrence (p = 
0.013). 
• Multivariable analysis adjusted for 
histologic grade and axillary node 
involvement (p = 0.25 and p = 0.01), 
PVB risk of recurrence was 
significantly less HR 0.21, (p = 
0.012) 
• Exadaktylos et al. (2006) concluded 
the PVB for breast cancer surgical 
patients reduced the risk of 
recurrence or metastasis 
• Exadaktylos et al. (2006) concluded 
that regional anesthesia may play an 
important role in preserving immune 
function during surgical intervention. 
This technique is thought to decrease 
the GA and opioid requirements that 
are known to suppress the immune 
system, and thus reduce the risk of 
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tumor metastasis and/or recurrence. 
• PVB for breast cancer surgery 
reduced the risk of 
recurrence/metastasis during the 2 to 
4 year follow up. 
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Appendix B-2 
Biki, Mascha., Moriarty., Fitzpatrick, Sessler, and Buggy. (2008). Anesthetic technique 
for radical prostatectomy surgery affects cancer recurrence: Retrospective analysis 
Purpose Design Findings 
To test the 
hypothesis 
that recurrence 
of prostate 
cancer is less 
common with 
combined 
general 
anesthesia and 
epidural 
analgesia than 
with general 
anesthesia 
alone.” 
 
Retrospective Study • EA group had higher ASA statuses 
ASA III 8 vs. 3 (EA vs. GA) (p = 
0.11), and shorter surgeries (1.8 +/- 
0.4 hours vs. 2.0 +/- 0.5 hours) (p = 
0.06). EA group had more 
postoperative complications 
including pneumonia, postoperative 
bleeding and other respiratory 
complications. These variables were 
included in the multivariate model. 
• Patients who received EA had a 
lowered estimated risk of recurrence 
to that of GA group, hazard ratio 
(HR) 0.34, 95% CI = [0.19-0.61]. 
• In the univariate analysis, the Cox 
Regression HR for the Gleason score 
was 1.53, 95% CI = [1.29-1.80], (p = 
0.001), preoperative PSA HR 1.01, 
95% CI = [1.00-1.03], the size of the 
tumor HR 1.25, 95% CI = [1.13-
1.38], and length of surgery HR 1.79, 
95% CI = [1.09-2.92] were noted to 
have relation with recurrence. 
• After adjustments were made for the 
above variable, EA had a lower risk 
for recurrence compared to GA HR 
57%, 95% CI = [17-78%], 
multivariable cox regression model 
showed HR 0.43%, 95% CI = [0.22-
0.83], (p = 0.012). 
• The sensitivity analysis was used to 
account for potential bias due to loss 
of follow-up after four years. 
Anesthetic group was reviewed 
against recurrence for the first 3 
years, the univariable (p = 0.012) and 
multivariable (p = 0.033) results 
were similar to the full year data 
results. 
• Propensity score matching was also 
used (n = 71 each group) which 
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assessed the relation between cancer 
recurrence and anesthetic technique. 
After matching, little significance 
was noted between GA and EA 
groups.  
• To further the investigation, the 
propensity matched pairs were 
assessed using the cox regression. 
Results showed EA at 52% less to 
have recurrence compared to that of 
the GA group (Univariable HR 0.48, 
95% CI = [0.23-1.00], (p = 0.049)), 
multivariable cox regression showed 
HR 0.51, 95% CI = [0.25-1.06], (p = 
0.07). 
• The authors identified a 57% lower 
risk in the EA group for cancer 
recurrence compared to GA group.  
• Propensity matching showed similar 
results of 52% lower risk in the EA 
group for cancer recurrence 
compared to the GA group.  
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Appendix B-3 
Lin, Liu, Tan, Ouyang, Zhang, and Zeng. (2011). Anesthetic technique may affect 
prognosis for ovarian serous adenocarcinoma: a retrospective analysis. 
Purpose Design Findings 
To test the 
hypothesis that 
patients with 
ovarian serous 
adenocarcinoma 
who had 
surgery with 
epidural 
anesthesia and 
analgesia would 
have better 
long-term 
outcome than 
those who were 
given general 
anesthesia and 
IV opioid 
analgesia. 
Retrospective Study • Three- and 5-year overall survival 
rates-78% and 61% were found in 
the EA group, and 58% and 49% in 
the GA group. Both groups had 
attrition with lack of follow-up.  
• Results suggest patients who 
underwent surgical intervention for 
ovarian serous adenocarcinoma with 
EA had better survival outcomes 
than GA patients.  
• Univariable Cox Regression showed 
a higher risk of death for GA 
compared to EA with HR of 1.818, 
95% CI = [1.048–3.153]. The length 
of surgery, pre-op status, FIGO stage 
and histological grade, residual 
tumor, and lymph metastasis 
impacted survival rate in univariable 
analysis.  
• The Kaplan–Meier survival rate 
estimates and 95% CIs at follow-up 
times showed that EA demonstrated 
greater survival rates than GA. The 
1-, 3-, and 5-yr overall survival rates 
were as follows:  
EA: 96%, 95% CI = [92–99%], 78% 
(95% CI = [70–86%], and 61%, 95% 
CI = [52–71%]. 
GA: 78%, 95% CI = [64–91%], 
58%, 95% C =, [42–74%], and 49%, 
95% CI = [32– 65%].  
• After adjusting for data 
characteristics: pre-op status, FIGO 
stage, histological grade, residual 
tumor, and lymph metastasis, the 
Multivariable Cox Regression model 
was used showing the GA group had 
a 21.4%, 95% CI = [7.5– 43.1%] 
increased mortality rate compared to 
the EA group, with a corresponding 
HR of 1.214, 95% CI = [1.075–
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1.431], (p = 0.043). 
-the association between the 
anesthetic group and overall survival 
rate were assessed using the first 5 
years of data. The univariable and 
multivariable associations were 
similar (p = 0.034 and 0.045). 
Propensity score matching was used 
to assess the association between 
anesthesia type/technique and 
survival rate. Twenty-nine matched 
pairs were obtained (n = 58 patients). 
Anesthesia type and survival rate on 
the propensity-matched pairs using 
Cox’s regression were also 
reviewed. GA group: univariable HR 
of 1.322, 95% CI = [1.083– 1.697], 
(p = 0.039) compared with EA 
group. A multivariable Cox 
regression analysis on the 
propensity-matched patients resulted 
in an HR of 1.201, 95% CI = [1.015–
1.502],  
(p = 0.042). 
• Analysis suggests that the use of 
epidural anesthesia for patients with 
ovarian serous adenocarcinoma may 
have a reduction in mortality during 
initial follow-up years.  
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Appendix B-4 
Cummings, Xu, Cummings, and Copper. (2012). A Comparison of Epidural Analgesia 
and Traditional Pain Management Effects on Survival and Cancer Recurrence after 
Colectomy A Population-based Study 
Purpose Design Findings 
To compare 
cancer 
recurrence and 
survival rates 
of colorectal 
surgical 
patients who 
received 
epidurals vs. 
those who did 
not.  
Population-based study Association Between Epidural and Overall 
Survival.  
• 5-yr overall survival was 61% 
(epidural group) and 56% (traditional 
pain management group).  
• The median survival was 7.24 years 
(95% CI = [6.96, 7.51]) (Epidural) 
and 6.09 yr. (95% CI = [5.97, 7.51] 
(non- epidural). 
• Kaplan–Meier survival curves for the 
two groups; the curves were 
significantly different (log-rank test p 
< 0.001).  
• Model checking was based on 
cumulative sums of Martingale based 
residuals and the models had a good 
fit. The study adjusted for multiple 
patient characteristics and identified a 
significant association between 
epidural use and improved overall 
survival, adjusted hazard ratio = 0.91, 
95% CI = [0.87, 0.94], (p < 0.001).  
• The adjusted model was used. 
Several covariates were predictors of 
increased mortality: age, male, 
African American, single, higher 
comorbidity scoring, higher staging, 
poorly-differentiated tumors, distal 
location, diagnosis before 2005, and 
recipient of a blood transfusion were 
all associated with a higher hazard 
ratio for death. The association 
between blood transfusion and 
mortality was predominantly strong, 
adjusted hazard ratio=1.34,95% CI = 
[1.28,1.40], (p < 0.001). 
Association B/T Epidural Use and 
Colorectal Cancer Recurrence. 
• Overall 4-yr cancer recurrence was 
14.3% in the epidural group and 
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13.8% in the nonepidural group. In 
the unadjusted logistic regression, an 
association existed between epidural 
use and increased cancer recurrence, 
odds ratio= 1.14,95% CI = 
[1.05,1.24], (p = 0.002).  
• Adjusting for demographic and 
clinical covariates, no significant 
difference was noted in the odds of 
recurrence between the groups, odds 
ratio= 1.05, 95% CI = [0.95, 1.15], (p 
= 0.28). Recipients of blood 
transfusion showed a significant 
relation to cancer recurrence in the 
adjusted model, odds ratio = 1.14, 
95% CI = (1.03, 1.25), (p = 0.01). 
• Results suggest early beneficial 
effects of epidural use on all 
mortality after colorectal resection 
for cancer.  
• The study found epidural use to be 
associated with improved survival 
rates in the colorectal cancer patient 
who underwent resection, but no 
significant relationship was made 
between epidural use and a reduction 
in cancer recurrence.  
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Appendix B-5 
Chen, and Miao. (2013). The effect of anesthetic technique on survival in human cancers: 
A Meta-analysis of Retrospective and Prospective Studies 
Purpose Design Findings 
To test a given 
hypothesis that 
patients with 
cancer who 
underwent 
surgical 
intervention 
under epidural 
anesthesia vs. 
those who 
underwent 
general 
anesthesia 
would have 
better 
outcomes; 
reduced cancer 
recurrence and 
improved 
overall 
survival rates. 
 
 
Meta-analysis • For the EA group, 12,000 cases were 
included. For the GA group, 35,000 
cases were included.  
• End points that were reviewed 
included, recurrence free survival 
(RFS- from day of surgery to first 
disease relapse from primary cancer) 
and overall survival (OS- from day of 
surgery until death). 
• For the OS- 7 studies were included, 
with 4 studies showing a significant 
relationship between that of EA and 
improved OS.) 
• For the RFS- 11 studies with 
numerous cancer types were included 
in the meta-analysis. Out of the 11 
studies, 4 showed positive relation 
between improved RFS and EA.  
• Authors identified heterogeneity 
significance in the HRs for OS; 0.84 
95% CI = [0.74 to 0.96], 
heterogeneity for chi-squared 0.063 
and for I-squared 49.8%. The random 
effects model was utilized due to the 
I-squared cut off 25%. This model 
was used to analyze data to locate a 
favorable relationship between OS 
and EA vs. GA.  
• Significance was identified between 
heterogeneity for HRs and RFS: 
heterogeneity chi-squared = 88.0, I-
squared = 88.6%, (p > 0.001).  
• The random effects model was also 
used for analysis and with a 
HR=0.88, 95% CI = [0.64 to 1.22], (p 
= 0.457), no association was 
identified between EA and RFS. 
• This meta-analysis suggested a 
probable relationship between the use 
of epidural anesthesia/analgesia and 
improved overall survival in patients 
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undergoing colorectal cancer surgery. 
Chen and Miao (2013) note this 
analysis does not support a 
relationship between epidural 
anesthesia and cancer control. The 
need for prospective studies was 
recommended to determine a 
causative association between 
survival and epidural use 
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Appendix B-6 
Jang, Lim, Shin, Kwon Ko, Park, Hyun Song, and June Kim, B. (2016). A comparison of 
regional and general anesthesia effects on 5 years survival and cancer recurrence after 
transurethral resection of the bladder tumor: a retrospective analysis 
Purpose Design Findings 
To determine 
if mortality 
from bladder 
cancer is 
different 
between 
patients who 
underwent 
surgical 
intervention 
with general 
anesthesia vs. 
regional 
anesthesia.  
Retrospective Study • No significance was shown in 
logistic regression analysis for 
between-groups: gender, height and 
weight, pathologic stage of cancer 
(I/II), hospital length of stay, history 
of diabetes, history of hypertension, 
ASA status, history of smoking, and 
history of BCG treatment. The only 
significance was shown with age (p 
= 0.029) and duration of anesthesia 
(p = 0.000). Patients were noted to 
be (67.5 +/- 9 years) in the GA group 
and (62.4 +/- 10 years) in the RA 
group. The surgical time length was 
noted 23 minutes longer for GA 
compared to RA.   
• The GA recurrence rate was noted at 
(0.5 +/- 0.8 years) compared to that 
of RA (0.9 +/- 1.4 years). The 5-year 
follow up was noted to be higher in 
the RA group.  
• For the recurrence free time, the GA 
group time frame was (45 +/- 22 
months) and for the RA group (40 +/- 
24 months).  
• Chi-squared test of 5-year survival 
was performed identifying a higher 
survival in the RA group (96.3%) vs. 
the GA group (87.5%) and was not 
statistically significant (p = 0.099).  
• Logistic Regression was completed 
for 5- year survival noted age data 
with an odds ratio of 0.847, (p = 
0.005), therefore identified as the 
primary contributor to a reduced 5-
year survival after surgical 
intervention.  
• Multivariate correlation analysis was 
performed to explore age association 
with survival, (coefficient = -0.272, p 
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= 0.000), and age association with 
recurrence (coefficient = 0.168, p = 
0.033).  
• To further evaluate age as a primary 
contributor to shorter 5-year survival, 
Spearman Rho correlation analysis 
was performed. A significant 
correlation was made with age and 
recurrence (rs = 0.168, p = 0.033) 
and survival (rs = -0.272, p = 0.000). 
• Younger patients showed longer 
recurrence free times (coefficient = -
0.172, p = 0.029), by the person 
analysis. 
Anesthesia duration (coefficient = 
0.363), (p = 0.000) showed 
correlation with recurrence. The 
longer the length of anesthesia time, 
the shorter the recurrence free time 
(coefficient = -0.169), (p = 0.032). 
• Partial correlation analysis was used 
to identify a relationship on 5-year 
influence. Controlling for extra 
variables, age showed (coefficient = -
0.186), (p = 0.024). RA (coefficient 
= -0.167, (p = 0.044) showing great 
5-year survival, compared to GA. 
• Overall, the study found that 5-year 
survival was higher in patients who 
received regional anesthesia vs. those 
who received general, through partial 
correlation analysis. The association 
was not significant with logistic 
regression or chi-squared test. 
Authors of the retrospective study 
identify the need for larger 
prospective studies to further 
determine if a relationship exists 
between survival rates and anesthesia 
type.  
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Appendix B-7 
Cho, Lee, Kim, Park, Park, Oh, Ho Lee, and Koo. (2017). The effects of perioperative 
anesthesia and analgesia on immune function in patients undergoing breast cancer 
resection: a prospective randomized study 
Purpose Design Findings 
To compare 
the effects of 
two different 
types of 
anesthetic/ 
analgesic 
methods on 
the natural 
killer cell 
cytotoxicity of 
patients 
undergoing 
elective 
surgery for 
breast cancer.  
A Prospective 
Randomized Study 
• Baseline NKCC (%) between the two 
groups (p = 0.082). Compared with 
the baseline value, NKCC (%) 
increased in the Propofol-Ketorolac 
group [15.2 (3.2) to 20.1 (3.5)], (p = 
0.048), whereas it decreased in the 
Sevoflurane-Fentanyl group [19.5 
(2.8) to 16.4 (1.9)], (p = 0.032). The 
change of NKCC over time was 
significantly different between the 
groups (p = 0.048).  
• Pain scores during 48 hours after 
surgery and post-surgical 
inflammatory responses were 
comparable between the groups.  
• IL-2 concentration showed no 
significant postoperative changes in 
either group preoperative to 
postoperative; 2.75 (1.61, 4.97) to 
3.16 (1.97, 5.52), (p = 0.721) in the 
P-R-K group, and 2.65 (2.15, 3.96) to 
2.81 (2.00, 4.62), (p = 0.523) in the 
S-R-F group. The change of IL-2 
levels over time was not significant 
between the groups (p = 0.620). 
• Inflammatory response: Changes of 
total leukocyte, neutrophil, and 
lymphocyte counts and NLR over 
time were not significant between the 
groups. Lymphocyte counts after 
surgery decreased in both groups 
compared to the baseline, but the 
difference was significant only in the 
S-R-F group (p = 0.037).   
• Postoperative outcomes: 1 patient in 
the S-R-F group had recurrence in 
the contralateral breast 18 months 
after surgery and underwent a partial 
mastectomy. No patient had 
metastasis in either group within two 
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years after surgery. 
• Researchers concluded Propofol 
anesthesia and postoperative 
Ketorolac analgesia in breast cancer 
surgery demonstrated a better effect 
on the immune function by 
preserving NKCC compared to 
Sevoflurane anesthesia and 
postoperative Fentanyl analgesia. 
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Appendix B-8 
Peres-Gonzales, Cuellar-Guzman, Soliz, and Cata. (2017). Impact of reginal anesthesia 
on recurrence, metastasis, and immune response in breast cancer surgery: a systematic 
review of the literature. 
Purpose Design Findings  
To assess the 
impact of 
regional 
anesthesia on 
metastasis, 
inflammation, 
and 
immunosuppre-
ssion during 
breast cancer 
surgery, and 
recurrence of 
cancer after 
surgical 
intervention. 
Systematic Review of the 
Literature  
• Six studies investigated the 
association between PVB/ propofol 
and volatile GA/opioid-based 
anesthesia on cancer recurrence 
rates, overall survival, recurrence 
free survival, and cancer-specific 
survival.  
• All studies, except one, were 
retrospective and included sample 
sizes ranging from 60 to 1107 
patients. The only RCT showed no 
difference in rate of recurrence 
between PVB vs. GA (Finn et 
al.,2017). 
• For the retrospective studies, only 1 
study showed any association of 
PVB and the reduction of cancer 
recurrence. Exadaktylos et al. 
(2006) showed the patients who 
received regional anesthesia with 
PVB/propofol, had a slower time to 
the rate of cancer recurrence vs. the 
GA group. Recurrence time was 
24% for the GA group vs. 6% for 
the PVB/propofol group HR 0.21, 
(p = 0.012) 
• Four RCTs studied the impact of 
PVB on Biomarkers. Studies 
showed minimal to no difference in 
inflammatory biomarkers and 
markers of stress response between 
regional and general anesthesia 
(Deegan et al., 2010; Looney et al., 
2010; O’Riain et al., 2005; Sultan et 
al., 2013).  
• Two studies investigated GF 
concentrations and effects of 
angiogenesis/proliferation in the 
PVB/propofol group and the GA 
group. The concentrations of GF in 
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the post-operative period were 
studied. Results showed no impact 
on concentrations in relation to 
anesthesia technique used (Looney 
et al., 2010; O’Riain et al., 2005)  
• Two studies identified women who 
received GA. A significant decrease 
in NK cell function and count were 
noted (Ramirez et al., 2015; Woo et 
al., 2015). These authors 
hypothesized that regional 
anesthesia could amend the 
suppressive effect of surgery, and 
effect on human cells from volatile 
anesthetic impact and opioids.  
• Three studies focused on 
inflammatory mediators and 
surgical stress. Small difference 
was noted in markers of 
inflammation and stress response 
between regional and general 
anesthesia (Deegan et al., 2010; 
O’Riain et al., 2005; Sultan et al., 
2013).  
• The Impact of PVB on cell immune 
response and cancer cell function 
regarding apoptosis and cancer cell 
proliferation was reviewed in 4 
RCTs. Deegan et al. (2009) showed 
a reduction in breast cancer cells in 
the PVB/Propofol group. Desmond 
et al. (2015) showed an increase in 
NK cells and T-helper cells 
numbers in breast cancer tissue in 
the PVB/Propofol group. Buckley 
et al. (2014) presented the 
PVB/propofol group preserved NK 
activity. Jaura et al. (2014) exposed 
cancer cell apoptosis was reduced 
in the GA group but cancer cell 
capability was the same in both 
groups. Women who received GA 
in all studies showed significant 
decrease in NK cell function and 
count. An additional hypothesis was 
made stating regional anesthesia 
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could ameliorate the suppressive 
effects from surgery, volatile 
anesthetics and opioid on the cells.  
• Two studies involving anesthetic 
effect during breast cancer surgery 
on proliferation and apoptosis of 
cells showed antiapoptopic effects 
in women who received a GA and 
inhibition of cell proliferation after 
exposure to PVB (Deegan et al., 
2010; Jaura et al., 2014). 
• Two RCTs presented data that after 
mastectomy surgery, women who 
received PVB anesthesia showed 
NK cell preservation vs. the women 
who received GA (Buckley et al., 
2014; Desmond et al., 2015). 
• The review found a low level of 
supportive evidence of the impact 
of regional anesthesia on survival 
outcomes after surgical intervention 
for breast cancer.   
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Appendix C 
Cross Table Analysis 
Author Exadaktylos et al. (2006). 
Key Findings -Paravertebral anesthesia and analgesia 
reduce the chance of recurrence/metastasis 
after breast cancer surgery compared to 
general anesthesia.  
 
-Recurrence/metastasis was documented in 
6% of patients in the paravertebral group 
and 24% in the general anesthesia group.   
Recommendations -Limited by the retrospective design and 
small sample size. 
 
-Authors suggests the need for prospective 
trials to further evaluate the impact of 
regional anesthesia with analgesia on 
cancer recurrence.  
Author Biki et al. (2008). 
Key Findings -Patients who received general anesthesia 
with epidural analgesia had a 57% reduced 
risk of cancer recurrence compared to 
patients who received general anesthesia 
with postoperative opioids. 
 
-Propensity score matching was used to 
even the epidural analgesia group and the 
general with opioid analgesia group to 
improve the balance and reliability of the 
study. After matching, a 52% risk reduction 
was noted. This showed similar results to 
the 57% risk reduction with general 
anesthesia with epidural analgesia 
compared to the general anesthesia with 
opioid analgesia.  
Recommendations -Limited by uneven group sizes, unequal 
ASA scores different complications and 
different surgery lengths.  
 
-Other limitations include non-
randomization, non-standardized clinical 
care,  
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-Authors suggests the need for larger 
randomized controlled trials. 
Author Lin et al. (2011). 
Key Findings -Survival rates for three years following 
surgical intervention showed survival rates 
of 78% for the epidural anesthesia group, 
compared to 58% in the general anesthesia 
group. 
 
Five year follow up showed survival rates 
of 61% in the epidural anesthesia group vs. 
49% in the general anesthesia group. 
 
The study suggests the use of epidural 
anesthesia during the surgical intervention 
of ovarian serous adenocarcinoma may 
reduce mortality during early years 
following surgery.  
Recommendations -The authors identify testable possibilities.  
 
-Important limitations to the study include; 
non-randomization, uneven sample sizes 
and confounding variable impact that 
cannot be excluded.  
 
-Authors identify the need for randomized 
controlled trials to compare epidural 
anesthesia and general anesthesia and the 
impact on ovarian cancer outcomes.  
Author Cummings et al. (2012). 
Key Findings -This cohort study identified five-year 
survival was greater in colon cancer 
patients who underwent colon resections 
with epidural anesthesia compared to 
general anesthesia (61% vs. 55%). 
-Cancer recurrence- measured using 
chemotherapy or radiation, however, did 
not significantly differ between the two 
groups (14.3% epidural vs. 13.8% general).  
 
Recommendations -Authors identify that compared to earlier 
studies, the results of this study are minor at 
best.  
-Authors identify the need for clinical trials 
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to evaluate the differences in tumor 
biology, different patient populations and 
long term follow up obstacles.  
-Authors acknowledge significant 
association between intraoperative blood 
transfusions and increased cancer 
recurrence and mortality and identify the 
need for further investigation into blood 
transfusions and anesthesia impacts on 
colon cancer patients for cancer recurrence.  
-Limitations to the study include; weakness 
of an observational study, selection bias, 
unmeasured confounding variables, limited 
clinical data (types of drugs administered), 
and timing of epidural placement. 
Author Chen and Miao. (2013). 
Key Findings -SEER based study showed significant 
positive outcomes on all-cause mortality of 
patients with colorectal cancer after 
epidural use.  
 
-The Prospective Master trial did not 
identify any difference in overall survival 
for patients with abdominal cancers 
undergoing surgical intervention with 
epidural anesthesia. 
 
-Results suggest that the use of epidural 
anesthesia may be associated with 
improved overall survival in the surgical 
cancer patient.  
 
Recommendations -Authors identify the need for prospective 
studies to validate a causative association 
between survival and epidural use  
Author Jang et al. (2016). 
Key Findings -Five-year survival for regional anesthesia 
(spinal or epidural) was 96% vs. 87.5% for 
general anesthesia for patients undergoing 
bladder cancer surgical intervention- found 
by partial correlation analysis. 
 
-Older age was a significant factor that 
reduced survival in both groups (p = 0.001) 
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-Chi-square and logistic regression did not 
find significant association between the 
two. 
 
-Therefore, the effects of general vs. 
regional anesthesia on cancer recurrence 
and 5-year survival after bladder resection 
cannot be certain.  
Recommendations -Authors acknowledge the need for larger 
prospective studies to determine a causative 
association between regional anesthesia and 
survival.  
 
Author Cho et al. (2017).  
Key Findings -Natural killer cells increased with the use 
of propofol and ketorolac group (15.2 to 
20.1, p = 0.048) and decreased in the 
sevoflurane and fentanyl group (19.5 to 
16.4, p = 0.032).  
 
-No metastasis found in either group. 
 
-Recurrence found in contralateral breasts 
of sevoflurane/fentanyl group patient.  
 
-Incidence between the two groups for 
short-term recurrence was not significant 
between groups.  
 
-Findings in this study are consistent with 
the hypothesis of avoiding volatile 
anesthetics (general anesthesia) and opioids 
to potentially decrease immunosuppression 
during surgery and decrease the risk of 
cancer spread. 
Recommendations -Authors recommend further investigation 
and studies to identify anesthetic methods 
to avoid immunosuppression in cancer 
surgery.  
Author Pere-Gonzales et al. (2017). 
Key Findings -This systematic review indicated that there 
was no data to disprove or support the use 
of paravertebral blocks for cancer 
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recurrence reduction or cancer survival 
improvement.  
 
-Authors do identify an association between 
paravertebral block and a decrease in 
inflammation and thus better overall 
immune system response compared to that 
of general anesthesia.  
Recommendations -Authors identify a current randomized 
control trial currently enrolling cancer 
patients with random assignment to 
epidural anesthesia/analgesia and general 
anesthesia with opioid analgesia to identify 
the better anesthetic choice for cancer 
patients. This study is said to finish 
recruitment in 2019.   
 
 
 
